TW475927B - Arylalkyl-pyridazinone - Google Patents
Arylalkyl-pyridazinone Download PDFInfo
- Publication number
- TW475927B TW475927B TW085102257A TW85102257A TW475927B TW 475927 B TW475927 B TW 475927B TW 085102257 A TW085102257 A TW 085102257A TW 85102257 A TW85102257 A TW 85102257A TW 475927 B TW475927 B TW 475927B
- Authority
- TW
- Taiwan
- Prior art keywords
- ethyl
- ketone
- chloride
- tetrahydro
- trap
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Abstract
Description
475927 A7 B7 五、發明説明(1 ) 本發明係關於式I化合物及其生理上可接受之塩類 1 R2475927 A7 B7 V. Description of the invention (1) The present invention relates to compounds of formula I and their physiologically acceptable species 1 R2
(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)
)=〇 I) = 〇 I
N Q-R5 其中 R 1及R 2 各別獨立地係爲Η或A, R3及R4 各別獨立地係爲一 0H,一〇R1(D, — S — Ri〇,一 S〇-Ri〇,一 SO - R,, — S〇2R10,Ha5 ,甲二氧基,一 N〇2 ,一NH2 ,—NHR10 或一 NR10R1:L, R 5 係爲苯基,其係未經取代或經R6及/或 R 7之單或雙取代, Q 係不存在或爲Ci-6烷撑基, R6及R7 各別獨立地係爲—NH2 ,一 NR8R9 ,一 NHRI0, 一 NRioRU, 一N〇2 , Ha^ , 一 CN , - 0A,一 COOH 或一 COOA, 經濟部中央標準局員工消費合作社印製 R8,R9各別獨立地係爲Η,可由1至5個氟及/ 或氯原子取代之〇1-8酿基’一(^〇〇八,—30_八, 一 S〇2A ,一 CONH2 ,一 CONHA, 一 C0NA2 ,一 C0 — COOH,一 C〇 一 CO〇A, 一 CO — C0NH2 ,一 CO — CONHA 或一 CO — C 0 N A 2 , A 係爲Ci-e烷基,其係可由1至5個氟及/或氯 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-4 - 475927 A7 _ B7 五、發明説明(2 ) 原子加以取代, R 1Q及R 11 各別獨立地係爲A,C 3-7環烷基, C4-8甲撑基環烷基或C2-8烯基,以及 H a 係爲氟,氯,溴或碘。 類似之化合物係揭示於D E 1 9 5 0 2 6 9 9.3 0 本發明係基於發現新穎之化合物,其係具有有用之性 質,特別係可用於產製藥物。 式I化合物及其塩類具有有用之藥理性質以及良好之 可耐受性。詳言之,其係具有對磷酸二酯酶IV之抑制作用 ,且可用於治療氣喘疾病。可藉由,例如,?.0133〇11,人-eta allergologica 438 - 4 47 ( 1 97 1 )所揭示之方法, 測定該抗氣喘作用。 該化合物額外地顯示對TNF(腫瘤壞死因子)之形 成具有抑制作用,因而係適合用於治療過敏及發炎疾病, 自體免疫疾病,及移植排斥反應。其亦可用於治療記憶性 疾病。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 因此,式I化合物可充作人體及獸用藥物中之藥學活 性化合物。其係可進一步充作用於製備其他藥學活性化合 物之中間體。 於是,本發明係關於式I化合物及其塩類,以及該化 合物及其塩類之製法,其特徵係在於令式II化合物 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)-5 - 475927 A7 B7 五、發明説明(N Q-R5 where R 1 and R 2 are each independently Η or A, and R 3 and R 4 are each independently 0 H, 10 R 1 (D, — S — Ri 0, 1 S 0 — Ri 0. , -SO-R ,, -S〇2R10, Ha5, methyldioxy, -NO2, -NH2, -NHR10 or -NR10R1: L, R5 is phenyl, which is unsubstituted or R6 And / or single or double substitution of R7, Q is absent or is Ci-6 alkylene, R6 and R7 are each independently -NH2, -NR8R9, -NHRI0, -NRioRU, -N02, Ha ^, one CN, -0A, one COOH or one COOA, printed by R8 and R9 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, each of which is Η, which can be replaced by 1 to 5 fluorine and / or chlorine atoms. 1-8 brewing group 'a (^ 〇〇 八, -30_ 八, a S02A, a CONH2, a CONHA, a CONA2, a CO-COOH, a CO-CO0A, a CO-CONH2, One CO — CONHA or one CO — C 0 NA 2, A is a Ci-e alkyl group, which can be from 1 to 5 fluorine and / or chlorine. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm). ) -4-475927 A7 _ B7 V. Invention Note (2) that the atom is substituted, and R 1Q and R 11 are each independently A, C 3-7 cycloalkyl, C4-8 methylidylcycloalkyl or C2-8 alkenyl, and H a is Fluorine, chlorine, bromine or iodine. Similar compounds are disclosed in DE 195 0 2 6 9 9.3 0 The present invention is based on the discovery of novel compounds which have useful properties and are especially useful for the production of drugs. Formula I The compounds and their hydrazones have useful pharmacological properties and good tolerability. In particular, they have an inhibitory effect on phosphodiesterase IV and can be used to treat asthma diseases. For example,? .0133 〇11, the method disclosed in human-eta allergologica 438-4 47 (1 97 1) was used to measure the anti-asthmatic effect. The compound additionally showed an inhibitory effect on the formation of TNF (tumor necrosis factor), and was therefore suitable for use in Treatment of allergies and inflammatory diseases, autoimmune diseases, and transplant rejection. It can also be used to treat memory diseases. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) Therefore, Compounds of formula I can be charged In human and veterinary medicine of pharmaceutically active compounds which may be further based purported to intermediates for the preparation of other pharmaceutically active compounds. Therefore, the present invention relates to a compound of formula I and its hydrazones, and a method for preparing the compound and its hydrazones, which is characterized in that the paper size of the compound of formula II is adapted to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)- 5-475927 A7 B7 V. Description of the invention (
:0: 0
其中,R 1 所界定者,與式ΠΙ化合物反應 R 5 — Q — X 項Among them, those defined by R 1 react with the compound of formula ΠΙ R 5 — Q — X
III (請先閲讀背面之注意事項再填寫本頁)III (Please read the notes on the back before filling this page)
Γ· -L 裝· 其中,R5及Q係爲如前述所定義者,且X係爲氯,溴 〇Η或反應性酯化0H基, 訂 或其特徵係在於令式IV化合物Γ · -L, where R5 and Q are as defined above, and X is chlorine, bromine or a reactive esterified OH group, or is characterized in that the compound of formula IV
RR
0 R Ε 經濟部中央標準局員工消費合作社印製0 R Ε Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs
V 其中,R1 ,R2 ,R3及R4係爲如前述所定義者,且 E爲氫或C^-4烷基,與式V化合物反應V wherein R1, R2, R3 and R4 are as defined above, and E is hydrogen or C ^ -4 alkyl, which is reacted with a compound of formula V
H2N — NH — Q — R 其中,Q及R5係爲如前述所定義者, 或其特徵係在於藉由還原硝基,烷化或醯化一級或二級月安 基或水解氰基,將式I化合物中之R5基團轉化爲另一個 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)- 475927 A7 B7 五、發明説明(4 ) R5基團,及/或係在於令相對應於該式I之化合物(但 含有一個或兩個游離羥基,以取代R3及/或R4 )可選 擇地與式R3 — X —或R4 — X之化合物(其中,R3 , R5及X係爲如前述所定義者)反應,及/或藉由與酸作 用,將該式I之鹼轉化爲其塩。H2N — NH — Q — R, where Q and R5 are as defined above, or their characteristics are that by reducing nitro, alkylating or tritiating a primary or secondary moonyl or hydrolyzing cyano, the formula The R5 group in the compound I is converted into another paper size that is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)-475927 A7 B7 V. Description of the invention (4) R5 group, and / or Let the compound corresponding to the formula I (but contain one or two free hydroxyl groups to replace R3 and / or R4) optionally with a compound of formula R3 — X — or R4 — X (wherein R3, R5 and X Is a reaction as defined above), and / or converts the base of formula I to hydrazone by interacting with an acid.
於上述及下文中,除非另有特別之說明,R1 ,R2 ,R3 ,R4 ,R5 ,Q及X基團之定義係爲如式I,II 及III中所界定者。 Α爲烷基。 於上述式中,烷基適宜地係爲未具支鏈且具有1至6 個碳原子,較適宜地具有1,2,3或4個碳原子,且較 適宜地係爲甲基,進一步較適宜地係乙基或丙基,更進一 步較適宜地係爲異丙基,丁基,異丁基,另-丁基或特-丁基,亦係爲正戊基或異戊基。 環烷基適宜地具有3至7個碳原子且適宜地係爲環丙 基或環丁基,進一步較適宜地係爲環戊基或環己基,且進 一步亦係爲環庚基。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 甲撑基環烷基適宜地係具有4至8個碳原子,且較適 宜地係爲甲撑基環丙基或甲撑基環丁基,進一步較適宜地 係爲甲撑基環戊基或甲撑基環己基,且進一步亦係爲甲撑 基環庚基。 烯基較適宜地係爲乙烯基,1一或2—丙烯基,1一 丁烯基,異丁烯基,另一 丁烯基,且進一步較適宜地係爲 1 一戊烯基,異戊烯基或1 一己烯基。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ γ - 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(5 ) 烷撑基較適宜地係爲未具支鏈,且較適宜地係爲甲撑 基或乙撑基,且進一步較適宜地係爲丙撑基或丁撑基。 R1及R2基團,其一較適宜地係爲氫,而另一個較 適宜地係爲丙基或丁基,特別適宜地係爲乙基或甲基。 R1及R2進一步較適宜地亦皆爲氫。 H a ί較適宜地係爲氟,氯或溴,亦係爲碘。 R3及R4基團可爲相同或不同,且較適宜地係位於 苯環之第3 —或4 一位置上。其係,例如,彼此各別獨立 爲羥基,—S — CH3 ,— SO — CH3 ,一 SO2CH3 ,氟,氯,溴或碘,或一起形成甲二氧基。然而,其係特 別適宜地各別爲甲氧基,乙氧基,丙氧基,環戊氧基,或 爲氟一,二氟一或三氟甲氧基,或1 一氟一,2氟一,1 ,2 -二氟—,2,2 -二氟一,1,2,2 —三氟一或 2 ,2 ,2 —三氟乙氧基。 R5基團適宜地係爲苯基。該苯基適宜地係單-或雙 取代。適宜之取代基係爲氣基,硝基,胺基,乙醯胺基, 三氟乙醯胺基,甲氧基及/或氯,適宜者亦係甲磺醯胺撑 ,丙醯胺基,2 -甲基丙醯胺基,異丁醯胺基及/或特戊 醯胺基,且進一步較適宜者係爲甲氧羰基胺基,甲草醯胺 基,脲基及/或羧基。 Q — R5較適宜地係爲笮基,2 —,3 -或4 一硝基 笮基,2 —,3 —或4 一氰基笮基,2 -,3 -或4 一胺 基環,2 —,3 —或4 一乙醯胺基苄基,2 —,3 —或4 一三氟乙醯胺基笮基,2 —,3 —或4 一甲氧基笮基,2 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)_ 8 - (請先閱讀背面之注意事項再填寫本頁) 475927 經濟部中央標準局員工消費合作社印製 A7 _B7 __五、發明説明(6 ) _,3 -或4 一氯苄基,進一步較適宜地係爲2 —,3 — 或4 一甲磺醯胺撑笮基,2 —,3 -或4 一丙醯胺基笮基 ,2 —,3 —或4 一(2 —甲基丙酿胺基)爷基’ 2 ’ 3 一或4 一異丁醯胺基苄基,2 -,3 -或4 一特戊醯胺基 苄基,2 —,3 —或4 一甲氧羰基胺基苄基,2 —,3 — 或4 一腺基爷基’ 2 - ’ 3 -或4 一竣基窄基’ 2 - ’ 3 一或4 一甲草醯胺基笮基,且較適宜地亦爲2,3 —,2 ,4 一,2,5 -,2,6 —,3, 4 —或 3,5 -二硝 基窄基,2,3 -,2,4 一,2,5 -,2,6 —,3 ,4 一或 3,5 - 二胺基苄基,2,3-,2,4 一,2 ,5 —,2,6 -,3,4 一或3,5 —二乙醯胺基苄基 ’2,3 — 9 2 9 4 一 9 2 9 5 一 9 2 9 6 一,3,4 一 或3,5 —雙(三氟乙醯胺基)爷基,2,3 —,2,4 一 ’ 2 ,5 —,2 ,6 —,3,4 —或 3 ,5 —二甲氧基 苄基,2,3-,2, 4一,2,5-,2, 6-, 3, 4 —或 3,5 -二氯书基,2,3 —,2,4 —,2,5 —,2,6 —,3,4 一或3,5 -二甲磺醯胺撑苄基, 2, 3 —,2,4 — ,2,5—,2,6 —,3,4 一或 3,5 -二丙醯胺基笮基,2,3 —,2,4 —,2,5 —,2,6-,3,4 一或3,5 —雙(2 —甲基丙醯胺 基)卞基 ’ 2 , 3 — , 2,4 一,2,5 —,2 ’ 6 -, 3,4 一或3,5 —二異丁醯胺基苄基,2,3 -,2, 4-,2,5 —,2,6 —,3,4 —或 3,5 —二甲氧 鑛基胺基爷基,2,3 —,2,4 一,2,5 —,2,6 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)_ 9 - (請先閱讀背面之注意事項再填寫本頁) ----裝· 475927 A 7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(7 ) 一,3,4 一或3,5—二甲草醯胺基笮基,2,3—, 2,4 —,2,5—,2,6 —,3,4一或3,5—二 脲基苄基,2,3_,2,4-,2,5-,2,6-, 3,4 —或3,5 -二竣基爷基。 因此,本發明特別係關於式I之化合物,其中至少一 個該基團具有如上所述之較適宜的取代基含意。某些較佳 之化合物可以下式I a至I e表示,該式I a至I e係相 對應於該式I ,且其中未詳細敘述之基團係如該式I所界 界定者,但其中 於式I a中 R 1係氫, R 2係氫或A, R 3 係 Ο A ; 於式I b中 R 1係氫, R 2係甲基或乙基, R3及R4係皆爲0A; 於式I c中 R 1係氫, R 2係甲基或乙基, R 3 係 0 A, R 4係經單一,二一,或三氟取代之C : - 6 烷基, 於式I d中 R 1係氫, R 2係甲基或乙基, R3及R4係皆爲0R1Q, R5係單一或雙取代之苯基; (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 1〇 _ 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(8 ) 於式Ie中 R1及R2係氫, R3及R4係皆爲0A,且係0A ; R5係單一或雙取代之苯基。 製備式I化合物及其用於製備之起始物係藉由利用已 知之方法,諸如文獻中所述及之方法(例如,諸如Ho II be-n-Weyl,Methoden der organ i schen Ch e m i e [Methods of Organic Chemistry] , Geory-Thieme-Verlag, S t u 11 -gar t所揭示之標準步驟;但,特別係述於D E 195502699.3),即於已知且適合該反應之反 應條件下。於此一情況下,亦可利用其本身已知之變異方 法,但並未詳述於本文中。 於式II及IV之化合物中,R 1 ,R 2 ,:R 3及R 4係 爲如上述所界定者,特別係爲較適宜之基團。 於式III及V之化合物中,Q較適宜地係爲甲撑基或乙 撑基,且亦爲丙撑基或乙撑基。 於式IV之化合物中,E較適宜地係爲氫,甲基或乙基 ,且亦爲丙基或丁基。 於式III及V之化合物中,R5係爲如上述所界定之較 適宜的基團,而X係爲氯,溴,羥基或反應酯化羥基。 若X係爲反應性酯化羥基,其較適宜地係爲C卜6烷 基磺醯氧基(較適宜地係爲甲基磺醯氧基)或Cuo芳基 磺醯氧基(較適宜地係爲苯基-或對-甲苯基磺醯氧基, 及2 —棻磺醯氧基)。 如有需要,起始物亦可於原位(in situ)形成,使 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-11 - (請先閱讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(9 ) 其無需自反應混合液中加以分離,而能立即進一步反應以 生成式I化合物。 另一方面,亦可進行逐步反應。 較適宜地,可藉由令式II化合物與式III化合物反應, 以生成式I化合物。 於某些情況下,式II及III之起始物係爲已知。若其非 爲已知,則可藉由本身已知之方法加以製備。 式II之嗒阱酮係描述於,例如,Enr. J. Med. Chem. -Chim· Therapeut. 644-650 (1977)中0 另一方面,藉由本身已知之方法,諸如描述於文獻( 例如,諸如 Houben-Weyl,Methoden der organischen C-hemie [Methods of Organic Chemistry], Georg-Thieme -Verlag, Stuttgart所揭示之標準步驟)中,即於已知且 適合進行該反應之反應條件下,製備式III之化合物。於此 情況下,亦可利用其本身已知之變異方法,但其並未詳述 於本文中。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 詳言之,於存在或不存在惰性溶劑下,於約一 2 0至 約1 5 0°C之溫度下,較適宜地係介於2 0至1 0 0°C之 溫度下,進行2,3,4,5 —四氫嗒阱與式III化合物之 反應。 適當之惰性溶劑係爲,例如,烴,諸如己烷,石油醚 ,苯,甲苯或二甲苯;氯化烴,諸如三氯乙烯,1 ,2 — 二氯乙烷,四氯化碳,氯仿或二氯甲烷;醇,諸如甲酯, 乙酯,異丙酯,正丙酯,正丁酯或特丁酯;醚,諸如乙醚 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 12 _ 475927 A7 B7 _ 五、發明説明(1〇) ,異丙醚,四氫呋喃(THF)或二噁烷;乙二酯醚,諸 如乙二酯單甲醚或單乙醚(甲基乙二酯或乙基乙二酯), 乙二酯二甲醚(digly me);酮,諸如丙酮或丁酮;醯胺 ,諸如乙醯胺,二甲基乙醯胺或二甲基甲醯胺(DMF ) :睛,諸如乙腈;亞碼,諸如二甲亞砚(DMSO):二 硫化碳;羧酸,諸如甲酸或乙酸;硝基化合物,諸如硝基 甲烷或硝基苯;酯,諸如醋酸乙酯;或,該諸溶劑之混合 液。 進一步,可藉由令式IV之化合物與式V之化合物反應 ,以生成式I化合物。 詳言之,係於存在或不存在惰性溶劑下,且於如上所 述之溫度下,進行式IV化合物與式V化合物之反應。 於某些情況下,式IV及V之起始物係爲已知。若其非 爲已知,則可藉由本身已知之方法加以製備。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 另一方面,藉由本身已知之方法,諸如描述於文獻( 例如,諸如 Houben-Weyl,Methoden der* organischen C-hemie [Methods of Organic Chemistry], Georg-Thieme -Verlag, Stuttgart所揭示之標準步驟)中,即於已知且 適合進行該反應之反應條件下,製備式IV及V之化合物。 於此情況下,亦可利用其本身已知之變異方法,但其並未 詳述於本文中。 亦可藉由,例如,還原硝基(例如,藉由於諸如甲醇 或乙醇之惰性溶劑中,以Raney鎳或鈀-硝之氫化反應) 至胺基,或水解氰基至羧基,將式I化合物中之R5基團 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐)-13 - ~ 475927 A7 B7 五、發明説明(11) 轉化爲另一個R5基團。亦可方便地於*二氯甲烷或TH F之惰性溶劑中,及/或於*三乙胺或吡啶之鹼的存在下 ,且於一 6 0至+ 3 0°C之溫度下,以慣用之方式利用醯 基氯或酸酐醯化游離胺基,或利用未經取代或經取代之烷 基鹵化物烷化游離胺基。 亦可令相對應於該式I之化合物(但含有一個或兩個 游離羥基,以取代R3及/或R4 )與式R3 — X或R4 一X之化合物(其中,R3 ,R4及X係爲如前述所界定 者)反應。該羥基之醚化反應係藉由本身已知之方法加以 進行,諸如描述於文獻(例如Houben-Weyl, Methoden d-e r organischen Chemie [Methods of Organic Chemist-ry],Georg-Thieme -Verlag,Stuttgart 所揭示之標準步 驟)中,即於已知且適合進行該反應之反應條件下。於此 情況下,亦可利用其本身已知之變異方法,但其並未詳述 於本文中。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 可利用酸將式I之鹼轉化爲其相關之酸加成塩,其係 藉由,例如,令相當用量之該鹼與酸於諸如乙醇之惰性溶 劑中反應,並隨後進行蒸發。對於該反應,適當之酸係特 別地爲能生成生理上可接受之塩者。因此,可利用無機酸 ,例如硫酸;硝酸;氫鹵酸,諸如氫氯酸或氫溴酸;磷酸 ,諸如正磷酸;氨基磺酸;亦可利用有機酸,特別係脂族 酸,脂環酸,芳脂族酸,芳族酸或雜環單-或多元羧酸, 磺酸或硫酸,例如甲酸,乙酸,丙酸,特戊酸,二乙基乙 酸,丙二酸,丁二酸,庚二酸,富馬酸,馬來酸,乳酸, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ - 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(12) 酒石酸,蘋果酸,檸檬酸,葡糖酸,抗壞血酸,菸酸,異 菸酸,甲烷一或乙烷磺酸,乙烷二磺酸,2 —羥基一乙烷 磺酸,苯,對一甲苯磺酸,棻單一或二磺酸,及月桂酸。 具有生理上不可接受之酸的塩,例如苦味酸塩,可用以分 離及/或純化式I化合物。 另一方面,若有需要,可利用鹼(例如,氫氧化鈉, 氫氧化鉀,或碳酸塩)自式I化合物之塩,釋出式I化合 物之游離鹼。 式I化合物可含有一個或多個不對稱中心。於此情況 下,其通常係以消旋之型式存在。藉由利用本身爲已知之 方法,可物理性地或化學性地分離所獲致之消旋產物成爲 其對映異構物。較適宜地,藉由與光學活性解析劑反應, 可自消旋混合物生成非對映異構物。 當然,藉由上述之方法,利用光學活性起始物,亦可 獲致光學活性之式I化合物。 式I化合物係包括所有之立體異構物及其混合物,例 如消旋體。 塩類亦係關於式I化合物及/或其生理上可接受之塩 於生成藥學製劑上的用途,特別係藉由非化學的途徑。於 本文中,式I化合物及/或其生理上可接受之塩係可與至 少一種固體,液體及/或半液體之賦形劑或輔劑,以及如 適當的,一種或多種其他之活性化合物,一起製成適當之 劑型。 ' 本發明亦係關於式I化合物及其生理上可接受之塩的 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-15 _ (請先閱讀背面之注意事項再填寫本頁) •裝· 、11 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(13 ) 藥劑,以充作磷酸二酯酶[V抑制劑。 本發明進一步係關於藥學製劑,其係包含至少一種式 I化合物及/或一種其生理上可接受之塩。 該製劑可充作人體用或獸用之藥物。適當之賦形劑係 爲有機或無機物質,其係適於經腸(例如,口服)或非經 腸投藥或局部用藥,且不會與該新穎化合物起反應,其係 例如水,植物油,苄醇,烷撑二醇,聚乙二醇,甘油三醋 酸酯,明膠,碳水化合物,諸如乳糖或澱粉,硬脂酸鎂, 滑石及礦脂。藥片,藥丸,塗覆藥片,膠襄,粉末,顆粒 ,糖漿,果汁或滴液,係特別適用於口服投藥;栓劑係適 用於直腸投藥;溶液,較適宜的係爲油性或水性溶液,及 懸浮液,乳化液或植入片係適於非經腸投藥;且軟育,7jc 漿膏或粉末係適於局部用藥。亦可將該新穎之化合物冷凍 乾燥,且利用所獲致之冷凍乾燥產物以製備,例如,注射 製劑。該製劑可經滅菌處理,及/或含有輔劑,諸如潤滑 劑,防腐劑,安定劑及/或潤濕劑,乳化劑,影響滲透壓 \ 之塩,緩衝物質,著色劑,芳香劑及/或一種或多種其他 活性化合物,例如一種或多種維生素。 式I化合物及其生理上可接受之塩,可用於控制疾病 (其中,環腺苷酸(CAMP )量之增加係導致抑制或防 止發炎及肌肉鬆弛)。本發明之化合物可特別用於治療過 敏,氣喘,慢性支氣管炎,異位皮膚炎,牛皮癬及其他皮 膚疾病,以及自體免疫疾病。 上述及下文中,所有溫度單位係爲。C。於下述實施例 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-16 - (請先閲讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(14 ) 中,a慣用處理方式"係意謂:如有需要,加入水;如胃 需要,依據最終產物之組成,調整混合液之p Η値介 至1 0 ;以醋酸乙酯或二氯甲烷加以萃取;分離有機相, (請先閱讀背面之注意事項再填寫本頁) 置於硫酸鈉上乾燥,經蒸發後,藉由矽膠層析及/或 加以純化。 實施例1 對溶於1 5 Omj?之THF中的4 · 7 Og之6 —( 3,4 一二甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱— 3 —酮()懸浮液,加入2 · 2 4 g之特一 丁醇鉀 ,且攪拌達30分鐘。隨後,加入4 . 32g之4一硝基 -苄基氯,且於室溫下攪拌該混合液達10小時。除去溶 劑,且以慣用之方式處理(如前述者)殘餘物。獲致2 — (4 —硝基苄基)一6 —(3,4一二甲氧基苯基)一 2 ,3,4,5—四氫嗒阱一3—酮,111.?.126。。 經濟部中央標準局員工消費合作社印製 以類似之方式,藉由令〃與下述之反應物反應, 以獲致下述之產物(即,以a反應物A %產物'之方式 表示); 與3 —硝基爷基氯: 2 —(3 —硝基爷基)一6 —(3,4 一 一甲氧基本 基)一2,3,4,5 —四氫嗒阱一3 —酮, m . p . 12 2° ; 與2 —硝基笮基氯: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)—I?- 475927 A7 B7 五、發明説明(15 ) 2—(2 —硝基苄基)一6_ (3,4 一二甲氧基苯 基)一2,3,4,5-四氫嗒阱一 3 —酮; 與2,3 —二硝基笮基氯: 2 — (2 ,3 —二硝基苄基)一6 — (3,4-二甲 氧基苯基)一 2 ’ 3 ’ 4 ’ 5 —四氫塔哄一 3 —酮; 與2,4一二硝基笮基氯: 2— (2 ,4 —二硝基苄基)一6- (3 ,4-二甲 氧基苯基)_2,3,4,5 —四氮嗜哄一3_嗣; 與2 —甲氧基苄基氯: 2 — (3 —甲氧基笮基)_6—(3 ,4 —二甲氧基 苯基)一2 ’ 3 ’ 4 ’ 5 —四氣塔哄一3 —酮; 與4 一甲氧基苄基氯: 2— (4 —甲氧基苄基)一6— (3 ,4 —二甲氧基 苯基)一 2,3,4,5 —四氣卩荅哄一3 — 11 ; 與2 -氯爷基氯: 2 — (2 —氯爷基)一 6 —(3,4 —二甲氧基苯基 )一 2,3,4,5—四氫嗒阱一3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與2,6 —二氯苄基氯: 2 —(2 ,6 —二氯苄基)一6— (3,4 -二甲氧 基苯基)一 2,3,4,5 —四氫嗒哄一 3— 11; 與4 一氣基苄基氯: 2— (4 —氣基爷基)一6— (3,4 —二甲氧基苯 基)一2 ,3,4 ,5 —四氮塔哄一3 —酮I; 與4 一羧基笮基氯: 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)-18 - 475927 A7 B7 五、發明説明(16 ) 2 —(4 一羧基苄基)一 6 —(3,4 一二甲氧基苯 基)—2,3,4,5-四氫嗒阱一3 —酮。 實施例2 類似於實施例1之方式,藉由令6 —(3,4 一二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 一酮()與4 —硝基苄基氯反應,以獲致2— (4 —硝基苄基)一 6 — (3,4 一二甲氧基苯基)一5 —乙 基一2 ,3,4 ’ 5 —四氮塔哄一 3 —酮。 以類似之方式,藉由令iB'與下述之反應物反應, 以獲致下述之產物(即,以a反應物":%產物"之方式 表示); 與3 -硝基苄基氯: 2—(3 —硝基窄基)一 6 —(3,4 —二甲氧基苯 基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與2 -硝基苄基氯: 2 — (2 —硝基爷基)—6— (3,4 一二甲氧基苯 基)一5 —乙基一 2,3,4 ,5 —四氫嗒阱一3 —酮; 與2,3 —二硝基苄基氯: 2 —(2 ,3-二硝基笮基)一6— (3 ,4 —二甲 氧基苯基)一 5 —乙基_2,3,4,5 —四氫嗒阱-3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-19 - 475927 A7 B7 五、發明説明(17 ) 與2,4 —二硝基苄基氯: 2 — (2 ,4 -二硝基笮基)一 6 —(3,4 -二甲 氧基苯基)一 5_乙基一 2,3,4,5 —四氫嗒阱一3 -酮; 與2 —甲氧基苄基氯: 2 — (2 —甲氧基爷基)一6—(3 ’ 4 —二甲氧基 苯基)一5 —乙基一2 ,3 ’ 4 ,5 —四氮卩荅哄一3 —嗣 赘 與3 —甲氧基苄基氯: 2— (4 —甲氧基苄基)一 6— (3 ,4 —二甲氧基 苯基)一5 —乙基一2 ,3,4 ,5 —四氮塔哄一 3 —嗣 與2 —氯;基氯: 2 — (2_氯苄基)—6 —(3,4 一二甲氧基苯基 )—5 —乙基一2 ,3 ,4 ,5_四氫嗒阱一3 —酮; 與2,6 —二氯苄基氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(2 ,6 —二氯爷基)一6— (3 ,4 一 二甲氧 基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一 3 — 酮; 與4 一氤基笮基氯: 2 — (4 —氰基爷基)一6 —(3 ,4 一二甲氧基苯 基)一 5 -乙基一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與4 一羧基笮基氯: 2— (4 —羧基笮基)—6— (3,4 —二甲氧基苯 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)-2〇 - 475927 A7 B7 五、發明説明(18 ) 基)一5—乙基一 2 ,3,4 ,5_四氮塔哄一3 —酬。 實施例3 類似於實施例1之方式,藉由令6 —(3,4 一三氟 甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮()與4 一硝基苄基氯()反應,以 獲致2— (4 —硝基笮基)一6 —(3 —甲氧基一4 —三 氟甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫嗒阱 —3 —酮0 以類似之方式,藉由令'與下述之反應物反應, 以獲致下述之產物(即,以%反應物':%產物#之方式 表示); 與6 —(3 —甲氧基一 4 一二氟甲氧基苯基)一 5 — 乙基一2 ,3,4 ,5 —四氣塔哄一3 —酮: 2 — (4 —硝基笮基)一6— (3 —甲氧基一4 —二 氟甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氫嗒阱 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) -3 -酮; 與6 —(3 —甲‘氧基一 4 —氣甲氧基苯基)一5 —乙 基一2 ,3,4 ,5 —四氮塔哄一3—酮I: 2— (4 —硝基爷基)一 6 —(3—甲氧基一4 —氟 甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氮塔哄一 3 —酮; 與6 — (3 —二氟甲氧基_4 —甲氧基苯基)一5 — 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)-21 - 475927 A7 B7 五、發明説明(19 ) 乙基一2 ,3,4 ,5—四氣塔哄一3 —鋼: 2 —(4 —硝基爷基)一 6 —(3 —二氧甲氧基一 4 —甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫嗒阱 一 3 —酮; 與6 —(3 —三氟甲氧基一 4 一甲氧基苯基)一5 — 乙基一 2 ,3,4 ,5 —四氫嗒阱一3—酮: 2 —(4 一硝基苄基)_6—(3 —三氟甲氧基一 4 一甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫嗒阱 —3 —酮; 與6— (3 —氟甲氧基一 4 —甲氧基苯基)一 5 —乙 基一2,3,4,5 —四氮塔哄一3 —酬: 2 —(4 一硝基爷基)一 6 — (3 —氟甲氧基一4 一 甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與6— (3 —甲氧基一 4 一乙氧基苯基)一5 —乙基 —2 ,3,4 ,5 —四氮嗜哄一 3—酿: 2— (4 —硝基爷基)一6 — (3 —甲氧基一4 一乙 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 氧基苯基)一5 —乙基一2,3,4,5 —四氮卩荅哄一 3 -酮; 與6— (3 —甲氧基一 4 —甲氧基苯基)_5 —乙基 —2 ,3,4 ,5 —四氫嗒阱一3—酮: 2 —(4 一硝基爷基)一6— (3 —乙氧基一4 一甲 氧基苯基)一 5 —乙基一 2,3,4,5 —四氮塔哄一3 -酮; 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)-22 - 475927 A7 B7 五、發明説明(2〇 ) 與6 —(3 —羥基一4 一甲氧基苯基)一5_乙基一 2 ,3,4 ,5 —四氮塔哄一 3 —酬: 2 —(4_硝基窄基)一 6 — (3 —經基一 4 一甲氧 基苯基)一 5 —乙基一 2,3,4,5 —四氣塔哄一 3 — 酮; 與6—(4 一甲磺醯基苯基)一5 —乙基一2,3, 4 ,5 —四氮卩荅哄一3 —酮: 2 —(4_硝基苄基)一6 —(4 一甲磺醯基苯基) —5 —乙基一 2 ,3 ,4 ,5 —四氮塔哄一3—嗣; 與6_ (4 —甲撑氧基苯基)一5_乙基一2 ,3 , 4 ,5 —四氮卩荅哄一3 —嗣: 2 — (4 —硝基苄基)一 6— (4 —甲撑氧基苯基) 一 5 —乙基一 2 ,3 ,4 ,5 —四氫喀哄一3 —酮; 與6— (3 —環戊基氧一 4 —甲氧基)一 5 —乙基一 2 ,3,4 ,5 —四氮卩荅哄一3 —酮: 2 — (4 —硝基苄基)—6 — (3 —環戊基氧—4_ 甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5-四氫嗒阱一 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 3 -酮。 實施例4 於Raney鎳之存在下,氫化溶於6 0m5甲醇中之 4 · 6g,2— (4 —硝基笮基)一6- (3 ,4 —二甲 氧基苯基)一 2 ’ 3,4,5 —四氫卩答哄一3 —酮溶液。 過濾除去觸媒,且將該溶液加以濃縮。經再結晶後,獲致 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-23 - 475927 A7 B7 五、發明説明(21 ) 2 —(4 —胺基苄基)一6 —(3,4 一二甲氧基苯基) —2 ,3 ,4 ,5 —四氣塔哄一3 —嗣,m· p · 1 8 4 ° 〇 以類似之方式,藉由氫化下述之反應物,以獲致下述 之產物(即,以%反應物':%產物'之方式表示); 2— (3 —硝基笮基)一6_ (3,4 —二甲氧基苯 基)一2 ,3,4,5 —四氣塔哄一3 —嗣: 2 —(3 —胺基苄基)一6 —(3,4 —二甲氧基苯 基)一2 ,3,4,5 -四氫嗒阱一 3-酮,m.p · 14 0°; 2— (2 —硝基苄基)一 6— (3,4 —二甲氧基苯 基)一2,3,4,5 —四氣塔哄一3 —酮: 2—(2_胺基苄基)一6— (3,4_二甲氧基苯 基)一2 ,3,4,5 —四氫塔哄一3 —酮; 2— (2 ,3 —二硝基爷基)一6— (3 ,4 —二甲 氧基苯基)一2,3,4 ,5 —四氫嗒阱一3 —酮: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(2 ,3 —二胺基笮基)一6— (3 ,4 —二甲 氧基苯基)一2,3,4,5 —四氫嗒阱一3 —酮; 2— (2 ,4 —二硝基笮基)一6- (3,4 —二甲 氧基苯基)一2 ,3,4 ,5 —四氮卩荅哄一3—嗣: 2 —(2 ,4 —二胺基苄基)一 6 —(3 ,4 —二甲 氧基苯基)一2,3,4,5 —四氫嗒阱一3 —酮; 2— (4 —硝基笮基)—6 —(3,4_二甲氧基苯 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-24 - 475927 A7 B7 五、發明説明(22 ) 基)一5 -乙基一2 ,3,4 ,5—四氫嗒阱一 3-酮: 2 —(4 一胺基爷基)一6— (3,4 一二甲氧基苯 基)一5 —乙基一 2 ,3,4 ,5 —四氣塔哄一嗣; 2 —(3 —硝基苄基)一 6—(3,4 —二甲氧基苯 基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮: 2 —(3 —胺基爷基)一6—(3,4 一二甲氧基苯 基)一5 —乙基一2 ,3,4 ,5 —四氮卩荅明:一3 —酬’ m . ρ . 4 9 ° ; 2 —(2 —硝基爷基)一 6 —(3,4 一二甲氧基苯 基)一5 —乙基一2 ,3,4 ,5 —四氣塔哄一3 —酮1: 2— (2 —胺基窄基)一 6— (3,4 —二甲氧基苯 基)一5 —乙基一2 ,3,4 ,5 —四氮塔哄一3 —嗣; 2 —(2 ,3 —二硝基爷基)一 6— (3 ,4 —二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氮塔哄一3 一酮: 2— (2 ,3 —二胺基苄基)一6 —(3 ,4 —二甲 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氫嗒阱一3 一酮; 2—(2 ,4一 二硝基爷基)一6— (3 ,4 —二甲 氧基苯基)一5-乙基一 2,3,4 ,5 —四氫嗒阱一3 一酮: 2— (2,4 —二胺基苄基)-6— (3,4 一 二甲 氧基苯基)一5 —乙基一2,3,4 ,5 —四氮卩荅哄一3 -酮; 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐)-25 - 475927 A7 B7 五、發明説明(23 ) 2 —(4 一硝基窄基)一 6 —(3 —甲氧基一 4 一二 氟甲氧基苯基)一 5_乙基一 2,3,4 ,5 —四氫嗒阱 一 3 -酮: 2 —(4 —胺基爷基)一 6 —(3 —甲氧基一 4 —二 氣甲氧基苯基)一5 —乙基一 2 ’ 3 ’ 4 ’ 5 —四氣塔哄 —3 -酮; 2 —(4 —硝基爷基)一6 —(3 —甲氧基一4 —二 氟甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫嗒阱 —3 —酮: 2— (4 —胺基爷基)一6_ (3 —甲氧基一4_二 氣甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氮塔哄 —3 -酮; 2— (4_硝基苄基)一 6 — (3 —甲氧基一4 —氟 甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氫嗒阱一 3 —酮: 2— (4 —胺基窄基)一 6 — (3 —甲氧基一4 —氟 甲氧基苯基)一5 —乙基一2,3 ,4 ,5 —四氫塔哄一 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 3 -酮; 2 —(4 一硝基笮基)一 6 —(3 —二氟甲氧基一4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮塔哄 —3 —酮: 2— (4 —胺基笮基)一 6_ (3 —二氟甲氧基一4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮塔哄 —3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-26 - 475927 A7 B7 五、發明説明(24 ) 2 — (4_硝基爷基)一6 —(3 —三氟甲氧基一 .4 一甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氫嗒阱 -3 —酮: 2 —( 4 —胺基苄基)一 6 - (3 —三氟甲氧基—4 —甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氮卩荅哄 —3 —酮; 2—(4_硝基苄基)一6—(3_氟甲氧基一4— 甲氧基苯基)一5 —乙基_2 ,3 ,4 ,5 —四氮塔哄一 3 —酮: 2— (4 —胺基爷基)一6 —(3 —氟甲氧基一4 — 甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氣喀哄一 3 -酮; 2 —(4 —硝基苄基)一6 —(3 —甲氧基一4 —乙 氧基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一 3 ―酮: 2— (4 —胺基爷基)一 6— (3 —甲氧基一4 —乙 經濟部中央標準局員工消費合作社印裝 (請先閲讀背面之注意事項再填寫本頁) 氧基苯基)_5 —乙基一 2,3,4,5 —四氯塔哄一3 -酮; 2 —(4 一硝基爷基)一 6— (3 —乙氧基一4 —甲 氧基苯基)一5 —乙基一 2,3,4,5 —四氮塔哄一3 —酮: 2— (4 —胺基爷基)一6— (3 —乙氧基一 4 一甲 氧基苯基)一5 —乙基一 2,3,4,5 —四氮塔哄一3 -酮; 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)_ _ 475927 A7 B7 五、發明説明(25 ) 2 —(4 一硝基书基)一 6 —(3 —羥基一 4_甲氧 基苯基)一 5 —乙基_2,3,4,5 —四氫嗒阱一3 — 酮: 2 - ( 4 -胺基苄基)一 6 -(3 -羥基—4 一甲氧 基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一 3 — 酮; 2 —(4 —硝基苄基)一 6 —(4 一甲磺醯基苯基) —5 —乙基一2 ,3,4 ,5 —四氫嗒阱一3 —酮: 2 —(4 一胺基韦基)一 6 —(4 —甲礦酿基苯基) —5 —乙基一2 ,3,4 ,5 —四氮卩荅哄一3 —酮; 2 — (4 —硝基苄基)一 6 — (4 —甲撑氧基苯基) 一 5 —乙基一2 ,3 ,4 ,5 —四氣卩荅哄一3 —酮: 2 — (4 —胺基苄基)一 6 —(4 —甲撑氧基苯基) —5 —乙基一 2 ,3,4 ,5 —四氣塔哄一3—酮1; 2 — (4 -硝基爷基)一 6 — (3 -環戊基氧一 4 — 甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 -酮: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(4 一胺基苄基)—6 — (3 —環戊基氧—4 — 甲氧基苯基)一5 —乙基一2,3,4 ,5 —四氫嗒阱一 3 —酮; 2_ (3 —硝基笮基)一6 -(3 -環戊基氧—4 — 甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮: 2 — (3 —胺基苄基)—6 -(3 —環戊基氧—4 — 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ μ 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(26 ) 甲氧基苯基)一5 —乙基一 2 ,3 ,5 —四Μ塔哄一 3 —銅,γώ·ρ·109ο ; 2 —(4 一硝基苯乙基)一6_ (3,4 一二甲氧基 苯基)一5 —乙基一 2 ,3,4 ,5 —四氣塔哄一3 —嗣 2— (4 —胺基苯乙基)一6 —(3,4_二甲氧基 苯基)一5 —乙基一2,3,4 ,5 —四氫嗒阱一 3—酮 , 2— (4 —硝基苯乙基)一6— (3 ,4 一二甲氧基 苯基)一5 —乙基—2 ,3,4 ,5 —四氫嗒阱一3 —酮 2 —(4 一胺基苯乙基)一 6— (3 ,4 —二甲氧基 苯基)一5 —乙基一 2 ,3 ’ 4 ,5 —四氮卩荅哄一3 —酮I 9 2— (3 —硝基苄基)一 6 —(3 —乙氧基一4 一甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氮塔哄一 3 一酮: 2—(3 —胺基爷基)一 6 — (3 —乙氧基一4 一甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 —酮,m.p.1120 0 實施例5 將1 Og之2_ (4 —氰基书基)一6 — (3,4一 二經基苯基)一 5 —乙基—2 ’ 3 ’ 4 ’ 5 —四氮塔哄一 ;_|_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) m' ϋϋ —Lr - - * I 1.^1 1.^1 n (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 475927 A7 B7 五、發明説明(27 ) 3 —酮以一邊加入同時攪拌之方式,加入至溶於1 0 0 mi水之1·2g NaOH冷溶液中,且隨後攪拌該混 合液達1 0小時。進一步,小心加熱,且空氣流通過該溶 液。隨後,加入冷硫酸及水。以慣用之方式處理該混合液 ,而獲致2 -(4 一羧基苄基)一 6 -(3,4 一二羥基 苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 —酮 實施例6 對溶於8 Omj?之二氯甲烷中的3 · 0 g之2 — ( 4 一胺基苄基)一 6 —(3,4 一二甲氧基苯基)一2,3 ,4 ,5 —四氫嗒阱一 3 — 酮()及 0 . 75mj? 之吡啶所形成之溶液,加入1 · 0 g之丁醯氯,且隨後攪 拌達1小時。除去溶劑,且以慣用之方式處理殘餘物。經 再結晶後,獲致2 -(4 一丁醯胺基笮基)一 6 -(3, 4一二甲氧基苯基)一2,3,4,5 —四氫嗒阱一3 — 酮,m . ρ · 1 4 8。。 以類似之方式,藉由令、D"與下述之反應物反應, 以獲致下述之產物(即,以、反應物〃 :%產物"之方式 表示); 與乙醯氯: 2— ( 4 —乙醯胺基笮基)一6 — (3 ,4 —二甲氧 基苯基)一2,3,4,5 —四氫嗒阱一 3 -酮, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) IV I ill· n 1 ili I (請先閲讀背面之注意事項再填寫本頁) 訂 -30 - 475927 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(28 ) m . p . 18 3° ; 與三氟乙醯氯: 2 —(4 一三Μ乙醯胺基窄基)一 6 —(3,4 一二 甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮, m . p . 2 1 0 ° ; 與甲磺醯氯: 2— (4 —甲磺醯胺撑窄基)一6 —(3 ,4 —二甲 氧基苯基)一 2,3,4,5 —四氮塔哄一 3 —酮, m . p . 1 3 8 ° ; 與丙醯氯: 2— (4 —丙醯胺基爷基)一6— (3,4 —二甲氧 基苯基)_2,3,4,5 —四氮塔哄一3 —酮, m . p . 17 6° ; 與2,2 —二甲基丙醯氯: 2 —(4 一特丁基羰基胺基笮基)一 6— (3,4 — 二甲氧基苯基)一2 ,3,4 ,5 —四氮塔哄一3 —嗣’ m . p . 15 5° ; 與異丁醯氯: 2 —(4 一異丁醯胺基笮基)—6 —(3,4 —二甲 氧基苯基)一2 ,3,4,5 —四氫嗒阱一 3 —酮; 與氯甲酸甲酯: 2— (4 —甲氧鑛基胺基爷基)一6 — (3 ,4 —二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與特戊醯氯: 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ _ n' I .........1 Him H m I (請先閲讀背面之注意事項再填寫本頁) 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(29 ) 2—(4 一特戊醯胺基窄基)一 6 —(3,4 一二甲 氧基苯基)一 2,3,4,5 —四氣塔哄一 3 —酬; 與環戊烷碳醯氯: 2 -(4 一環戊基氨基甲醯苄基)一 6 -(3,4-二甲氧基苯基)一2 ,3,4,5 —四氫嗒阱一 3 —酮; 與氯甲酸乙酯: 2 —(4 —乙氧裁基胺基爷基)一6— (3,4 一二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮, m . ρ · 1 4 7 0 ; 與甲草醯氯: 2— (4 —甲草醯脖基苄基)一 6 —(3 ,4 —二甲 氧基苯基)一 2,3,4,5 —四氮塔哄一3 —酮1; 與氯甲醯胺: 2 —(4 —腺基爷基)一6 —(3,4 —二甲氧基苯 基)一2,3,4,5 —四氫嗒阱一 3 —酮; 與戊醯氯: 2— (4 —戊醯胺基爷基)一6— (3,4 —二甲氧 基苯基)一2 ,3,4,5 —四氮塔哄一3 —酮I: 與己醯氯: 2 —(4 一己酿胺基爷基)一6_ (3 ,4 —二甲氧 基苯基)一2 ,3,4,5 —四氮卩荅哄一 3 —酮1; 與五氟丙醯氯: 2 -(4 —五氟丙醯胺基笮基)—6 — (3,4 —二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮。 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 32 - (請先閲讀背面之注意事項再填寫本頁) 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(30 ) 以類似之方式,藉由令2 -(4 —胺基爷基)一 6 — (3 ,4 —二甲氧基苯基)一5 —乙基一2 ,3 ’ 4 ,5 一四氫嗒阱一 3 —酮與下述之反應物反應,以獲致下述之 產物(即,以%反應物';"產物'之方式表示); 與乙醯氯: 2 —(4 —乙酿胺基爷基)一6 — (3 ’ 4 —二甲氧 基苯基)_2,3,4,5 —四氫嗒阱一3 —酮; 與三氟乙醯氯: 2— (4 —三氟乙醯胺基爷基)一6 — (3,4_二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱—3 —酮, m . p . 1 3 3 ° ; 與甲磺醯氯: 2 —(4 一甲磺醯胺撑苄基)一 6— (3 ,4 一二甲 氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氫嗒阱一3 一酮; 與丙醯氯: 2 —(4 —丙醯胺基书基)一 6 —(3,4 一二甲氧 基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫嗒阱一 3 — 酮,m · p · 8 1 0 與二甲基丙醯氯: 2 —(4 —特丁基幾基胺基窄基)一 6 —(3 ,4 — 二甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氫嗒阱 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 33 _ (請先閲讀背面之注意事項再填寫本頁) 裝· 訂In the above and below, unless specifically stated otherwise, the definitions of the groups R1, R2, R3, R4, R5, Q and X are as defined in formulae I, II and III. A is an alkyl group. In the above formula, the alkyl group is suitably unbranched and has 1 to 6 carbon atoms, more suitably 1, 2, 3, or 4 carbon atoms, and more preferably a methyl group, further more preferably Suitably it is ethyl or propyl, and even more suitably is isopropyl, butyl, isobutyl, other-butyl or t-butyl, and also n-pentyl or isopentyl. The cycloalkyl group suitably has 3 to 7 carbon atoms and is suitably a cyclopropyl group or a cyclobutyl group, more preferably a cyclopentyl group or a cyclohexyl group, and further a cycloheptyl group. Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) Methylcycloalkyl is suitably 4 to 8 carbon atoms, and more preferably Methylcyclo The propyl or methylidene cyclobutyl group is more preferably methylidylcyclopentyl or methylidylcyclohexyl, and further is methylidylcycloheptyl. Alkenyl is more preferably vinyl, 1- or 2-propenyl, 1-butenyl, isobutenyl, another butenyl, and further more preferably 1-pentenyl, isopentenyl Or 1-hexenyl. This paper size applies to China National Standard (CNS) A4 (210X297 mm) _-475927 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (5) The alkylene group is more suitable It has a branched chain, and is more preferably a methylidene group or an ethylene group, and further preferably a propylene group or a butylene group. One of the R1 and R2 groups is more preferably hydrogen, and the other is more preferably propyl or butyl, and particularly suitably ethyl or methyl. R1 and R2 are further preferably both hydrogen. H a ί is more suitably fluorine, chlorine or bromine, and also iodine. The R3 and R4 groups may be the same or different, and are more preferably located at positions 3-or 4 of the benzene ring. It is, for example, hydroxyl groups, —S—CH3, —SO—CH3, —SO2CH3, fluorine, chlorine, bromine, or iodine, or methyldioxy, respectively, independently of each other. However, they are particularly suitably methoxy, ethoxy, propoxy, cyclopentyloxy, or fluoro-, difluoro- or trifluoromethoxy, or 1-fluoro-1,2 fluorine, respectively. Mono-1,2-difluoro-, 2,2-difluoro- 1,1,2,2-trifluoro- or 2,2,2-trifluoroethoxy. The R5 group is suitably phenyl. The phenyl is suitably mono- or di-substituted. Suitable substituents are gas, nitro, amine, acetamido, trifluoroacetamido, methoxy and / or chlorine, and also suitable are methanesulfonylamine, propylamino, 2-Methylpropanamido, isobutyramido and / or pentamidine, and more preferably, it is methoxycarbonylamino, acetochlor, urea and / or carboxyl. Q — R5 is more preferably fluorenyl, 2-, 3- or 4-mononitrofluorenyl, 2-, 3- or 4-monocyanofluorenyl, 2-, 3- or 4-monoamino ring, 2 —, 3 — or 4 monoethylaminobenzyl, 2 —, 3 — or 4 monotrifluoroethylamidinofluorenyl, 2 —, 3 — or 4 monomethoxyfluorenyl, 2 This paper size applies China National Standard (CNS) A4 Specification (210 X 297 mm) _ 8-(Please read the precautions on the back before filling this page) 475927 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _B7 __ V. Description of the Invention (6) _, 3-or 4- monochlorobenzyl, further more suitably 2-, 3-, or 4-monosulfonylamidofluorenyl, 2-, 3-, or 4-propanamidofluorenyl , 2 —, 3 — or 4 mono (2-methylpropylamino) alkynyl '2' 3 or 4 monoisobutylamidinobenzyl, 2-, 3-or 4 monotetramethylammonium Benzyl, 2-, 3-, or 4-monomethoxycarbonylaminobenzyl, 2-, 3-, or 4-adenosyl '2-' 3-or 4-one condensed narrow group '2-' 3- Or 4-Alachlorpyridinyl, and more suitably also 2,3 -—, 2,4-a, 2,5— 2,6 —, 3, 4 —or 3,5-dinitro narrow group, 2,3-, 2,4 one, 2,5-, 2,6 —, 3,4 one or 3,5-two Aminobenzyl, 2,3-, 2,4 mono, 2,5 —, 2,6-, 3,4 mono or 3,5-diethylamidobenzyl'2,3 — 9 2 9 4 One 9 2 9 5 one 9 2 9 6 one, 3, 4 one or 3, 5 —bis (trifluoroacetamido) yl group, 2, 3 —, 2, 4, one '2, 5 —, 2, 6 —, 3,4 —or 3,5-dimethoxybenzyl, 2,3-, 2,4-mono, 2,5-, 2, 6-, 3, 4 —or 3,5-dichloro Book base, 2, 3 —, 2, 4 —, 2, 5 —, 2, 6 —, 3, 4 mono or 3, 5-dimethylsulfamidinobenzyl, 2, 3 —, 2, 4 — , 2,5—, 2,6—, 3,4 mono or 3,5-dipropionamidofluorenyl, 2,3 —, 2,4 —, 2,5 —, 2,6-, 3, 4 mono or 3,5-bis (2-methylpropylamido) fluorenyl '2, 3 —, 2,4 mono, 2, 5 —, 2' 6-, 3, 4 mono or 3, 5 — Diisobutylamidinoaminobenzyl, 2,3-, 2,4-, 2,5 —, 2,6 —, 3,4 —or 3,5 —dimethoxyaminoamino, 2 ,, 3 —, 2,4 1,2,5 —, 2,6 This paper size is applicable to Chinese National Standard (CNS) A4 (210 X 297 mm) _ 9-(Please read the precautions on the back before filling this page)- -Equipment · 475927 A 7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (7) One, 3, 4 one or 3, 5—Dimethoxamine, 2, 3—, 2,4 —, 2, 5 —, 2, 6 —, 3, 4 mono or 3, 5-diureidobenzyl, 2, 3 —, 2, 4-, 2, 5-, 2, 6-, 3 , 4 — or 3, 5-two end of the foundation. Therefore, the present invention relates in particular to compounds of formula I, in which at least one of the groups has the meaning of a more suitable substituent as described above. Certain preferred compounds can be represented by the following formulae I a to I e, the formulae I a to I e are corresponding to the formula I, and the groups not described in detail are as defined by the formula I, but where In formula I a, R 1 is hydrogen, R 2 is hydrogen or A, and R 3 is 0 A; in formula I b, R 1 is hydrogen, R 2 is methyl or ethyl, and R3 and R4 are 0A; In formula I c, R 1 is hydrogen, R 2 is methyl or ethyl, R 3 is 0 A, and R 4 is C: -6 alkyl substituted with single, dione, or trifluoro, in formula I d R 1 is hydrogen, R 2 is methyl or ethyl, R3 and R4 are all 0R1Q, and R5 is single or double substituted phenyl; (Please read the precautions on the back before filling out this page) This paper size applies China National Standard (CNS) A4 specification (210X297 mm) _ 1〇_ 475927 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention description (8) R1 and R2 are hydrogen, R3 and R4 in formula Ie All are 0A, and are 0A; R5 is a single or disubstituted phenyl. The preparation of compounds of formula I and the starting materials for their preparation are by using known methods, such as those described in the literature (for example, such as Ho II be-n-Weyl, Methoden der organ i schen Ch emie [Methods of Organic Chemistry], Geory-Thieme-Verlag, Stu 11 -gart revealed standard procedures; however, it is specifically described in DE 195502699. 3), under known reaction conditions suitable for the reaction. In this case, a variation method known per se may be used, but it is not described in detail herein. In the compounds of the formulae II and IV, R 1, R 2,: R 3 and R 4 are as defined above, and particularly are more suitable groups. In the compounds of the formulae III and V, Q is more suitably a methyl group or an ethylene group, and is also a propylene group or an ethylene group. In compounds of formula IV, E is more preferably hydrogen, methyl or ethyl, and is also propyl or butyl. In the compounds of the formulae III and V, R5 is a more suitable group as defined above, and X is chlorine, bromine, a hydroxyl group or a reactive esterified hydroxyl group. If X is a reactive esterified hydroxyl group, it is more preferably C6 alkylsulfonyloxy (more preferably methylsulfonyloxy) or Cuoarylsulfonyloxy (more suitably Is phenyl- or p-tolylsulfonyloxy, and 2-sulfonylsulfonyloxy). If necessary, the starting material can also be formed in situ, so that the paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -11-(Please read the precautions on the back before filling in this (Page) 475927 A7 B7 V. Description of the invention (9) It does not need to be separated from the reaction mixture, but can be further reacted immediately to form a compound of formula I. On the other hand, a stepwise reaction is also possible. More suitably, a compound of formula I can be formed by reacting a compound of formula II with a compound of formula III. In some cases, the starting materials of formulae II and III are known. If it is not known, it can be prepared by a method known per se. Titracones of formula II are described, for example, in Enr. J. Med. Chem. -ChimTherapeut. 644-650 (1977) 0 On the other hand, by methods known per se, such as described in the literature (for example, such as Houben-Weyl, Methoden der organischen C-hemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, In the standard procedure disclosed by Stuttgart), the compound of formula III is prepared under reaction conditions known and suitable for carrying out the reaction. In this case, a variation method known per se may be used, but it is not described in detail herein. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page). In detail, in the presence or absence of inert solvents, at a temperature of about -20 to about 150 ° C Next, the reaction of 2, 3, 4, 5-tetrahydro-trapping well with the compound of formula III is preferably performed at a temperature between 20 and 100 ° C. Suitable inert solvents are, for example, hydrocarbons such as hexane, petroleum ether, benzene, toluene or xylene; chlorinated hydrocarbons such as trichloroethylene, 1,2-dichloroethane, carbon tetrachloride, chloroform or Dichloromethane; alcohols, such as methyl, ethyl, isopropyl, n-propyl, n-butyl, or t-butyl; ethers, such as diethyl ether; this paper is sized for China National Standard (CNS) A4 (210X297 mm) _ 12 _ 475927 A7 B7 _ 5. Description of the invention (10), isopropyl ether, tetrahydrofuran (THF) or dioxane; ethylene glycol ethers, such as ethylene glycol monomethyl ether or monoethyl ether (methyl ethylene glycol Or ethyl ethylene glycol), digly me; ketones, such as acetone or methyl ethyl ketone; ammonium, such as acetamide, dimethylacetamide, or dimethylformamide (DMF ): Eyes, such as acetonitrile; subcodes, such as dimethyl sulfoxide (DMSO): carbon disulfide; carboxylic acids, such as formic acid or acetic acid; nitro compounds, such as nitromethane or nitrobenzene; esters, such as ethyl acetate; or , The mixed solution of the solvents. Further, a compound of formula I can be produced by reacting a compound of formula IV with a compound of formula V. In particular, the reaction of the compound of formula IV with the compound of formula V is carried out in the presence or absence of an inert solvent and at a temperature as described above. In some cases, the starting materials of formulae IV and V are known. If it is not known, it can be prepared by a method known per se. Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page) On the other hand, by methods known per se, such as described in the literature (for example, such as Houben-Weyl, Methoden der * organischen In C-hemie [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart (standard procedures disclosed), the compounds of formulae IV and V are prepared under known reaction conditions suitable for the reaction. In this case, a mutation method known per se may be used, but it is not described in detail herein. Compounds of formula I can also be prepared, for example, by reducing a nitro group (for example, by hydrogenation with Raney nickel or palladium-nitrate in an inert solvent such as methanol or ethanol) to an amine group, or by hydrolyzing a cyano group to a carboxyl group. The R5 group in this paper applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) -13-~ 475927 A7 B7 5. Description of the invention (11) Converted into another R5 group. It can also be conveniently used in an inert solvent of * dichloromethane or TH F, and / or in the presence of a base of * triethylamine or pyridine, and at a temperature of 60 to + 30 ° C, as is customary. This is accomplished by using a fluorenyl chloride or an acid anhydride to mash the free amine group, or using an unsubstituted or substituted alkyl halide to alkylate the free amine group. The compound corresponding to the formula I (but containing one or two free hydroxyl groups to replace R3 and / or R4) and the compound of the formula R3-X or R4-X (where R3, R4 and X are As defined above). The etherification of the hydroxyl group is performed by a method known per se, such as described in the literature (for example, Houben-Weyl, Methoden de r organischen Chemie [Methods of Organic Chemist-ry], Georg-Thieme-Verlag, Stuttgart) Standard procedure), that is, under known reaction conditions suitable for the reaction. In this case, a variation method known per se may be used, but it is not described in detail herein. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page) The acid can be used to convert the base of formula I to its related acid addition 加, for example, by The base is reacted in an amount with an acid in an inert solvent such as ethanol, and then evaporated. For this reaction, suitable acids are particularly those capable of generating physiologically acceptable maggots. Therefore, inorganic acids such as sulfuric acid; nitric acid; hydrohalic acids such as hydrochloric acid or hydrobromic acid; phosphoric acids such as orthophosphoric acid; aminosulfonic acids; organic acids, especially aliphatic acids, alicyclic acids, can also be used , Araliphatic, aromatic or heterocyclic mono- or polycarboxylic acids, sulfonic acids or sulfuric acids, such as formic acid, acetic acid, propionic acid, pivalic acid, diethylacetic acid, malonic acid, succinic acid, heptane Diacid, fumaric acid, maleic acid, lactic acid, this paper size applies Chinese National Standard (CNS) A4 (210X297 mm) _-475927 Printed by A7 B7, Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 12) Tartaric acid, malic acid, citric acid, gluconic acid, ascorbic acid, nicotinic acid, isonicotinic acid, methane mono or ethanesulfonic acid, ethanedisulfonic acid, 2-hydroxymonoethanesulfonic acid, benzene, para-one Toluenesulfonic acid, hydrazone mono- or disulfonic acid, and lauric acid. A hydrazone having a physiologically unacceptable acid, such as a picrate, can be used to isolate and / or purify a compound of formula I. On the other hand, if desired, a base (e.g., sodium hydroxide, potassium hydroxide, or rhenium carbonate) can be used to release the free base of the compound of formula I from the hydrazone of the compound of formula I. Compounds of formula I may contain one or more asymmetric centers. In this case, it usually exists in a racemic form. The resulting racemic product can be physically or chemically separated into its enantiomer by using a method known per se. Preferably, diastereomers can be generated from the racemic mixture by reaction with an optically active resolving agent. Of course, by the method described above, optically active compounds of formula I can also be obtained using optically active starting materials. Compounds of formula I include all stereoisomers and mixtures thereof, such as racemates. Class VIII also relates to the use of compounds of formula I and / or their physiologically acceptable properties to produce pharmaceutical preparations, in particular by non-chemical means. Herein, the compound of formula I and / or its physiologically acceptable compounds can be combined with at least one solid, liquid and / or semi-liquid excipient or adjuvant, and, as appropriate, one or more other active compounds , Together into an appropriate dosage form. '' The present invention also relates to the compound of formula I and its physiologically acceptable tincture. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -15 _ (Please read the precautions on the back before filling this page ) • Packing, 11 475927 A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention (13) A medicament for use as a phosphodiesterase [V inhibitor. The invention further relates to pharmaceutical formulations comprising at least one compound of formula I and / or one physiologically acceptable tincture. The preparation can be used as a human or veterinary drug. Suitable excipients are organic or inorganic substances that are suitable for enteral (e.g., oral) or parenteral or topical administration and do not react with the novel compound, such as water, vegetable oil, benzyl Alcohols, alkylene glycols, polyethylene glycols, triacetin, gelatin, carbohydrates such as lactose or starch, magnesium stearate, talc and petrolatum. Tablets, pills, coated tablets, capsules, powders, granules, syrups, juices or drops are particularly suitable for oral administration; suppositories are suitable for rectal administration; solutions, more suitable are oily or aqueous solutions, and suspensions Liquids, emulsions or implants are suitable for parenteral administration; and soft, 7jc paste or powder is suitable for topical administration. The novel compound can also be freeze-dried and the resulting freeze-dried product can be used to prepare, for example, injection preparations. The preparation can be sterilized and / or contain adjuvants such as lubricants, preservatives, stabilizers and / or wetting agents, emulsifiers, osmotic pressure, buffer substances, colorants, fragrances and / Or one or more other active compounds, such as one or more vitamins. The compounds of formula I and their physiologically acceptable pupae are useful for controlling diseases (wherein an increase in the amount of cyclic adenylate (CAMP) results in inhibition or prevention of inflammation and muscle relaxation). The compounds of the present invention are particularly useful in the treatment of allergies, asthma, chronic bronchitis, ectopic dermatitis, psoriasis and other skin diseases, as well as autoimmune diseases. Above and below, all temperature units are. C. In the following examples, the paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -16-(Please read the precautions on the back before filling this page) 475927 A7 B7 5. In the description of the invention (14), a customary processing method means: if necessary, add water; if the stomach needs, adjust the p of the mixed solution to 10 according to the composition of the final product; extract with ethyl acetate or dichloromethane; Separate the organic phase, (please read the precautions on the back before filling out this page), dry on sodium sulfate, evaporate, and then purify by silica gel chromatography and / or. Example 1 To 4 · 7 Og of 6 — (3,4 -dimethoxyphenyl) — 2, 3,4,5 —tetrahydrodatrap — 3 —one dissolved in 15 Omj? Of THF () Suspension, add 2.24 g of potassium t-butoxide, and stir for 30 minutes. Then, add 4. 32 g of 4-mononitro-benzyl chloride, and the mixture was stirred at room temperature for 10 hours. Remove the solvent and dispose of (as before) the residue in the usual way. Obtained 2- (4-nitrobenzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydrodatrapne 3-ketone, 111. ?. 126. . Printed in a similar manner by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, by reacting 〃 with the following reactants to obtain the following products (ie, expressed as a reactant A% product '); and 3-Nitromethyl chloride: 2- (3-Nitromethyl) -6- (3,4-monomethoxybenzyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone, m. p. 12 2 °; and 2—Nitrofluorenyl chloride: This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) —I?-475927 A7 B7 V. Description of the invention (15) Benzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; and 2,3-dinitrofluorenyl chloride: 2- (2,3-dinitrobenzyl) -6- (3,4-dimethoxyphenyl) -2'3'4'5-tetrahydro tower coaxing a 3-ketone; and 2,4 one two Nitrofluorenyl chloride: 2- (2,4-dinitrobenzyl) -6- (3,4-dimethoxyphenyl) _2,3,4,5-tetrazine ; With 2-methoxybenzyl chloride: 2- (3-methoxymethoxy) -6- (3,4-dimethoxyphenyl)-2 '3' 4 '5-four-gas tower 3-ketone; and 4-monomethoxybenzyl chloride: 2- (4-methoxybenzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetra Discouragement of 3-11; and 2-chloromethyl chloride: 2- (2-chloromethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5- Tetrahydrotrap 3-ketone; printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) and 2,6-dichlorobenzyl chloride: 2- (2,6-dichlorobenzyl )-6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydroda-co-a 3-11; and 4-afluorobenzyl chloride: 2- (4- A) 6- (3,4-dimethoxyphenyl) -2,3,4,5-tetraaza-tower to coax a 3-keto I; and 4-carboxymethylfluorenyl chloride: This paper standard applies to China Standard (CNS) A4 specification (210X297 mm) -18-475927 A7 B7 V. Description of the invention (16) 2-(4-monocarboxybenzyl) 6-(3,4-dimethoxyphenyl) -2 , 3,4,5-tetrahydrodatrapone 3-ketone. Example 2 In a manner similar to Example 1, by making 6— (3,4—dimethoxyphenyl) —5—ethyl—2, 3, 4, 5—tetrahydrotrap — 3—one () Reacted with 4-nitrobenzyl chloride to obtain 2- (4-nitrobenzyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4 '5-tetrazolium coaxes a 3-ketone. In a similar manner, by reacting iB ′ with the following reactants, the following products are obtained (ie, expressed as a reactant ":% product >); and 3-nitrobenzyl Chlorine: 2- (3-nitro-narrow group) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrodatrapeptone 3-ketone; Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and 2-nitrobenzyl chloride: 2 — (2 —nitromethyl) — 6 — (3, 4 a Dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and 2,3-dinitrobenzyl chloride: 2- (2,3-di Nitrofluorenyl) -6- (3,4-dimethoxyphenyl) -5-ethyl_2,3,4,5-tetrahydro-3 trap-one; This paper size applies to Chinese national standards (CNS) A4 specification (210X297 mm) -19-475927 A7 B7 V. Description of the invention (17) and 2,4-dinitrobenzyl chloride: 2-(2,4-dinitrofluorenyl)-6 — (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5 — Hydrogen trap 3-ketone; and 2-methoxybenzyl chloride: 2- (2-methoxymethoxy) -6- (3'4-dimethoxyphenyl) -5-ethyl- 2,3'4,5-tetraazaphosphonium coaxes 3-3-benzyl and 3-methoxybenzyl chloride: 2- (4-methoxybenzyl) -6- (3,4-dimethoxy Phenyl) a 5-ethyl-2,3,4,5-tetrazol tower to cope with a 3-fluorene and 2-chloro; chloro: 2- (2-chlorobenzyl) -6 — (3,4 1-dimethoxyphenyl) -5-ethyl-2,3,4,5_tetrahydrodatrapeptone 3-ketone; and 2,6-dichlorobenzyl chloride: Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs Printed (please read the precautions on the back before filling out this page) 2 — (2, 6 — dichloromethyl) — 6 — (3, 4 —dimethoxyphenyl) — 5 — ethyl — 2, 3,4,5-tetrahydro-trap-a-3 ketone; and 4-amidinofluorenyl chloride: 2— (4-cyanoyl) —6— (3,4-dimethoxyphenyl) — 5 -Ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and 4-monocarboxyfluorenyl chloride: 2- (4-carboxyfluorenyl) -6- ( 3,4-dimethoxybenzene paper size applies to Chinese National Standard (CNS) A4 specifications (210X297 mm) -2-475927 A7 B7 V. Description of the invention (18) -based) 5-ethyl-2, 3,4,5_ four nitrogen towers coax one 3 — reward. Example 3 In a manner similar to Example 1, by making 6— (3,4-trifluoromethoxyphenyl) —5-ethyl-2,3,4,5-tetrahydrotrap —3— Ketone () reacts with 4-nitrobenzyl chloride () to obtain 2- (4-nitrofluorenyl) -6- (3-methoxy-4-trifluoromethoxyphenyl) -5- Ethyl-2,3,4,5-tetrahydrotrapping well 3-ketone 0 In a similar manner, by reacting with the reactants described below, the following products are obtained (ie, in% reactants ':% 产品 # The way is expressed); and 6- (3-methoxy-4 difluoromethoxyphenyl) -5-ethyl-2,3,4,5- 4-gas tower —Ketone: 2 — (4-nitrofluorenyl) — 6 — (3-methoxy-4 —difluoromethoxyphenyl) — 5 —ethyl-2, 3, 4, 5 — tetrahydro Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) -3 -ketones; and 6- (3-methyl'oxy-1, 4-methoxymethoxyphenyl) 5-Ethyl-2,3,4,5-tetrazol tower coaxes 3-keto I: 2— (4 Nitromethyl) -6- (3-methoxy-4-fluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrazol tower co-a 3-ketone; and 6- (3 —Difluoromethoxy_4 —methoxyphenyl) — 5 — This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) -21-475927 A7 B7 V. Description of the invention (19) Ethyl-2,3,4,5-Four gas towers coax a 3-Steel: 2- (4-Nitromethyl) -6- (3-Dimethoxymethoxy-4-methoxyphenyl) A 5-ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone; and a 6- (3-trifluoromethoxy-4 4-methoxyphenyl) a 5-ethyl-2 , 3,4,5-tetrahydro-trap-a 3-ketone: 2- (4-mononitrobenzyl) -6- (3-trifluoromethoxy-4 4-methoxyphenyl) -5-ethyl -2,3,4,5-tetrahydro-3-well; and 6- (3-fluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5 —The tetrazolium tower coaxes one to three—Remuneration: 2— (4-Nitromethyl) —6— (3-Fluoromethoxy—4—methoxyphenyl) —5 Ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and 6- (3-methoxy-4 4-ethoxyphenyl) -5-ethyl-2,3,4, 5 —Tetrazine coaxing — 3 — Brewing: 2 — (4 —Nitromethyl) — 6 — (3 —methoxy — 4 —B Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the Note: Please fill in this page again) oxyphenyl) a 5-ethyl-2,3,4,5-tetraazepine co-a 3-ketone; and 6- (3-methoxy a 4-methoxy Phenyl) _5 -ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone: 2-(4-nitrophenyl)-6-(3-ethoxy-4 -methoxy Phenyl) -5 -ethyl -2,3,4,5 -tetrazole tower coke 3 -one; This paper size applies to China National Standard (CNS) A4 specifications (210X297 mm) -22-475927 A7 B7 V. Description of the invention (20) and 6- (3-hydroxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrazol tower coax 3 -Reward: 2-( 4-nitro-narrow group)-6- (3-Cyclo-4-methoxyphenyl) -5-Ethyl-2,3,4 , 5-tetragas tower to coax a 3-ketone; and 6- (4-methylsulfonylphenyl)-5-ethyl-2,3,4,5-tetraazepine to coax a 3-ketone: 2 — (4-nitrobenzyl) -6— (4-methylsulfonylphenyl) —5 —ethyl-2,3,4,5 —tetrazolium tower — 3 —fluorene; and 6_ (4 — (Methoxyphenyl) -5-ethyl-2,3,4,5-tetraazaphosphonium-coated 3-phosphonium: 2- (4-nitrobenzyl) -6- (4-methyloxy Phenyl) -5 -ethyl -2,3,4,5-tetrahydrocarbazine -3 -one; and 6-(3-cyclopentyloxy-4 -methoxy)-5 -ethyl- 2,3,4,5-tetraazaphosphonium coke a 3-ketone: 2- (4-nitrobenzyl) -6- (3-cyclopentyloxy-4_methoxyphenyl) -5-ethyl 1,2,3,4,5-tetrahydro-trap- printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) 3 -one. Example 4 In the presence of Raney nickel, 4.6 g of 2- (4-nitrofluorenyl) -6- (3,4-dimethoxyphenyl)-2 'dissolved in 60m5 methanol was hydrogenated. 3,4,5-tetrahydropyridine coaxes a 3-ketone solution. The catalyst was removed by filtration, and the solution was concentrated. After recrystallization, the paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) -23-475927 A7 B7 V. Description of the invention (21) 2 — (4 —aminobenzyl) — 6 — ( 3,4 -dimethoxyphenyl) -2,3,4,5-four gas towers coax a 3-嗣, m · p · 1 8 4 ° 〇 In a similar manner, by hydrogenating the following reaction Products, in order to obtain the following products (that is, expressed as% reactant ':% product'); 2- (3-nitrofluorenyl) -6- (3,4-dimethoxyphenyl)- 2,3,4,5—Four gas towers coerce a 3— 嗣: 2— (3-aminobenzyl) -6— (3,4-dimethoxyphenyl) —2,3,4,5 -Tetrahydrodatrapeptone 3-ketone, m. p · 14 0 °; 2- (2-nitrobenzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5- four-gas towers coax a 3-ketone: 2 — (2-aminobenzyl) —6- (3,4-dimethoxyphenyl) —2,3,4,5-tetrahydro tower to coax 3-ketone; 2- (2,3-di Nitromethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone: Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please Read the notes on the back before filling in this page) 2 — (2,3-diaminofluorenyl) —6— (3,4-dimethoxyphenyl) —2,3,4,5-tetrahydro Datra-3-ketone; 2- (2,4-dinitrofluorenyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetraazafluorene 3-fluorene: 2- (2,4-diaminobenzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap- 3-ketone; 2— (4-Nitrofluorenyl) —6 — (3,4_dimethoxybenzene paper size applies to Chinese National Standard (CNS) A4 specifications (210X297 mm) -24-475927 A7 B7 Specify (22) yl) -5-ethyl-2,3,4,5-tetrahydrodatrapeptone 3-ketone: 2- (4-aminoamino) -6- (3,4-dimethylamine Oxyphenyl)-5-ethyl-2,3,4,5-tetragas tower coercion; 2- (3-nitrobenzyl) -6- (3,4-dimethoxyphenyl) ) A 5-ethyl-2,3,4,5-tetrahydro trap-a 3-ketone: 2- (3-aminoamino)-6- (3,4-dimethoxyphenyl)- 5-Ethyl-2,3,4,5-tetraazapyrene: one 3-reward 'm. ρ. 4 9 °; 2-(2-nitromethyl)-6-(3,4-dimethoxyphenyl)-5-ethyl-2, 3, 4, 5-four gas towers coax a 3- Ketone 1: 2- (2-amino narrow group) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrazolium tower ; 2— (2,3-dinitromethyl) —6— (3,4-dimethoxyphenyl) —5—ethyl—2,3,4,5—tetrazolium tower—1 Ketones: 2— (2,3—diaminobenzyl) —6— (3,4—Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Oxygen Phenyl)-5 -ethyl-2,3,4,5-tetrahydrodatrapeptone 3 -one; 2- (2,4-dinitromethyl)-6- (3,4-dimethoxy Phenyl) -5-ethyl-2,3,4,5-tetrahydrodatrapeptone-3 monoketone: 2- (2,4-diaminobenzyl) -6- (3,4-dimethyl (Oxyphenyl)-5 -ethyl-2,3,4,5-tetraazepine-co- 3 -one; This paper size applies to China National Standard (CNS) A4 (210X297 mm) -25-475927 A7 B7 V. Description of the invention (23) 2 — (4-nitronitro group) — 6 — (3-methoxyl 4 —difluoromethoxyphenyl) — 5_ethyl — 2 , 3,4,5-tetrahydro trap-3-ketone: 2- (4-aminoamino) -6- (3-methoxy-4-dimethoxymethoxyphenyl) -5-ethyl A 2 ′ 3 ′ 4 ′ 5 —four-gas tower co- 3 —one; 2 — (4-nitromethyl) — 6 — (3 —methoxy — 4 —difluoromethoxyphenyl) — 5-Ethyl-2,3,4,5-tetrahydro trap-3 Ketone: 2- (4-aminoamino) -6- (3-methoxy-4-dimethoxymethoxyphenyl ) A 5-ethyl-2,3,4,5-tetraaza-tower coke-3 -one; 2- (4-nitrobenzyl) -6- (3-methoxy-4-fluoromethoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydro-trap-3-ketone: 2-(4-amino narrow group)-6-(3 -methoxy-4 -fluoromethyl (Oxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the note on the back first) Please fill in this page again for the matters) 3 -ketone; 2-(4-mononitrofluorenyl) -6- (3-difluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3, 4,5 -tetrazolium tower -3-ketone: 2-(4-aminoamino)-6-(3-difluoromethoxy-4 -methoxyphenyl)-5-ethyl -2, 3,4,5 —tetrazole tower coke —3 —ketone; This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) -26-475927 A7 B7 V. Description of the invention (24) 2 — (4_ Nitromethyl) -6- (3-trifluoromethoxy-1. 4-monomethoxyphenyl)-5-ethyl-2,3,4,5-tetrahydro-3 -one: 2- (4-aminobenzyl) -6- (3-trifluoromethyl Oxy-4-methoxymethoxy) -5ethyl-2,3,4,5-tetraazepine-3-3-ketone; 2- (4-nitrobenzyl) -6- (3 _Fluoromethoxy-4-methoxyphenyl)-5-ethyl_2,3,4,5-tetrazol tower co-a 3-ketone: 2- (4-aminomethyl) -6- (3-Fluoromethoxy-4-methoxyphenyl)-5-ethyl-2,3,4,5-tetrakiazol-a 3-ketone; 2- (4-nitrobenzyl)- 6- (3-methoxy-4-ethoxyphenyl)-5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone: 2- (4-aminoamino) 6— (3—Methoxy—4—B Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) oxyphenyl) _5 —Ethyl-2,3, 4,5-tetrachloro tower coaxes a 3-ketone; 2- (4-nitromethyl) -6- (3-ethoxy-4-methoxyphenyl) -5-ethyl-2,3 , 4,5-tetrazolium tower co-a 3-ketone: 2- (4-aminoamino) -6- (3-ethoxy-4 4-methoxyphenyl) -5-ethyl-2,3 , 4,5 —tetrazol tower co-a 3-ketone; This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) _ 475927 A7 B7 V. Description of the invention (25) 2 — (4-mononitro Book base) 6- (3-Hydroxy-4_methoxyphenyl) -5-Ethyl-2,3,4,5-tetrahydro-trap-3-ketone: 2-(4-aminobenzyl Group)-6-(3-hydroxy-4-methoxyphenyl)-5-ethyl-2, 3, 4, 5-tetrahydrodatra well-3-ketone; 2-(4-nitrobenzyl )-6- (4-Methanesulfonylphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone: 2- (4-aminoamidoxy) -6- (4-Methenylphenyl) —5 —ethyl-2,3,4,5-tetraazepine to coke 3-ketone; 2 — (4-nitrobenzyl) — 6 — (4 — (Methoxyphenyl) 5-ethyl-2,3,4,5-tetrakidone co-a 3-ketone: 2- (4-aminobenzyl) -6- (4 Methyloxyphenyl) —5 —ethyl-2,3,4,5-4-gas tower coaxed a 3-keto 1; 2 — (4-nitromethyl) — 6 — (3-cyclopentyl Oxy-4—methoxyphenyl) -5—ethyl-2,3,4,5-tetrahydro trap-3—one: Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the note on the back first) Please fill in this page for more details) 2 — (4-monoaminobenzyl) -6— (3-cyclopentyloxy-4—methoxyphenyl) -5—ethyl-2,3,4,5—tetra Hydrogen trap 3-ketone; 2- (3-nitrofluorenyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5- Tetrahydro trap- 3 -ketone: 2-(3-aminobenzyl) -6- (3-cyclopentyloxy-4)-This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ μ 475927 A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (26) methoxyphenyl)-5-ethyl-2, 3, 5-four Μ tower coaxed a 3-copper, ρ · 109ο; 2 — (4-nitrophenylethyl) -6_ (3,4-dimethoxy Phenyl) a 5-ethyl-2,3,4,5-tetragas tower to coax a 3-fluorene-2- (4-aminophenethyl) -6- (3,4-dimethoxybenzene A) 5-ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone, 2- (4-nitrophenethyl) -6- (3,4-dimethoxyphenyl ) A 5-ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone 2- (4-aminoaminophenethyl)-6- (3,4-dimethoxyphenyl)- 5-Ethyl-2,3'4,5-tetraazaphosphonium co-a 3-keto I 9 2- (3-nitrobenzyl) -6- (3-ethoxy-4 4-methoxybenzene A) 5 -ethyl-2,3,4,5 -tetrazol tower to cope with a 3 -ketone: 2-(3 -aminomethyl)-6-(3 -ethoxy-4 -methoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydro-trapping well 3 -one, m. p. 1120 0 Example 5 1 Og of 2- (4-Cyanosyl) -6- (3,4-dioxetylphenyl) -5-ethyl-2'3'4'5-tetrazolium tower I; _ | _ This paper size applies to China National Standard (CNS) A4 (210X297 mm) m 'ϋϋ —Lr--* I 1. ^ 1 1. ^ 1 n (Please read the precautions on the back before filling this page) Order printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 475927 A7 B7 V. Description of the invention (27) 3-Ketone is added while stirring at the same time. It was dissolved in a cold solution of 1.2 g NaOH in 100 mi water, and the mixture was then stirred for 10 hours. Further, careful heating was applied and air flow passed through the solution. Subsequently, cold sulfuric acid and water were added. The mixture was treated in the usual manner, resulting in 2- (4-carboxycarboxybenzyl) -6- (3,4-dihydroxyphenyl) -5-ethyl-2,3,4,5-tetrahydroda Trap 3 -one Example 6 To 3.0 g of 2- (4-aminoaminobenzyl) -6- (3,4-dimethoxyphenyl) dissolved in 8 Omj? Of dichloromethane A 2,3,4,5-tetrahydro-trap well a 3-ketone () and 0. A solution of 75 mj? Of pyridine was added with 1.0 g of butanyl chloride and then stirred for 1 hour. The solvent was removed and the residue was treated in the usual manner. After recrystallization, 2- (4-butyridinoaminofluorenyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap- 3-ketone was obtained , M. ρ · 1 4 8. . In a similar manner, by reacting, D " with the following reactants to obtain the following products (ie, expressed as, reactant 〃:% product "); and acetyl chloride: 2— (4-Ethylamidofluorenyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone (CNS) A4 specification (210X 297 mm) IV I ill · n 1 ili I (Please read the notes on the back before filling in this page) Order -30-475927 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Invention description (28) m. p. 18 3 °; with trifluoroacetamyl chloride: 2- (4-trimethylacetamide narrow group) -6- (3,4-dimethoxyphenyl) -2,3,4,5--4 Hydrogen trap-3-ketone, m. p. 2 1 0 °; with methanesulfonyl chloride: 2- (4-methanesulfonylamine-narrow group) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrazine Tower coaxes a 3-ketone, m. p. 1 3 8 °; with propionyl chloride: 2- (4-propanylaminomethyl)-6- (3,4-dimethoxyphenyl) _2,3,4,5-tetrazolium tower 3-ketone, m. p. 17 6 °; with 2,2-dimethylpropanyl chloride: 2- (4-tert-butylcarbonylaminofluorenyl)-6- (3,4-dimethoxyphenyl)-2, 3, 4, 5 —tetrazolium tower coaxes 3 — 嗣 'm. p. 15 5 °; with isobutylphosphonium chloride: 2- (4-isobutylphosphoniumaminofluorenyl) -6- (3,4-dimethoxyphenyl) -1,2,3,4,5-tetrahydroda Trap 3-ketone; and methyl chloroformate: 2- (4-methoxymethoxyaminomethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5 — Tetrahydro-trap-one 3-ketone; and Tetrazine chloride: This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ _ n 'I. . . . . . . . . 1 Him H m I (Please read the precautions on the back before filling out this page) 475927 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (29) 2— (4 Tetamidine Narrow Base ) A 6- (3,4-dimethoxyphenyl) -2,3,4,5-tetragas tower to cope with a 3-payer; and cyclopentanecarbamyl chloride: 2-(4-cyclopentylamino Formamyl benzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap- 3-ketone; and ethyl chloroformate: 2-(4 -ethyl Oxydiaminyl)-6-(3,4 -dimethoxyphenyl) -2,3,4,5-tetrahydro trap-3-ketone, m. ρ · 1 4 7 0; and chlorantrol chloride: 2— (4- chloroformylbenzyl) —6— (3,4-dimethoxyphenyl) —2,3,4,5— The four nitrogen tower coaxes a 3-keto-1; and chloroformamide: 2- (4-adenosyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5 — Tetrahydrotrapeptone 3-ketone; and pentamidine chloride: 2- (4-pentanylaminomethyl)-6- (3,4-dimethoxyphenyl)-2, 3, 4, 5 — The four nitrogen tower coaxed a 3-keto I: and hexamethylene chloride: 2- (4-hexylaminomethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetra Azapine coaxes 3-keto-1; and pentafluoropropanyl chloride: 2- (4-pentafluoropropanamidofluorenyl) -6- (3,4-dimethoxyphenyl) -2,3 , 4,5-tetrahydro-trap-a 3-ketone. This paper size applies to China National Standard (CNS) A4 (210X297 mm) _ 32-(Please read the precautions on the back before filling out this page) 475927 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (30) In a similar manner, by making 2- (4-aminoamino) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3'4,5- Tetrahydrotrapone 3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactants '; "products'); and acetamidine: 2 — (4 — Ethylaminomethyl) -6- (3'4-dimethoxyphenyl) _2,3,4,5-tetrahydrodatrapeptone 3-ketone; and trifluoroacetamidine: 2- (4 —Trifluoroacetamido) — 6 — (3,4-dimethoxyphenyl) — 2, 3, 4, 5 —tetrahydro trap — 3 — ketone, m. p. 1 3 3 °; with methanesulfonyl chloride: 2— (4-methanesulfonylaminobenzyl) —6— (3,4—dimethoxyphenyl) —5—ethyl—2, 3, 4 , 5-tetrahydro-trap-a-3 ketone; and propanyl chloride: 2- (4-propanamidinyl) -6- (3,4-dimethoxyphenyl)-5-ethyl- 2,3,4,5-tetrahydro-trap-a 3-ketone, m · p · 8 1 0 and dimethylpropanyl chloride: 2-(4-tert-butyl-chitylamino)-6- (3,4—dimethoxyphenyl) -5—ethyl-2,3,4,5—tetrahydrodatrap This paper is sized for China National Standard (CNS) A4 (210X297 mm) _ 33 _ (Please read the notes on the back before filling this page)
LP 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(31 ) —3 —酮; 與丁醯氯: 2— (4 — 丁醯胺基窄基)一 6— (3,4 一二甲氧 基苯基)一 5 —乙基—2,3,4,5 —四氣塔哄一 3 — 酮,m · ρ · 1 1 7 ° ; 與異丁醯氯: 2— (4 —異丁醯胺基爷基)一 6— (3,4 —二甲 氧基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一3 -酮; 與氯甲酸甲酯: 2— (4 —甲氧鑛基胺基爷基)一6 —(3 ,4 —二 甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫嗒阱一 3 —酮,m.p.1440 ; 與特戊醯氯: 2 —(4 一特戊醯胺基爷基)一 6— (3,4 一二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 -酮; 與環戊烷碳醯氯: 2 —(4 一環戊基氣基甲醯1j?基)一 6 —(3,4 一 二甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫嗒阱 一 3 —酮,· 與氯甲酸乙酯: 2 —(4 —乙氧裁基胺基窄基)一6 — (3,4 —二 甲氧基苯基)一 5 —乙基一 2 ’ 3 ^ 4 ,5 —四氮塔哄一 本紙張尺度適用中國國家標準(〇呢)八4規格(210'乂297公釐)_9/1_ (請先閲讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(32 ) 3 —酮|,πι·ρ·1540; 與甲草醯氯: 2— (4 —甲草酿胺基窄基)一6 —(3,4 一二甲 氧基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一 3 -酮; 與氯甲醯氯: 2— (4 —脲基苄基)一6 —(3,4 一二甲氧基苯 基)一5 —乙基一2,3,4 ,5 —四氫嗒阱一3 —酮; 與戊醯氯: 2 —(4 —戊醯胺基爷基)一 6— (3,4 —二甲氧 基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一 3-酮; 與己醯氯: 2— (4 —己醯胺基爷基)一6— (3,4 —二甲氧 基苯基)一5 —乙基一2,3,4,5 —四氮卩荅哄一3_ 酮; 與五氟丙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2— (4 —五氟丙醯胺基苄基)一 6 — (3,4 —二 甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮卩荅哄一 3 —酮。 以類似之方式,藉由令2_ (4 —胺基爷基)一 6_ (3 —乙氧基一4 —甲氧基苯基)一5 —乙基_2 ’ 3 ’ 4 ,5 —四氫嗒阱一3 —酮與下述之反應物反應,以獲致 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)_奶 475927 A7 B7 五、發明説明(33 ) 下述之產物(即,以 反應物 產物'之方式表示) 經 濟 部 t 央 標 準 員 工 消 費 合 作 社 與乙醯氯: 2— (4 —乙醯胺基爷基)一6 —(3 — —甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —3 —酮: 與三氟乙醯氯: 2— (4 —三氟乙醯胺基爷基)一6—( —4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 嗒阱—3 -酮; 與甲磺醯氯: 2— (4 —甲磺醯胺基爷基)—6— (3 4 —甲氧基苯基)一 5 —乙基一 2 ,3 ,4 , 阱—3 —酮; 與丙醯氯: 2— (4 —西酿胺基爷基)一 6_ (3 — 一甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —3 -酮; 與丁醯氯: 2 —(4一 丁醯胺基爷基)_6 —(3 —乙氧基_4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫嗒哄 —3 —酮; 與異丁醯氯: 乙氧基一 4 一四氫嗒阱 3 —乙氧基 ,5 —四氮 —乙氧基一 5 —四氮塔 乙氧基一 4 —四氮塔哄 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ % _ 475927 A7 B7 五、發明説明(34 ) 2 —(4_異丁醯胺基窄基)一6—(3 —乙氧基— 4 —甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5—四氣塔 哄—3 —酮; 與氯甲酸甲酯: 2 — (4-甲氧羰基胺基苄基)一6 —(3-乙氧基 一 4 —甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氣 塔哄—3 —酮; 與特戊醯氯: 2 —(4 —特戊醯胺基苄基)一6_ (3 —乙氧基一 4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氮口荅 阱_ 3 -酮; 與環戊烷碳醯氯: 2_ (4_環戊基氨基甲醯苄基)一6— (3 —乙氧 基一4~甲氧基苯基)一5—乙基一2 ,3 ,4 ,5 —四 氫塔阱_ 3 -酮; 與氯甲酸乙酯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2— (4_乙氧羰基胺基苄基)一6_ (3 —乙氧基 —4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮 塔阱—3 —酮; 與甲草醯氯: 2 —(4 一甲草醯胺基苄基)一6 —(3 —乙氧基一 4 -甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氫塔 阱—3 -酮; 與氯甲醯氯: _. I_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 475927 經濟部中央標準局員工消費合作社印製 A7 _B7___五、發明説明(35 ) 2— (4 —脲基笮基)一 6 —(3 —乙氧基一 4 一甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氣塔哄一 3 一酮; 與戊醯氯: 2 -(4一戊醯胺基笮基)一 6 —(3 -乙氧基一 4 一甲氧基苯基)一5 —乙基一 2,3,4,5 —四氣塔哄 一 3 -酮; 與己醯氯: 2 —(4 一己醯胺基苄基)一6 —(3 —乙氧基一 4 一甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氣塔阱 一 3 -酮; 與五氟丙醯氯: 2 —(4 一五氟丙醯胺基笮基)一6 —(3 —乙氧基 一 4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫 嗒哄一 3 -酮。 以類似之方式,藉由令2— (4 —胺基苄基)一 6 — (3 —環戊基氧一 4 一甲氧基苯基)一5 —乙基一2 ’ 3 ,4,5—四氫嗒阱一 3 —酮與下述之反應物反應,以獲 致下述之產物(即,以%反應物': >產物'之方式表示 ); 與乙醯氯: 2 —(4 一乙醯胺基爷基)一 6— (3 —環戊基氧一 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)0〇 -〇〇 - ·—Φ 裝— (請先閲讀背面之注意事項再填寫本頁) I Γ-ll I . 訂 —0 475927 附件2 :第85102257號專利申請案中文說明書修正頁 民國88年3月呈 五、發明説明(36) 4 一甲氧基苯基)一 5 —乙基一 2,3 ,4,5 —四氫塔 阱一 3 —酮; 與三氟乙醯氯: 2 -(4 一三氟乙酿胺基爷基)—6 — (3 —環戊基 氧一 4 一甲氧基苯基)一5 —乙基一 2,3 ,4,5 —四 氫嗒阱一3-酮;m.p·162° ; 與甲磺醯氯z 2 —(4 一甲磺醯胺撐苄基)—6 —(3 —環戊基氧 一 4 —甲氧基苯基)一5 —乙基一2 ,3 ,4,5 —四氫 嗒阱—3 —酮; 與丙醯氯: 2 -(4 一丙醯胺基爷基)一 6 -(3 —環戊基氧一 4 一甲氧基苯基)一 5—乙基一 2,3 ,4,5 —四氫嗒 阱一 3 -酮,πι·ρ·6 9。; 與2,2 —二甲基丙醯氯: 2 -(4 一特丁基羰基胺基笮基)一 6 -(3 -環戊 基氧一 4 —甲氧基苯基)一 5 —乙基一 2,3 ,4,5 — 四氫嗒阱一3—酮; 與丁醯氯: 2— (4 — 丁醯胺基爷基)一 6 —(3 —環戊基氧一 4 —甲氧基苯基)一 5 —乙基一 2,3 ,4,5 —四氫嗒 阱—3 —酮; 與異丁醯氯: 2 —(4 一異丁醯胺基爷基)一 6 —(3 —環戊基氧 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事 ,項再填· :寫本頁) 經濟部中央標準局員工消費合作社印製 - 39 - 475927 A7 B7 五、發明説明(37 ) 一 4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氣 塔哄—3 —酮; 與氯甲酸甲酯: 2 —(4 一甲氧羰基胺基苄基)_6 —(3 —環戊基 氧一 4 —甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 _四 氣塔哄—3 -酮; 與特戊醯氯: 2 —(4 —特戊醯胺基爷基)—6 -(3 —環戊基氧 —4—甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮 塔阱—3 —酮; 與環戊光碳醯氯: 2 —(4 —環戊基氨基甲醯苄基)一6— (3 —環戊 基氧一4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 — 四氣嗒阱—3 —酮; 與氯甲酸乙酯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2 —(4 —乙氧幾基胺基爷基)—6— (3 —環戊基 氧一4 一甲氧基苯基)一5-乙基一2 ,3 ,4 ,5 —四 氫嗒阱一3 —酮,m.p.73° ; 與甲草醯氯: 2 —(4 —甲草醯胺基笮基)—6_ (3 —環戊基氧 —4—甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5—四氯 塔哄—3 —酮; 與氯甲醯氯: 2 -(4_脲基笮基)—6— (3 —環戊基氧一 4 一 本紙張尺度適用中國國家標準(0奶)八4規格(210'/297公釐)_4〇_ 475927 A7 B7 五、發明説明(38 ) 甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四Μ塔哄一 3 —酮; 與戊醯氯: 2 —(4-戊醯胺基苄基)-6 -(3-環戊基氧一 4 一甲氧基苯基)一 5—乙基一 2 ,3,4 ,5 —四氮塔 阱—3 —酮; 與己醯氯: 2—(4 —己醯胺基苄基)—6 — (3 —環戊基氧— 4 一甲氧基苯基)_5 —乙基一 2 ,3 ,4 ,5 —四氫嗒 阱_ 3 —酮; 與五氟丙醯氯: 2 — (4 —五氟西醯胺基爷基)—6 — (3 —環戊基 氧一4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四 氫塔阱—3 —酮。 以類似之方式,藉由令2 — (4 —胺基苯乙基)一6 —(3 ,4 —二甲氧基苯基)一5 —乙基一2 ,3 ,4 , 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 5 -四氫嗒阱一 3 —酮與下述之反應物反應,以獲致下述 之產物(即,以a反應物':%產物#之方式表示); 與乙醯氯: 2 — (4 一乙酸胺基苯乙基)一 6 — (3 ,4 一二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 -酮; ' ί 本紙張尺度適用中國國家標準(〇呢)八4規格(210、乂297公釐)_>11_ 經濟部中央標準局員工消費合作社印製 475927 A7 B7 五、發明説明(39 ) 與三氟乙醯氯: 2 —(4 —三氟乙醯胺基苯乙基)一 6 —(3,4 — 二甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氫嗒阱 一 3 —酮; 與甲磺醯氯: 2 —(4 一甲磺醯胺撑苯乙基)一6 —(3 ,4 —二 甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與丙醯氯: 2— (4 —丙醯胺基苯乙基)一6 — (3 ,4 —二甲 氧基苯基)一5 —乙基一2,3,4,5 —四氫嗒阱一3 -酮: 與丁醯氯: 2_ (4 — 丁醯胺基苯乙基)一6_ (3 ,4_二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一3 -酮; 與異丁醯氯: 2— (4 —異丁醯胺基苯乙基)—6 — (3,4 一二 甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與氯甲酸甲酯: 2 —(4 一甲氧幾基胺基苯乙基)一 6 —(3 ,4 — 二甲氧基苯基)一 5—乙基一 2 ,3 ,4 ,5 —四氫嗒哄 一 3 - 酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) --------*---裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 475927LP 475927 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (31) —3-ketone; and Butanyl Chloride: 2— (4-Butanamine Narrow Base) —6— (3, 4 One dimethoxyphenyl) one 5-ethyl-2,3,4,5- four gas tower to coax one 3-one, m · ρ · 1 1 7 °; and isobutyrine chloride: 2-(4 —Isobutylamidinoyl) — 6 — (3,4-dimethoxyphenyl) — 5 —ethyl — 2,3,4,5 —tetrahydrotrap — 3-ketone; and chloroformic acid Methyl esters: 2- (4-methoxymethoxyaminomethyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrotrap A 3-ketone, mp1440; and pentamidine chloride: 2- (4-pentamylamino)-6- (3,4-dimethoxyphenyl) -5-ethyl-2, 3,4,5-tetrahydro-trap-3-ketone; and cyclopentanecarbamyl chloride: 2— (4-cyclopentylaminomethyl 1j? Yl) -6— (3,4-dimethoxy Phenyl)-5 -ethyl-2,3,4,5 -tetrahydro-trap well 3 -one, and ethyl chloroformate: 2-(4 -ethoxy Nylamino group)-6-(3,4-dimethoxyphenyl)-5-ethyl-2 '3 ^ 4, 5-tetrazolium tower, a paper size applicable to Chinese national standards (0? ) 8 4 specifications (210 '乂 297 mm) _9 / 1_ (Please read the notes on the back before filling out this page) 475927 A7 B7 V. Description of the invention (32) 3-ketone |, π · ρ · 1540; and Acetochlor: 2- (4--Aminopyrene narrow group) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro Trap-3-ketone; and chloroformamidine chloride: 2- (4-Ureabenzyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5 —Tetrahydro-trap-3-ketone; and pentamidine chloride: 2- (4-pentamylaminomethyl) —6- (3,4-dimethoxyphenyl) —5-ethyl-2, 3,4,5 —tetrahydrothrapy 3-ketone; and hexamethylene chloride: 2- (4-hexamethyleneaminomethyl) -6- (3,4-dimethoxyphenyl) -5— Ethyl-2,3,4,5-tetraazepine to coax 3_ ketone; and pentafluoropropanyl chloride: printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the precautions on the back before filling out this page) 2— (4-pentafluoropropylamidobenzyl) —6— (3,4-dimethoxyphenyl) —5—ethyl-2, 3,4,5-tetraazepine coaxes a 3-ketone. In a similar manner, by making 2_ (4-aminomethyl) -6_ (3-ethoxy-4_methoxyphenyl) -5_ethyl_2'3'4, 5-tetrahydro Datra-3 ketone reacts with the following reactants to obtain the paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) _milk 475927 A7 B7 V. Description of the invention (33) The following product ( That is, it is expressed in the form of a reactant product.) The Ministry of Economic Affairs and the Central Standard Employee Consumer Cooperative and Acetyl Chloride: 2— (4-Ethylaminomethyl) —6— (3——methoxyphenyl) — 5-Ethyl-2,3,4,5-3-ketone: and trifluoroacetamido chloride: 2- (4-trifluoroacetamidomethyl)-6-(-4 monomethoxyphenyl ) A 5-ethyl-2,3,4-datra-3-one; and methanesulfonyl chloride: 2- (4-methylsulfanylaminomethyl) -6- (3 4 -methoxyphenyl ) A 5-ethyl-2,3,4, trap-3-ketone; and propanyl chloride: 2- (4-mercaptoamino)-6_ (3-monomethoxyphenyl)-5 —Ethyl-2,3,4,5- 3 -one; and Butanidine : 2 — (4-Butylaminomethyl) -6— (3-ethoxy-4—methoxyphenyl) -5—ethyl-2,3,4,5—tetrahydroda —3 —Ketone; and isobutylammonium chloride: ethoxy-4, tetrahydrohydrogen trap 3—ethoxy, 5—tetrazol—ethoxy—5—tetrazol ethoxy—4—tetrazol tower ( Please read the precautions on the back before filling this page) This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) _% _ 475927 A7 B7 V. Description of the invention (34) 2 — (4_iso 丁 醯Narrow amino group)-6- (3-ethoxy-4 -methoxyphenyl)-5-ethyl-2,3,4,5-tetragas tower coke-3 -one; and methyl chloroformate Esters: 2- (4-methoxycarbonylaminobenzyl) -6- (3-ethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-4-gas tower Cocoa-3 ketone; and pentamidine chloride: 2- (4-pivalamidobenzyl) -6- (3-ethoxy-4-methoxyphenyl) -5-ethyl-2, 3,4,5 —tetrazolium hydrazone trap 3-ketone; and cyclopentanecarbamyl chloride: 2_ (4-cyclopentyl Methylformylbenzyl) -6- (3-ethoxy-4 ~ methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower trap 3-ketone; and chloroformic acid Ethyl ester: Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) 2— (4_ethoxycarbonylaminobenzyl) —6_ (3 —ethoxy-4— (Methoxyphenyl)-5-ethyl-2,3,4,5-tetraaza-trap-3-3-one; and chloroform: 2- (4-metachlor benzyl) -6 — (3-Ethoxy-4-methoxyphenyl) —5-Ethyl-2,3,4,5-tetrahydro tower trap—3-ketone; and chloroformyl chloride: _. I_ This paper The standard is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) _475927 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _B7___ V. Description of the invention (35) 2— (4—ureidofluorene-based) —6— (3-Ethoxy-4-methoxymethoxyphenyl) -5-ethyl-2,3,4,5-tetragas tower coax a 3-one ketone; and pentamidine chloride: 2-(4-pentamidine Aminofluorenyl) -6- (3-ethoxy-4-methoxy A) 5 -ethyl-2,3,4,5-four gas towers to cope with a 3-ketone; and hexamethylene chloride: 2-(4-hexamethyleneaminobenzyl)-6-(3-ethoxy -4 -methoxyphenyl) -5 -ethyl -2,3,4,5-four gas tower traps-3-ketone; and pentafluoropropanyl chloride: 2-(4-pentafluoropropanamido group (Methenyl) -6- (3-ethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydroda-co-3-ketone. In a similar manner, by making 2- (4-aminobenzyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2'3,4,5 -Tetrahydro trap-3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactant ': >product'); and acetamidine: 2-(4 Acetylamidoyl) 6- (3-Cyclopentyloxy) A paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 0〇-〇〇- · Φ Pack— (please first Read the notes on the reverse side and fill in this page) I Γ-ll I. Order-0 475927 Annex 2: Revised page of Chinese specification of Patent Application No. 85102257 March, 88, Republic of China 5. Fifth, the invention description (36) 4 Phenyl) a 5-ethyl-2,3,4,5-tetrahydro tower trap a 3-ketone; and trifluoroacetamyl chloride: 2-(4-trifluoroethylaminomethyl) -6 — (3-Cyclopentyloxy-4-methoxymethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrodatrapeptone 3-ketone; mp · 162 °; and methanesulfonyl chloride z 2 — (4-methanesulfenylbenzyl) -6— 3-Cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-3 trap-one; and propanyl chloride: 2-(4-propanyl Aminomethyl) -6- (3-Cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrodatrapeptone 3-π, π · ρ · 6 9. ; With 2,2-Dimethylpropionyl chloride: 2- (4-tert-butylcarbonylaminofluorenyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl 1,2,3,4,5 — Tetrahydro trap — 3-ketone; and butyl chloride: 2- (4-butanylaminomethyl) — 6 — (3-cyclopentyloxy — 4 —methyl (Oxyphenyl)-5 -ethyl-2,3,4,5 -tetrahydro trap-3 -one; and isobutyrine chloride: 2-(4-isobutylamidinoyl)-6- (3 —Cyclopentyloxy This paper is sized for China National Standard (CNS) A4 (210X 297 mm)) (Please read the notes on the back, and then fill in the items:: Write this page) Employees of the Central Bureau of Standards Printed by the cooperative-39-475927 A7 B7 V. Description of the invention (37)-4-methoxyphenyl)-5-ethyl-2, 3, 4, 5-four-gas tower coke-3-ketone; and chlorine Methyl formate: 2- (4-monomethoxycarbonylaminobenzyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5_tetra Air tower cooing—3-ketone; and Tetrazine Chloride: 2— (4-Tetrazine Methyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetraaza tower trap 3-ketone; and cyclopentyl Carbochloride: 2- (4-cyclopentylaminomethylbenzyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5 — Four air traps—3-ketone; and ethyl chloroformate: printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) 2 — (4 —ethoxyamino Hexyl) —6 -— (3-cyclopentyloxy-4—methoxyphenyl) —5-ethyl-2,3,4,5—tetrahydrodawell—3-ketone, mp73 °; and Acetochlor: 2- (4-Metosaminomethyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5- Tetrachloromethane—3—ketone; and methamidyl chloride: 2— (4_ureidofluorenyl) —6— (3—cyclopentyloxy—4—paper size applicable to Chinese national standard (0 milk) 4 specifications (210 '/ 297 mm) _4〇_ 475927 A7 B7 5. Description of the invention (38) methoxyphenyl) One 5-ethyl-2,3,4,5-tetra-M tower coaxes a 3-ketone; with pentamidine chloride: 2- (4-pentanamidobenzyl) -6- (3-cyclopentyloxy A 4-methoxyphenyl group) a 5-ethyl-2,3,4,5-tetraaza tower trap-3 ketone; and hexamethylene chloride: 2- (4-hexamidineaminobenzyl)- 6 — (3 —cyclopentyloxy — 4 monomethoxyphenyl) — 5 —ethyl — 2,3,4,5 —tetrahydrotrap — 3 —one; and pentafluoropropanyl chloride: 2 — ( 4-Pentafluoroazetidinylamino) -6- (3-Cyclopentyloxy-4-methoxyphenyl) -5-Ethyl-2,3,4,5-tetrahydro tower trap-3 -ketone. In a similar way, by making 2- (4-aminophenethyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4, the Ministry of Economic Central Standard Printed by the Bureau ’s Consumer Cooperative (please read the precautions on the back before filling out this page) 5-Tetrahydro trap-3-Ketone reacts with the following reactants to obtain the following products (ie, a reactant ':% 产品 # The way of expression); with acetamyl chloride: 2 — (4-monoacetamidophenethyl) — 6 — (3,4 —dimethoxyphenyl) — 5 —ethyl — 2, 3,4,5 —tetrahydro-trap-one 3-ketone; 'ί The paper size is applicable to the Chinese National Standard (0?) 8-4 specifications (210, 乂 297 mm) Printed 475927 A7 B7 V. Description of the invention (39) and trifluoroacetamido chloride: 2 — (4-trifluoroacetamidophenethyl) — 6 — (3, 4-dimethoxyphenyl) — 5-Ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and methanesulfonyl chloride: 2— (4-methanesulfonylphenylene phenethyl) —6— (3,4— Dimethoxyphenyl) 5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and propanyl chloride: 2- (4-propanamidophenethyl) -6- (3,4-dimethyl (Oxyphenyl)-5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone: and butanyl chloride: 2- (4-butanylaminophenethyl)-6_ (3, 4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and isobutylphosphonium chloride: 2- (4-isobutylamidinylphenylethyl) ) -6— (3,4-dimethoxyphenyl) —5—ethyl—2,3,4,5-tetrahydrotrap —3—one; and methyl chloroformate: 2— (4 Monomethoxyepiaminophenylethyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydroda-co- 3 -one; Paper size applies to China National Standard (CNS) A4 specification (210X297 mm) -------- * --- install-(Please read the precautions on the back before filling this page) Order 475927
7 B 40氯 丨醯 明戊 説特 ψ與 發 五 2 4 基 苯 基 氧 甲 阱 嗒 氫 四 I 5, _ 4 \J/ , 基 3 乙 , 苯 2 基 I 胺基 醯乙 戊 I 特 5 6 3 4 3 阱 苯 醯一 甲基 基乙 氨| :基 5 氯戊 I : 醯環} 酯 碳 I 基 乙 烷 4 苯·,酸 戊ί 基酮甲 •,環 I 氧 I 氯 酮與 2 甲 3 與 基 乙 6 3 4 嗒 氫 四 1 5, 4, 3, 2 (請先閲讀背面之注意事項再填寫本頁) 2 4 乙 苯 基 I 胺基 基乙 羰 I 氧 5 乙 I : I Ν/ 氯 基 醯 苯;草 基酮甲 氧 I 與 甲 3 2 基 3 4 6 5 - 阱 4 塔 , 氫 3 四 阱 嗒 氫 四( - I 5 C3 , I 4\1/ , 基 3 乙 , 苯 2 基一 胺基 醯乙 草| 甲 5 : I I 胺 4 ) 醯 { 基 甲 1 苯·,氯 2 基酮與 氧 I 甲 3 3 4 經濟部中央標準局員工消費合作社印製 2 基 乙 苯 基 脲 I 4 6 4 基 氧 甲 基 苯 氯 醯 戊 與 2 4 11 1 3- 阱 嗒 氫 四- 5, 4, 3, 2 I 基 乙 基 苯; 基酮 氧| 57 B 40 Chloride, Benzene, pentamidine, and pentamyl 2 4 phenylphenyloxymethane, tetrahydrogen I 5, _ 4 \ J /, radical 3 ethyl, benzene 2 radical I, ammonium pentamide I, special 5 6 3 4 3 Trap Benzamidine Monomethyl Ethyl Ammonia |: Group 5 Chloropentyl I: Fluorene Ring} Ester Carbon I Ethyl Ethyl 4 Benzene, Pentyl Alkyl Ketone •, Cyclic I Oxygen I Chloroketone and 2 Methyl 3 and ethyl 6 3 4 Hydrogen tetra 1 5, 4, 3, 2 (Please read the precautions on the back before filling out this page) 2 4 Ethylphenyl I Amino Ethyl Carbon I Oxy 5 Ethyl I: I Ν / chlorobenzylbenzene; oxalone methoxy I and methyl 3 2 radicals 3 4 6 5-well 4 tower, hydrogen 3 tetra well hydrogen tetra (-I 5 C3, I 4 \ 1 /, radical 3 ethyl, Benzene 2-Amino-Acetoacetone | Methyl 5: II Amine 4) {{Methyl 1 Benzene, Chloro-2 Ketones and Oxygen I A 3 3 4 Printed by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, 2 Ethylbenzene Urea I 4 6 4 Methoxymethyl benzylchloride and 2 4 11 1 3-Tradahydrotetra-5, 4, 4, 3, 2 I ethyl ethylbenzene; Ketone oxygen | 5
嗒 氫 四 I 5, I 4 \1/ , 基 3 乙 , 苯 2 基 I 胺基 醯乙 戊 I 6 3 4 阱 甲 3 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 475927 A7 B7 五、發明説明(41 ) —酮; 與己醯氯: 2— (4 —己醯胺基苯乙基)一 6 —(3,4 一二甲 氧基苯基)一 5 _乙基一 2,3,4,5 —四氮塔哄一3 一酮; 與五氟丙醯氯: 2_ (4 —五氟丙醯胺基苯乙基)一6 —(3,4 — 二甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氫嗒哄 —3 —酮0 以類似之方式,藉由令2 —(3 —胺基爷基)一6 — (3 ,4 —二甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫嗒阱一3 -酮與下述之反應物反應,以獲致下述之 產物(即,以%反應物':%產物'之方式表示); 與乙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2— (3 —乙醯胺基笮基)一6— (3,4 —二甲氧 基苯基)一5 —乙基一2,3,4,5 —四氮卩荅哄一3 — 酮; 與三氟乙醯氯: 2— (3 —三氣^乙醯胺基爷基)一 6_ (3,4 —二 甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮,m.p.1420 與甲磺醯氯:Hydrogen tetrahydrogen I 5, I 4 \ 1 /, radical 3 ethyl, benzene 2 radical I, amino ammonium pentamide I 6 3 4 trap A 3 This paper size applies to China National Standard (CNS) A4 specifications (210X297 mm) _ 475927 A7 B7 V. Description of the invention (41) -one; and hexamethylene chloride: 2- (4-hexamidoaminophenethyl) -6- (3,4-dimethoxyphenyl) -5_ethyl Benzyl-2,3,4,5-tetrazolium towers cope with a 3 monoketone; and pentafluoropropanyl chloride: 2_ (4-pentafluoropropanamidophenethyl) -6- (3,4 —dimethyl (Oxyphenyl)-5-ethyl-2,3,4,5-tetrahydro-co--3 -keto0 In a similar manner, by making 2- (3-aminomethyl) -6- ( 3,4-dimethoxyphenyl)-5-ethyl-2,3,4,5-tetrahydro-trap- 3-ketone is reacted with the following reactants to obtain the following product (ie, Expressed in the form of% reactant ':% product'); and Acetyl chloride: Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) 2— (3 — Ethylamine Amidino)-6- (3,4-dimethoxyphenyl A 5-ethyl-2,3,4,5-tetraazepine co-a 3-ketone; and trifluoroacetamido chloride: 2- (3-trifluoro ^ ethylamidomethyl)-6_ (3 , 4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone, mp1420 and methanesulfonyl chloride:
: I 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(42 ) 2 — (3 —甲磺醯胺撑笮基)一 6 —(3 ,4 一二甲 氧基苯基)一 5 —乙基一 2,3,4,5 —四氮塔哄一 3 -酮; 與丙醯氯: 2 —(3 —丙醯胺基爷基)一6 —(3,4一二甲氧 基苯基)一5 —乙基一 2,3,4,5 —四氮塔哄一3 — 酮,m . p . 1 2 6 0 ; 與丁醯氯: 2 —(3 — 丁醯胺基爷基)一6— (3 ,4 一二甲氧 基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱一 3 — 酮; 與異丁醯氯: 2 —(3 —異丁醯胺基爷基)一 6— (3,4 一二甲 氧基苯基)一5 —乙基一 2,3,4,5 —四氣塔哄一3 —酮; 與氯甲酸甲酯: 2— (3 —甲氧羰基胺基苄基)—6 —(3 ,4 —二 甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氮塔哄一 3 —酮; 與特戊醯氯: 2 —(3 —特戊醯胺基爷基)一6 —(3,4 一二甲 氧基苯基)一 5 —乙基一2,3,4,5 —四氮塔哄一 3 —酮; 與環戊烷碳醯氯: _ I_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 4 φ 裝II (請先閲讀背面之注意事項再填寫本頁) 訂 475927 A7 B7 五、發明説明(43 ) 2_ (3 —環戊基氨基甲醯笮基)一 6 —(3,4 — 二甲氧基苯基)_5 —乙基一 2 ,3,4 ,5 —四氫嗒阱 —3 —酮,· 與氯甲酸乙酯: 2_ (3 —乙氧羰基胺基苄基)一6 —(3,4 一二 甲氧基苯基)一 5—乙基一 2 ^ 3 ^ 4 ^ 5 —四氮塔哄一 3 —嗣,τη·ρ·540 ; 與甲草醯氯: 2 — (3 —甲草醯胺基爷基)一6— (3 ,4 —二甲 氧基苯基)一 5 —乙基_2,3,4,5 —四氫嗒阱一3 一酮; 與氯甲醯氯: 2 —(3 —腺基爷基)一6 —(3,4 一二甲氧基苯 基)一5 —乙基一2 ,3,4 ,5 —四氮塔哄一3 —酮; 與戊醯氯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2 —(3 —戊醯胺基爷基)一6_ (3,4 一二甲氧 基苯基)一 5 —乙基一 2,3,4,5 —四氮卩答哄一3 — 酮; 與己醯氯: 2—(3 —己醯胺基窄基)一6— (3,4 —二甲氧 基苯基)一 5 —乙基一2,3,4,5 —四氫嗒阱一 3 — 酮; 與五氟丙醯氯: 2— (3 —丙氟丙醯胺基笮基)—6 -(3,4 一二 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)_ μ 475927 A7 B7 一 _ 一㈣ 五、發明説明(44 ) 甲氧基苯基)一 5 —乙基一 2,3,4,5 —四氫嗒阱一 3 —酮。 以類似之方式,藉由令2 —(4 一胺基笮基)一 6 — (3 —氟甲氧基一 4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4,5 —四氫嗒阱一 3 —酮與下述之反應物反應,以獲 致下述之產物(即,以%反應物# %產物"之方式表示 ); 與乙醯氯: 2 —(4 一乙醯胺基苄基)一 6 —(3 —氟甲氧基一 4 一甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒 阱一 3 —酮; 與三氟乙醯氯: 2 —(4 一三氧乙醯胺基爷基)一 6 —(3 —氟甲氧 基一 4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四 氫嗒阱一 3 -酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與甲磺醯氯: 2 —( 4 一甲磺醯胺撑窄基)一6— ( 3 —氟甲氧基 一 4 一甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氫 嗒阱—3 —酮; 與丙醯氯: 2— ( 4 —丙醯胺基爷基)一 6 —(3 —氟甲氧基— 4 一甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐)一 47 - 475927 A7 B7 五、發明説明(45 ) 阱—3 -酮; 與丁醯氯: 2—(4一丁醯胺基笮基)一6—(3—氟甲氧基一 4 —甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒 阱—3 —酮; 與異丁醯氯: 2 —(4 一異丁醯胺基苄基)_6 —(3 —氟甲氧基 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氣 嗒阱—3 —酮; 與氯甲酸甲酯: 2 —(4 —甲氧羰基胺基苄基)一6— (3 —氟甲氧 基一4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5-四 氫嗒阱一 3 _酮; 與特戊醯氯: 2— (4 —特戊醯胺基苄基)—6_ (3_氟甲氧基 —4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ’ 5 —四氮 塔阱—3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與環戊烷碳醯氯: 2 —(4 一環戊基氨基甲醯笮基)一6 —(3 —氟甲 氧基一4 一甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 — 四氫塔哄一3 —酮; 與氯甲酸乙酯: 2 —( 4 一乙氧裁基胺基爷基)一6 —( 3 —氟甲氧 基一4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ’ 5 —四 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_化 經濟部中央標準局員工消費合作社印製 475927 A7 B7 五、發明説明(46 ) 氫嗒阱一 3 —酮; 與甲草醯氯: 2 —(4_甲草醯胺基苄基)一 6 —(3 —氟甲氧基 一 4 —甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四Μ 塔阱—3 —酮; 與氯甲醯胺: 2— (4 —脲基爷基)_6 —(3 —氟甲氧基一4 — 甲氧基苯基)一5-乙基一2 ,3,4 ,5 —四氮塔哄一 3 -酮; 與戊醯氯: 2 —( 4 —戊醯胺基爷基)一6 —( 3 —氟甲氧基一 4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮口荅 阱—3 -酮; 與己醯氯: 2— (4 —己醯胺基窄基)一6— (3 —氟甲氧基一 4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫塔 阱一 3 -酮; 與五氟丙醯氯: 2 —(4 一五氟丙醯胺基苄基)一 6 — (3 —氟甲氧 基一 4 一甲氧基苯基)一 5-乙基一 2 ,3 ,4 ,5 —四 氫塔阱一 3 —酮。 以類似之方式,藉由令2 —(4 一胺基爷基)一6 — (3 —二氟甲氧基一4 —甲氧基苯基)一 5 —乙基一 2 , 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)^ -4y - ---- I------^^裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(47 ) 3,4,5_四氫嗒阱一 3 —酮與下述之反應物反應,以 獲致下述之產物(即,以%反應物':%產物'之方式表 示); 與乙醯氯: 2— (4 —乙醢胺基爷基)一6 —(3 —二氣甲氧基 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氣 嗒阱一 3 —酮; 與三氟乙醯氯: 2 —(4 一二氟乙醯胺基爷基)一6 —(3 —二氟甲 氧基一 4 一甲氧基苯基)一5 —乙基_2 ,3 ,4 ,5 — 四氫塔阱一 3 —酮; 與甲磺醯氯: 2 —(4 一甲磺醯胺撑爷基)一6 —(3 —二氟甲氧 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫 嗒阱_ 3 —酮; 與丙醯氯: 2—(4 一丙醯胺基苄基)一 6_ (3 —二氟甲氧基 —4 —甲氧基苯基)一5 —乙基一2,3,4 ,5 —四氫 嗒阱一3 -酮; 與丁醯氯: 2 —( 4 — 丁醯胺基笮基)一 6— ( 3 —二氟甲氧基 —4-甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫 嗒阱—3 —酮; _ I_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -〇1) (請先閲讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(48 ) 與異丁醯氯: 2 —(4 一異丁醯胺基苄基)一 6 —(3 —二氟甲氧 基一4 —甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四 氫塔阱一 3 —酮; 與氯甲酸甲酯: 2 —(4 一甲氧羰基胺基苄基)一 6 —(3_二氟甲 氧基一 4 —甲氧基苯基)一5 —乙基一2 ,3,4 ,5 — 四氫塔哄一 3 —酮; 與特戊醯氯: 2 —(4 —特戊醯胺基爷基)—6 —(3 —二氟甲氧 基一 4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四 氫塔阱一 3 -酮; 與環戊烷碳醯氯: 2 —(4_環戊基氨基甲醯苄基)一 6 —(3 —二氟 甲氧基一4 一曱氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氫嗒阱一3—酮; 與氯甲酸乙酯: 經濟部中央標準局員工消費合作社印製 ^n. - -- —--I - . - * - - m I - I (請先閲讀背面之注意事項再填寫本頁) 2— (4 —乙氧羰基胺基苄基)一6— (3 —二氟甲 氧基一4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ’ 5 — 四氫塔哄_ 3 _酮; 與甲草醯氯: 2— ( 4 —甲草醯胺基窄基)—6_ ( 3 —二氟甲氧 基一4 一甲氧基苯基)一5-乙基一2 ,3 ,4 ,5 —四 氫塔哄一 3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)c, bl _ 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(49 ) 與氯甲醢氯: 2 —(4 —脲基苄基)一6 —(3 —二氟甲氧基一 4 一甲氧基苯基)一 5 —乙基一 2,3,4 ,5 —四氫嗒阱 —3 -酮; 與戊醯氯: 2 —(4 一戊醯胺基笮基)一 6 —(3 —二氟甲氧基 —4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氮 嗒阱一 3 —酮; 與己醯氯: 2 —(4 一己醯胺基窄基)一6 —(3 —二氟甲氧基 一 4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮 塔阱—3 —酮; 與五氟丙醯氯: 2 —(4 一五氟丙醯胺基爷基)一 6 —(3 —二氟甲 氧基一4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 — 四氫嗒阱一3 —酮。 以類似之方式,藉由令2—(4—胺基爷基)一6— (3 —二氣甲氧基一4 一二甲氧基苯基)一 5 —乙基一2 ,3,4,5 -四氫嗒阱一3 —酮與下述之反應物反應, 以獲致下述之產物(即,以%反應物';%產物#之方式 表示); 與乙醯氯: I 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)-52 - (請先閱讀背面之注意事項再填寫本頁) ~^裝· 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(5〇 ) 2 —(4 一乙醯胺基笮基)一 6 —(3 —三氟甲氧基 一 4 —甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氣 喀阱—3 _酮; 與三氟乙醯氯: 2 —(4 一三氟乙醯胺基节基)一6 —(3 —三氟甲 氧基一4_甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 — 四氫塔胼一3 —酮; 與甲磺醯氯: 2— (4 —甲磺醯胺撑苄基)一 6— (3 —三氟甲氧 基一4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四 氫嗒阱一 3 _酮; 與丙醯氯: 2_(4—丙醯胺基爷基)一6_(3—三氧甲氧基 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫 塔阱—3 —酮; 與丁醯氯: 2 —( 4 一丁醯胺基苄基)一 6 — ( 3 —三氟甲氧基 一 4 一甲氧基苯基)一5-乙基一2 ,3 ,4 ,5 —四氫 塔哄—3 —酮; 與異丁醯氯: 2—(4一異丁醯胺基窄基)一6—(3—三氟甲氧 基一 4 —甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四 氫嗒阱—3 —酮; 與氯甲酸甲酯: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 53 - (請先閱讀背面之注意事項再填寫本頁) 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(51 ) 2 —(4 一甲氧裁基胺基爷基)一 6 —(3 —二氟甲 氧基一 4 一甲氧基苯基)一5 —乙基一 2,3,4 ,5_ 四氣塔阱一3_酮; 與特戊醯氯: 2—(4 一特戊醯胺基苄基)一 6 —(3 —三氟甲氧 基一 4 -甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四 氫嗒阱一 3 —酮; 與環戊烷碳醯氯: 2— (4 —環戊基氣基甲醯爷基)一 6— (3 —三氟 甲氧基一4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 一四氫塔阱一3 —酮; 與氯甲酸乙酯: 2 —(4 —乙氧裁基胺基爷基)—6_ (3 —三氟甲 氧基一4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 — 四氫塔哄一 3 —酮; 與甲草醯氯: 2 —(4 —甲草醯胺基苄基)一6 —(3 —三氟甲氧 基一4 —甲氧基苯基)一 5 —乙基一2 ’ 3 ,4 ,5 —四 氫嗒阱—3 -酮; 與氯甲醯氯: 2 — (4_脲基笮基)一6 —(3 —三氟甲氧基一 4 一甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮塔哄 —3 -酮; 與戊醯氯: 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 54 - (請先閱讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(52 ) 2_ ( 4 —戊醯胺基爷基)一 6—( 3 —二氟甲氧基 —4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫 塔阱—3 —酮; 與己醯氯: 2—(4一己醯胺基苄基)一6—(3—三氟甲氧基 -4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5-四氫 11荅阱—3 —酮; 與五氟丙醯氯: 2— (4 —五氟丙醯胺基苄基)一 6_ (3 —三氟甲 氧基一 4 一甲氧基苯基)一 5 —乙基一2 ,3,4 ,5_ 四氫嗒阱一 3 —酮。 以類似之方式,藉由令2 —(4 一胺基爷基)一 6 — (3 —甲氧基一 4 一氟甲氧基苯基)一 5 —乙基一 2 ,3 ,4,5_四氫嗒阱一 3 —酮與下述之反應物反應,以獲 致下述之產物(即,以%反應物':a產物'之方式表示 ); 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與乙醯氯: 2 —(4 一乙醯胺基爷基)一 6 —(3 —甲氧基一 4 一甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氮塔哄 一 3 -酮; 與三氟乙醯氯: 2 —( 4 —三氖乙醯胺基爷基)一 6_ ( 3 —甲氧基 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 55 - 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(53 ) 一 4 —甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氮 嗒阱一 3 -酮; 與甲磺醯氯: 2 —( 4 一甲磺醯胺基爷基)_6 —( 3 —甲氧基一 4 —氟甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫 塔哄—3 -酮: 與丙醯氯: 2 —(4 一丙醯胺基笮基)一6 — (3 —甲氧基一4 —氣甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮塔 阱—3 -酮; 與丁醯氯: 2_(4_ 丁醯胺基苄基)一6 — (3 —甲氧基一 4 —氟甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四氫嗒 阱—3 —酮; 與異丁醯氯: 2—(4—異丁醯胺基苄基)一6—(3—甲氧基一 4 —氟甲氧基苯基)一5-乙基一2 ,3,4 ,5 —四氫 塔哄…3 —酮; 與氯甲酸甲酯: 2_ (4 —甲氧羰基胺基笮基)一 6 —(3 —甲氧基 -4 —氟甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四 氫塔阱一 3 —酮; 與特戊醯氯: 2— (4 —特戊醯胺基笮基)一6— (3 —甲氧基一 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ % - (請先閱讀背面之注意事項再填寫本頁) • - 1—1 8 I - --- 1 -0裝·: I This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) _ 475927 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (42) 2 — (3 — Methanesulfonamide Fluorenyl) -6- (3,4-dimethoxyphenyl) -5-ethyl-2,3,4,5-tetrazol tower co-a 3-ketone; and propionyl chloride: 2- (3 —Propanamido) — 6 — (3,4-dimethoxyphenyl) — 5 —ethyl — 2,3,4,5 —tetrazol tower co-a 3-ketone, m.p. 1 2 6 0; With butanyl chloride: 2-(3-butanylaminomethyl)-6- (3,4-dimethoxyphenyl)-5 -ethyl-2,3,4,5 —Tetrahydro-trap-a 3-ketone; and isobutylphosphonium chloride: 2- (3-isobutylamidoamino) -6- (3,4-dimethoxyphenyl) -5-ethyl- 2,3,4,5-Four gas towers cope with a 3-ketone; and methyl chloroformate: 2- (3-methoxycarbonylaminobenzyl) -6- (3,4-dimethoxyphenyl ) A 5-ethyl-2,3,4,5-tetrazol tower to coax a 3-ketone; and pivaloyl chloride: 2— (3 —Tentamylaminomethyl) — 6 — (3,4-dimethoxyphenyl) — 5 —ethyl — 2,3,4,5 —tetrazolidine — 3 —ketone; and cyclopentyl Alkyl chloride: _ I_ This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) _ 4 φ II (Please read the precautions on the back before filling this page) Order 475927 A7 B7 V. Description of the invention (43) 2_ (3-Cyclopentylcarbamoyl) -6- (3,4-dimethoxyphenyl) _5-ethyl-2,3,4,5-tetrahydrotrap-3 —Ketone, · and ethyl chloroformate: 2- (3-ethoxycarbonylaminobenzyl) —6- (3,4-dimethoxyphenyl) —5-ethyl—2 ^ 3 ^ 4 ^ 5 —The tetrazolium tower coaxes 3— 嗣, τη · ρ · 540; and chloroform: 2 -— (3-metamorphinomethyl) —6- (3,4-dimethoxyphenyl) One 5-ethyl-2,3,4,5-tetrahydro-trap-one 3-one ketone; and chloroformyl chloride: 2- (3-adenosyl) -6- (3,4-dimethoxy Phenyl) a 5-ethyl-2,3,4,5-tetrazol tower coax a 3-ketone; and pentamidine chloride: Printed by the Consumer Standards Cooperative of the Ministry of Standards of the People's Republic of China (Please read the notes on the back before filling this page) —Ethyl-2,3,4,5 —tetraazepine to cope with a 3 — ketone; and hexamethylene chloride: 2 ((3-hexamidine amino narrow group) — 6 — (3,4 —dimethoxy Phenyl) -5 -ethyl -2,3,4,5-tetrahydrodatrapeptone-3-ketone; and pentafluoropropanyl chloride: 2-(3-propfluoropropylamidinofluorenyl) -6 -(3,4 12 This paper size applies to Chinese National Standards (CNS) A4 specifications (210X297 mm) _ 475927 A7 B7 _ _ ㈣ Ⅴ. Description of the invention (44) methoxyphenyl) 1-5-B The base is a 2,3,4,5-tetrahydro-trap-a 3-ketone. In a similar way, by making 2- (4-aminoamino) -6- (3-fluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5 —Tetrahydro trap—3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactant #% product "); and acetamidine: 2— (4 a Acetylaminobenzyl) -6- (3-fluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrodatrapne 3-ketone; and Trifluoroacetamyl chloride: 2- (4-trimethoxyacetamidomethyl) -6- (3-fluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4 , 5-Tetrahydro trap 3 -one; Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and Methanesulfonium chloride: 2-(4 Methanesulfonamide Narrow group) a 6- (3-fluoromethoxy-4 a methoxyphenyl) a 5-ethyl-2,3,4,5-tetrahydro trap-3 ketone; and propanyl chloride : 2- (4-propanamidinyl) -6- (3-fluoromethoxy -4 -methoxymethoxyphenyl) -5 -ethyl-2,3,4,5-tetrahydroda This paper is sized to the Chinese National Standard (CNS) A4 (210X297 mm)-47-475927 A7 B7 V. Description of the invention (45) Trap-3 -one; and butyl chloride: 2- (4-butyridinoaminofluorenyl)-6- (3-fluoromethoxy-1, 4-methoxyphenyl) -1 5-Ethyl-2,3,4,5-tetrahydrodatra-3-one; and isobutylphosphonium chloride: 2- (4-isobutylamidobenzyl) -6- (3-fluoromethoxy —4 —methoxyphenyl) —5—ethyl—2,3,4,5—tetragas trap—3—one; and methyl chloroformate: 2— (4-methoxycarbonylaminobenzyl ) A 6- (3-fluoromethoxy-4-methoxyphenyl) a 5-ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone; and pivaloyl chloride: 2 — (4-Tetamylaminobenzyl) -6_ (3-fluoromethoxy-4—methoxyphenyl) -5—ethyl-2,3,4'5—tetraaza tower trap-3 — Ketone; Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) ) And cyclopentanecarbamyl chloride: 2- (4-cyclopentylcarbamoyl)-6- (3-fluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3 , 4, 5-tetrahydro tower coaxes a 3-ketone; with ethyl chloroformate: 2-(4-ethoxylated aminoamino)-6-(3-fluoromethoxy-4 -methoxy Phenyl) -5—Ethyl-2,3,4'5—Four paper sizes are applicable to China National Standard (CNS) A4 specifications (210X297 mm) _Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Chemical Industry and Economics 475927 A7 B7 V. Description of the invention (46) Hydrogen trap 3-ketone; and chlorfenone chloride: 2- (4-methyloxabenzylbenzyl) -6- (3-fluoromethoxy-4-4-methoxy Phenyl)-5 -ethyl-2,3,4,5-tetra-M tower trap-3 -one; and chloroformamide: 2-(4 -ureidomethyl) _6-(3-fluoromethoxy A 4-methoxy phenyl group) 5-ethyl-2,3,4,5-tetrazolidine co-a 3-ketone; and pentamidine chloride: 2- (4-pentanylaminomethyl) 6- (3-fluoromethoxy-4-methoxymethoxy) -5-ethyl 1,2,3,4,5- 4-tetranitropyrene trap 3-ketone; and hexamethylene chloride: 2- (4-hexamidine amino narrow group)-6- (3-fluoromethoxy-1 4- 1 (Methoxyphenyl) 5-ethyl-2,3,4,5-tetrahydro tower trap 3-ketone; and pentafluoropropanyl chloride: 2- (4-pentafluoropropanamidinylbenzyl) A 6- (3-fluoromethoxy-4, 4-methoxyphenyl), 5-ethyl-2, 3, 4, 5, 5-tetrahydro tower trap, a 3-one. In a similar manner, by making 2- (4-aminoamino) -6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2, this paper standard applies China National Standard (CNS) Α4 specification (210X297 mm) ^ -4y----- I ------ ^^ equipment-(Please read the precautions on the back before filling this page) Order 475927 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Standards Bureau. Reactant ':% product' is expressed in the way); and acetamidine chloride: 2- (4-acetamidoamino)-6- (3-dimethoxymethoxy-4-methoxyphenyl)- 5-Ethyl-2,3,4,5-Four air traps and 3-ketones; and trifluoroacetamido chloride: 2- (4-difluoroacetamidomethyl)-6- (3-di Fluoromethoxy-4, 4-methoxyphenyl), 5-ethyl-2,3,4,5, -tetrahydro tower trap, 3-ketone; and methanesulfonyl chloride: 2- (4-methanesulfonyl) Amine group) 6- (3-difluoromethoxy-4-methoxybenzene ) A 5-ethyl-2,3,4,5-tetrahydrothal — 3 -one; and propanyl chloride: 2- (4-propanamidobenzyl) -6- (3-difluoromethoxy -4-methoxymethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone; and butanyl chloride: 2- (4-butanylaminofluorenyl) A 6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap —3-ketone; _ I_ This paper size applies to China National Standard (CNS) A4 Specification (210X297mm) -〇1) (Please read the precautions on the back before filling this page) 475927 A7 B7 V. Description of the Invention (48) and Isobutyrium Chloride: 2 — (4 1 Isobutylammonium benzyl) -6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower trap 3-ketone ; And methyl chloroformate: 2- (4-monomethoxycarbonylaminobenzyl) -6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3, 4,5—tetrahydro tower coaxes a 3-ketone; and pivaloyl chloride: 2— (4-pentafluorenylamine ) -6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower trap 3-ketone; and cyclopentane carbon Ammonium chloride: 2- (4-cyclopentylaminomethylbenzyl) -6- (3-difluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5 — Tetrahydro trap-3—one; and ethyl chloroformate: Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs ^ n.------ I-.-*--M I-I (Please read first Note on the back page, please fill in this page again) 2— (4-ethoxycarbonylaminobenzyl) -6— (3-difluoromethoxy-4—methoxyphenyl) 5—ethyl-2, 3,4 '5 —tetrahydro tower to coax _ 3 _ ketones; and chlortoxanthine: 2-(4-chlortoxamine-based narrow group)-6_ (3 -difluoromethoxy-4 -methoxy Phenyl) -5-ethyl-2,3,4,5-tetrahydro tower coaxing a 3-ketone; This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) c, bl_475927 Ministry of Economic Affairs A7 B7 printed by the Consumer Standards Cooperative of the Central Bureau of Standards 5. Invention Description (49) : 2- (4-Ureabenzyl) -6- (3-Difluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro- 3-ketone; with pentamidine chloride: 2- (4-pentafluorenylaminofluorenyl) -6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl-2,3 , 4,5-tetraazapine-one 3-ketone; and hexamethylene chloride: 2- (4-hexamethyleneamino narrow group) -6- (3-difluoromethoxy-4 4-methoxyphenyl) One 5-ethyl-2,3,4,5-tetraaza-tower trap 3-ketone; and pentafluoropropanyl chloride: 2- (4-pentafluoropropylamidomethyl)-6- (3 — Difluoromethoxy-4, methoxymethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap-3-ketone. In a similar manner, by making 2- (4-aminomethyl) -6- (3-dimethoxymethoxy-4 dimethoxymethoxy) -5-ethyl-2,3,4 , 5 -tetrahydro trap-3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactant;% product #); and acetamidine: I paper Standards are applicable to China National Standard (CNS) A4 specifications (210X297 mm) -52-(Please read the precautions on the back before filling out this page) ~ ^ Order · Order 475927 Printed by A7 B7 of the Consumer Standards Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs Description of the invention (50) 2- (4-ethylamidoaminofluorenyl) -6- (3-trifluoromethoxy-4-methoxyphenyl) 5-ethyl-2,3,4 , 5-Four Gas Trap-3_one; and trifluoroacetamyl chloride: 2- (4-trifluoroacetamidomethylidene) -6- (3-trifluoromethoxy-4-methoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydropyrazol-3-one; and methanesulfonyl chloride: 2-(4 -methanesulfonylaminobenzyl) -6-(3 —Trifluoromethoxy-4 monomethoxyphenyl) -5 -2,3,4,5-tetrahydro-trap-a 3-ketone; and propanyl chloride: 2- (4-propanamidomethyl)-6- (3-trioxymethoxy-4 -methoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydro tower trap-3-ketone; and butyl chloride: 2-(4 -butyl fluorenylbenzyl)-6-(3 -tri Fluoromethoxy-4, 4-methoxyphenyl) 5-ethyl-2,3,4,5-tetrahydro tower coke-3, one ketone; and isobutyridine chloride: 2- (4-isobutyridine Narrow amino group)-6- (3-trifluoromethoxy-4-methoxyphenyl)-5-ethyl-2,3,4,5-tetrahydro trap-3 -one; and chlorine Methyl formate: This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) _ 53-(Please read the precautions on the back before filling out this page) 475927 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs V. Description of the invention (51) 2-(4-methoxymethoxyamino)-6-(3-difluoromethoxy-4-methoxyphenyl)-5-ethyl-2, 3 , 4,5_ Four gas tower traps and 3_ones; and Tetrazine chloride: 2— (4a Pentamidobenzyl)-6- (3-trifluoromethoxy-4-methoxyphenyl)-5-ethyl-2,3,4,5-tetrahydrodatrapeptone 3-ketone; With cyclopentanecarbamyl chloride: 2- (4-cyclopentylaminomethylmethyl)-6- (3-trifluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2 , 3,4,5 A tetrahydro tower trap a 3-ketone; and ethyl chloroformate: 2— (4-ethoxyalkylaminomethyl) -6— (3-trifluoromethoxy-4—methyl (Oxyphenyl)-5 -ethyl-2,3,4,5-tetrahydro tower coax a 3-ketone; and acetochlor: 2-(4-alachlor benzyl)-6- (3-trifluoromethoxy-4-methoxyphenyl) -5-ethyl-2'3,4,5-tetrahydro-3 trap-ketone; and chloroformyl chloride: 2-(4 _Ureidofluorenyl)-6- (3-trifluoromethoxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrazolidine-3 -one; and Pentamyl chloride: This paper size applies to China National Standard (CNS) A4 (210X297 mm) _ 54-(Please read the precautions on the back before filling (Write this page) 475927 A7 B7 V. Description of the invention (52) 2_ (4-pentamidoamino)-6- (3-difluoromethoxy-4-methoxyphenyl) -5-ethyl A 2,3,4,5-tetrahydro tower trap-3 ketone; and hexamethylene chloride: 2- (4-hexamethyleneaminobenzyl) -6- (3-trifluoromethoxy-4 monomethoxy Phenyl) a 5-ethyl-2,3,4,5-tetrahydro 11 hydrazone-3 ketone; and pentafluoropropanyl chloride: 2- (4-pentafluoropropylamidobenzyl) a 6_ (3-trifluoromethoxy-4_methoxymethoxyphenyl) -5_ethyl-2,3,4,5_tetrahydro-trap-3-ketone. In a similar manner, by making 2- (4-aminoamino) -6- (3-methoxy-4 4-fluoromethoxyphenyl) -5-ethyl-2,3,4,5 _ Tetrahydro trap- 3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactant ': a product'); printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the precautions on the back before filling out this page) and Acetyl Chloride: 2 — (4-Acetylamidomethyl) — 6 — (3 —Methoxy-4 —Methoxyphenyl) —5 —Ethyl-2,3,4,5-—tetrazolium towers cope with 3-ketones; and trifluoroacetamidine chloride: 2- (4-trineonylacetamidomethyl) —6- (3-methoxybenzyl Paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) _ 55-475927 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (53) 4-methoxyphenyl) 5 —Ethyl-2,3,4,5 —tetraaza-trap- 3-ketone; and methanesulfonyl chloride: 2 — (4 -methanesulfonylaminomethyl) — 6 — (3 —methoxyl-4 — (Methoxyphenyl)-5-ethyl-2,3,4,5-tetrahydro tower coke-3 -one: and propionyl chloride: 2-(4-propionamidofluorenyl)-6-( 3-methoxy-4, 4-methoxymethoxyphenyl) 5-ethyl-2,3,4,5-tetraaza-trap-3-3-one; and butanyl chloride: 2- (4-butanylamino) Benzyl)-6- (3-methoxy-4-fluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro trap-3-ketone; and isobutyryl chloride : 2- (4-isobutylamidinylbenzyl) -6- (3-methoxy-4-fluoromethoxyphenyl) 5-ethyl-2,3,4,5-tetrahydro tower Coax ... 3-ketone; and methyl chloroformate: 2- (4-methoxycarbonylaminofluorenyl)-6- (3-methoxy-4 -fluoromethoxyphenyl) -5-ethyl-2 , 3, 4, 5—tetrahydro tower trap—one 3-ketone; and pivaloyl chloride: 2 -— (4-tetramethylpyridinylamino) —6- (3-methoxy—a paper size applicable to China National Standard (CNS) A4 Specification (210X297mm) _%-(Please read the precautions on the back before filling this page) •-1—1 8 I---- 1 -0 pack ·
、1T 475927 A7 B7 五、發明説明(54 ) 4 一氟甲氧基苯基)_5_乙基一 2 ,3,4 ,5 —四氫 嗒阱一 3 _酮; 與環戊烷碳醯氯: 2_ (4 —環戊基氣基甲醯窄基)一 6 —(3 —甲氧 基一4 一氟甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 — 四氫嗒阱一 3 _酮; 與氯甲酸乙酯: 2_ (4 —乙氧裁基胺基爷基)一6 —(3 —甲氧基 —4 一氟甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四 氫塔阱一 3 —酮; 與甲草醯氯: 2— (4 —甲草醯胺基爷基)一 6— (3 —甲氧基一 4 —氣甲氧基苯基)一5 —乙基一2 ,3 ’ 4 ,5 —四氮 嗒阱_ 3 —酮; 與氯甲醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(4 —脲基爷基)一6— (3 —甲氧基一4 —氟 甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氮卩荅哄一 3 —酮; 與戊醯氯: 2 —(4 —戊醯胺基爷基)一6_ (3 —甲氧基一4 一氟甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5—四氫塔 阱一 3 -酮; 與己醯氯: 2— (4 —己醯胺基笮基)一 6— (3 —甲氧基一4 _ I_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 57 - 475927 A7 B7 五、發明説明(55 ) 一氟甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒 哄—3 —酮; 與五氟丙醯氯: 2— (4 —五氧丙醯胺基爷基)一 6 —(3 —甲氧基 一 4 —氟甲氧基苯基)一5—乙基一 2 ,3 ,4 ,5—四 氫塔阱一3-酮。 以類似之方式^藉由令2 —(4_胺基爷基)一6 — (3 —甲氧基一 4_二氟甲氧基苯基)一5_乙基一 2 , 3,4,5 —四氫嗒阱一 3 —酮與下述之反應物反應,以 獲致下述之產物(即,以%反應物':%產物'之方式表 示); 與乙醯氯: 2 —(4 一乙醯胺基爷基)一6 —(3 —甲氧基一4 —二氟甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫 嗒阱一 3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與三氟乙醯氯: 2— (4 —三氟乙醯胺基笮基)一6— (3_甲氧基 —4 —二氣甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 — 四氫嗒阱一3 —酮; 與甲磺醯氯: 2 —(4 一甲磺醯胺基爷基)一6 —(3 —甲氧基一 4 —二氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 58 - 475927 A7 B7 五、發明説明(56 ) 氣塔哄一 3 —酮; 與丙醯氯: 2 —(4 一丙醯胺基苄基)一 6 —(3 —甲氧基一 4 一二氟甲氧基苯基)一 5 —乙基一 2 ,3,4 ,5 —四氣 塔阱一 3 —酮; 與丁醯氯: 2— (4 — 丁醯胺基爷基)一6 —(3 —甲氧基一4 一二氟甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫 口荅阱—3 —酮; 與異丁醯氯: 2 —(4 —異丁醯胺基苄基)一6— (3 —甲氧基一 4 一二氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5_四 氫嗒阱一3 —酮; 與氯甲酸甲酯: 2 —(4 一甲氧幾基胺基爷基)一6_ (3 —甲氧基 一 4 —二氟甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 — 四氫塔阱一 3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與特戊醯氯: 2 —( 4 一特戊醯胺基书基)一 6— ( 3 —甲氧基一 4 —二氟甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四 氫嗒阱—3 -酮; 與環戊烷碳醯氯: 2 —( 4 一環戊基氨基甲醯1基)一6 — ( 3 —甲氧 基一4 一二氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 本紙張又度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 59 - 475927 A7 B7 五、發明説明(57 ) 一四氫嗒阱一3—酮; 與氯甲酸乙酯: 2_ (4 —乙氧鑛基胺基窄基)一6 —(3 —甲氧基 —4 —二氟甲氧基苯基)了5 —乙基一 2 ,3,4 ,5 — 四氫嗒阱_3_酮; 與甲草醯氯: 2— (4 —甲草醯胺基苄基)一6_ (3 —甲氧基一 4 一二氣甲氧基苯基)一5—乙基一2 ,3 ,4 ,5 —四 氣塔阱—3 —酮; 與氯甲醯氯: 2 —(4 —腺基爷基)一6 — (3 —甲氧基一4 —二 氟甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱 —3 —酮; 與戊醯氯: 2 —(4 一戊醯胺基爷基)一 6— (3 —甲氧基一4 —二氣甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮 塔阱—3 —酮; 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 與己醯氯: 2 —(4 —己酿胺基爷基)一 6— (3 —甲氧基一4 一二氣甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氮 嗒阱—3 -酮; 與五氟丙醯氯: 2— (4 —五氟丙醯胺基笮基)一6— (3 —甲氧基 —4 一二氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 — 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ go _ 475927 A7 B7 五、發明説明(58 ) 四氣塔哄一 3 —酮。 以類似之方式,藉由令2—(4一胺基爷基)_6_ (3 —甲氧基_ 4——三氟甲氧基苯基)一5 —乙基_2 , 3,4,5 —四氫嗒阱一 3 —酮與下述之反應物反應,以 獲致下述之產物(即,以a反應物':%產物'之方式表 示); 與乙醯氯: 2_ (4_乙醯胺基苄基)一 6 — (3 —甲氧基一4 —三氟甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氫 塔阱—3 —酮; 與三氟乙醯氯: 2— (4 —三氟乙醯胺基苄基)_6 —(3 —甲氧基 —4 —三氟甲氧基苯基)一5_乙基_2 ,3 ,4 ,5 — 四氫塔哄一 3 —酮; 與甲磺醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2— ( 4 —甲磺醯胺基窄基)一6— ( 3 —甲氧基_ 4 —三氟甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四 氫嗒阱—3 _酮; 與丙醯氯: 2— (4 —丙醯胺基苄基)一 6—(3_甲氧基一4 一三氟甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫 嗒阱一 3 —酮; _ i__ 本紙張尺度適用中國國家標準(〇奶)人4規格(210'乂297公釐)_61_ 475927 A7 B7 五、發明説明(59 ) 與丁醯氯: 2 —(4一 丁醯胺基笮基)一6 —(3—甲氧基_4 一三氟甲氧基苯基)一 5 —乙基一2 ,3,4 ,5 —四氫 嗒阱—3 —酮; 與異丁醯氯: 2 —(4 一異丁醯胺基苄基)一 6 —(3 —甲氧基一 4 一三氟甲氧基苯基)一 5 —乙基一 2 ,3 ,4 ,5 —四 氣塔阱一 3 -酮; 與氯甲酸甲酯: 2 —(4 一甲氧幾基胺基爷基)一 6_ (3 —甲氧基 —4 —二氣甲氧基苯基)一5 —乙基一2 ,3,4 ,5_ 四氫塔阱一 3 _酮; 與特戊醯氯: 2 —(4 —特戊醯胺基爷基)一6 —(3 —甲氧基一 4_三氟甲氧基苯基)一 5_乙基一2 ,3,4 ,5 —四 氫嗒阱—3 —酮; 與環戊烷碳醯氯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2— (4_環戊基氨基甲醯苄基)一6_ (3 —甲氧 基一 4 一三氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氣嗒哄一3 —酮; 與氯甲酸乙酯: 2 —(4 一乙氧幾氧胺基窄基)一6 —(3_甲氧基 —4 —三氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 — 四氫嗒阱一3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ - 475927 A7 B7 五、發明説明(60 ) 與甲草醯氯: 2 —(4 一甲草醯胺基笮基)一6 —(3_甲氧基一 4 —三氟甲氧基苯基)_5 —乙基一 2 ,3,4 ,5 —四 氫卩荅阱一 3 —酮; 與氯甲醯氯: 2 —(4 一腺基爷基)一 6 —(3 —甲氧基一 4 一二 氟甲氧基苯基)一5 —乙基一 2 ,3,4 ,5 —四氫嗒阱 —3 —酮; 與戊醯氯: 2_ (4 —戊醯胺基爷基)_6_ (3 —甲氧基一4 —三氟甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫 塔哄一 3 -酮; 與己醯氯: 2— (4 —己醯胺基苄基)一6 — (3 —甲氧基一4 —三氟甲氧基苯基)_5 —乙基一 2 ,3 ,4 ,5 —四氫 塔哄一3 —酮; 與五氟丙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(4 —五氟丙醯胺基苄基)—6— (3 —甲氧基 一 4 —三氟甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 — 四氫嗒阱一3—酮。 以類似之方式,藉由令2 —(4 一胺基苄基)一6 — (3 —乙氧基一4 —甲氧基苯基)一2 ,3 ,4 ,5 -四 氫嗒阱-3 —酮,m · ρ · 1 2 0°與下述之反應物反應 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)-63 - 475927 A7 B7 五、發明説明(61 ) ,以獲致下述之產物(即,以|反應物# : 1產物#之方 式表示); 與乙醯氯: 2 —(4 一乙醯胺基窄基)一 6 —(3 —乙氧基_4 —甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮, m . p . 1 7 0 ° ; 與三氟乙醯氯: 2 —(4 一三氟乙醯胺基爷基)—6— (3 —乙氧基 一 4 —甲氧基苯基)一 2 ,3,4 ,5 —四氮卩荅哄一 3 — 酮; 與甲磺醯氯: 2 —(4 一甲磺醯胺基苄基)一6— (3 —乙氧基_ 4 —甲氧基苯基)一 2 ,3 ,4 ,5 —四氮塔哄一 3 —嗣 9 與丙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2 —(4 一丙醯胺基爷基)一 6— (3 —乙氧基—4 一甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮; 與丁醯氯: 2—(4 一 丁醯胺基笮基)一6— (3 -乙氧基一 4 —甲氧基苯基)一 2 ’ 3 ’ 4 ^ 5 —四氮塔哄一3 —酮1; 與異丁醯氯: 2 —( 4 一異丁醯胺基笮基)一6—( 3_乙氧基一 4 —甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐)_ “ _ 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(62 ) , 與氯甲酸甲酯: 2 —(4 一甲氧鑛基胺基窄基)一 6 —(3 —乙氧基 -4 —甲氧基苯基)一2,3,4 ,5 —四氫嗒阱一 3 — 酮; 與特戊醯氯: 2_ (4 —特戊醯胺基窄基)一6 —(3_乙氧基一 4 —甲氧基苯基)一2,3,4,5 —四氫嗒阱一3 —酮 9 與環戊烷碳醯氯: 2 —(4 一環戊基氨基甲醯苄基)一 6 —(3 —乙氧 基一4 一甲氧基苯基)一 2,3,4 ,5 —四氣卩荅哄_3 一酮; 與氯甲酸乙酯: 2 —(4 一乙氧幾基胺基爷基)一 6— (3 —乙氧基 —4 —甲氧基苯基)一 2 ,3,4 ,5—四氣塔哄一3 — 酮,m · ρ · 1 2 8 0 ; 與甲草醯氯: 2 —(4 一甲草醯胺基笮基)一 6 —(3 —乙氧基一 4 一甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮 9 與氯甲醯氯: 2 —(4 一脲基笮基)一 6 —(3 —乙氧基一4 —甲 氧基苯基)_2 ,3,4 ,5 —四氫嗒阱一 3_酮; 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 65 _ (請先閱讀背面之注意事項再填寫本頁) 475927 A7 ^__E_ — 五、發明説明(63 ) 與戊醯氯: 2 —(4 一戊醯胺基笮基)一 6—(3 —乙氧基一 4 〜甲氧基苯基)一 2,3,4,5 —四氫嗒哄一 3 —酮; 與己醯氯: 2 —(4 一己醯胺基苄基)一 6 —(3 —乙氧基一 4 —甲氧基苯基)一 2 ,3,4 ,5-四氫嗒阱一 3—酮; 與五氟丙醯氯: 2 —(4 —五氟丙醯胺基苄基)一 6 —(3 —乙氧基 一4 一甲氧基苯基)一2,3,4,5 —四氫11荅阱一 3 — 酮0 以類似之方式,藉由令2 —(4 一胺基笮基)一 6 — (3 —環戊基氧一 4 一甲氧基苯基)一2 ’ 3 ’ 4 ,5 — 四氫嗒阱一 3 -酮與下述之反應物反應,以獲致下述之產 物(即,以%反應物〃 :a產物#之方式表示); 與乙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —( 4 一乙酿胺基爷基)一6 —( 3 —環戊基氧— 4 一甲氧基苯基)一2,3,4,5-四氫嗒阱一 3 —酮 , 與三氟乙醯氯: 2 —(4 一三氟乙醯胺基苄基)一 6 -(3 —環戊基 氧—4 一甲氧基苯基)一2,3,4,5 —四氫嗒阱一 3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ _ 經濟部中央標準局員工消費合作社印製 475927 A7 B7 五、發明説明(64 ) 與甲磺醯氯: 2 — (4 —甲磺醯胺撑苄基)一 6 —(3_環戊基氧 —4 —甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 — 酮; 與丙醯氯: 2 —(4 一丙醯胺基爷基)一6 -(3 —環戊基氧— 4 —甲氧基苯基)一2 ,3 ,4 ,5 —四氫嗒阱一3 —酮 與2 ,2 —二甲基丙醯氯: 2 -(4 —特丁基羰基胺基笮基)一 6 -(3 —環戊 基氧一4 一甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與丁醯氯: 2 —(4_ 丁醯胺基爷基)—6— (3 —環戊基氧一 4 —甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一3 —酮 與異丁醯氯: 2 —(4 —異丁醯胺基苄基)一 6 -(3 -環戊基氧 一 4 一甲氧基苯基)一2,3,4,5 —四氮塔哄一 3 — 酮; 與氯甲酸甲酯: 2 —(4 —甲氧鑛基胺基爷基)_6 —(3—環戊基 氧一4 —甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一3 -酮; 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ _ . .......- i— 11 - m. —1 111 - I ——- ϋ (請先閱讀背面之注意事項再填寫本頁) 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(65 ) 與特戊醯氯: 2 —(4 —特戊醯胺基窄基)一 6 -(3 —環戊基氧 一 4_甲氧基苯基)一 2 ,3,4 ,5 —四氮塔哄一 3 — 酮; 與環戊烷碳醯氯: 2 —( 4 一環戊基氣基甲醯窄基)一 6 —( 3 —環戊 基氧一4 一甲氧基苯基)一 2 ,3,4 ,5 —四氮塔哄一 3 —酮; 與氯甲酸乙酯: 2_ (4 —乙氧鑛基胺基爷基)一 6— (3 —環戊基 氧一4 —甲氧基苯基)一2 ,3,4 ,5 —四氮嗜哄一 3 -酮; 與甲草醯氯: 2 —(4 一甲草醯胺基苄基)一 6 —(3 —環戊基氧 —4 一甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一3 — 酮; 與氯甲醯氯: 2 -(4 一脲基笮基)一 6 — (3 —環戊基氧—4 一 甲氧基苯基)一2 ^ 3,4,5 —四氮塔哄一 3 —丽; 與戊醯氯: 2 -(4 一戊醯胺基苄基)一 6_ (3 -環戊基氧一 4 —甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮 與己醯氯: 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_明- I. I —T· ―- --*1 -— -—-- (請先閱讀背面之注意事項再填寫本頁) 、tr 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(66 ) 2 —(4 —己酿胺基爷基)一6 -(3 —環戊基氧一 4 —甲氧基苯基)一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮 赘 與五氟丙醯氯: 2 -(4 一五氟丙醯胺基窄基)一 6-(3 -環戊基 氧一 4 —甲氧基苯基)一 2 ,3,4,5 —四氫嗒阱一 3 -酮。 以類似之方式,藉由令2_(4—胺基苯乙基)_6 _ (3 ’ 4 一二甲氧基苯基)一 2 ’ 3 ’ 4 ’ 5 —四氣口荅 阱一 3 -酮與下述之反應物反應,以獲致下述之產物(即 ,以a反應物':%產物'之方式表示); 與乙醯氯: 2 —(4 —乙酿胺基苯乙基)一 6— (3 ,4 一二甲 氧基苯基)一 2,3,4,5 —四氮塔哄一 3 —嗣; 與三氟乙醯氯: 2—(4 —三氟乙醯胺基苯乙基)一 6— (3 ,4 — 二甲氧基苯基)一2,3,4,5 —四氫嗒阱一3 —酮; 與甲磺醯氯: 2— (4 —甲醯胺撑苯乙基)一 6— (3 ,4 一二甲 氧基苯基)一 2,3,4,5 -四氫塔阱—3 —酮; 與丙醯氯: 2 一(4 —丙酿胺基苯乙基)_6_ (3 ’ 4 — 一甲 本紙張尺度適用中國國家標準(CNS)A4規格(210X297公釐)_ 69 _ (請先閱讀背面之注意事項再填寫本頁) •—^裝· 訂 經濟部中央標準局員工消費合作社印製 475927 A7 B7 五、發明説明(67 ) 氧基苯基)_2,3,4,5 —四氬嗒阱一 3 —酮; 與丁醯氯: 2 —(4 一丁醯胺基苯乙基)一 6 —(3 ,4 一二甲 氧基苯基)一 2,3,4,5 —四氫嗒阱一 3 —酮; 與異丁醯氯: 2 —(4 一異丁醯胺基苯乙基)一 6 —(3,4 一二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與氯甲酸甲酯: 2—(4 —甲氧羰基胺基苯乙基)一 6 —(3 ^ 4 — 二甲氧基苯基)_2 ,3,4 ,5 —四氣塔哄一3 —酮; 與特戊醯氯: 2_ (4 —特戊醯胺基苯乙基)一6 —(3,4 一二 甲氧基苯基)一2 ,3 ,4 ,5 —四氮卩荅明1 一 3 —酮; 與環戊烷碳醯氯: 2— (4_環戊基氨基甲苯乙基)一 6 —(3 ,4 一 二甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮; 與氯甲酸乙酯: 2 —(4 一乙氧羰基胺基苯乙基)一 6— (3 ,4 — 二甲氧基苯基)一 2,3,4,5 —四氫嗒阱一 3 —酮; 與甲草醯氯: 2— (4_甲草醯胺基苯乙基)一 6 —(3 ,4 一二 甲氧基苯基)一2,3 ,4 ,5 —四氫嗒阱一 3 —酮; 與氯甲醯氯: 2 —(4 —脲基苯乙基)一 6 —(3 ,4 一二甲氧基 -!- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ — -- ·1,!! —--ivtn .....I- - H (請先閱讀背面之注意事項再填寫本頁) 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(68 ) 苯基)一2,3,4,5 —四氫嗒阱一 3 —酮; 與戊醢氯: 2 —(4 一戊醯胺基苯乙基)一 6 —(3 ,4_二甲 氧基苯基)一2 ’ 3,4,5 —四氣塔哄一 3 —酮; 與己醯氯: 2 —(4 一己醯胺基苯乙基)一 6 —(3 ,4 一二甲 氧基苯基)一2,3,4,5 —四氮塔哄一 3 —嗣; 與五氟丙醯氯: 2 —(4 一五氟两醯胺基苯乙基)一6 —(3,4 — 二甲氧基苯基)_2 ,3,4 ,5—四氫卩荅哄一 3 —酮。 以類似之方式,藉由令(3 —胺基爷基)一6 — (3,4 一二甲氧基苯基)一2,3,4,5 —四氫嗒阱 - 3 —酮與下述之反應物反應,以獲致下述之產物(即, 以%反應物':%產物"之方式表示); 與乙醯氯: 2 — (3 —乙醯胺基苯乙基)一6 — (3 ,4 —二甲 氧基苯基)一 2,3,4,5 —四氫嗒阱一 3 —酮, m . p . 1 0 5 ° ; 與三氟乙醯氯: 2— (3 —二氟乙醯胺基爷基)一6 —(3 ’ 4 —二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一3 —酮 m . p . 13 6° ; 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ _ -I- -- -I- ·1 -II ϋ (請先閱讀背面之注意事項再填寫本頁) 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(69 ) 與甲磺酿氯: 2 —(3 —甲磺醯胺撑爷基)一6 —(3,4_二甲 氧基苯基)一2,3,4,5 —四氣塔哄一 3 —酮, m . p . 1 7 7 ° ; 與丙醯氯: 2_ (3—H醯胺撑爷基)一 6 —(3,4 一二甲氧 基苯基)一2,3,4 ,5 —四氮塔哄一 3 —嗣; m . p . 1 5 2 0 ; 與二甲基丙醯氯: 2 —(3 —特丁基羰基胺基苄基)一 6 -(3,4 — 二甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3_酮; 與丁醯氯: 2— (3 — 丁醯胺基苄基)一6— (3,4 —二甲氧 基苯基)一 2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與異丁醯氯: 2 —(3 —異丁酿胺基爷基)一6 —(3,4 一二甲 氧基苯基)一 2,3,4,5 —四氫卩荅哄—3 —酮; 與氯甲酸甲酯: 2_ (3 —甲氧鑛基胺基爷基)一 6 — (3,4 一二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱—3 —酮; 與特戊醯氯: 2 —(3 —特戊醯胺基笮基)一6 —(3,4 一二甲 氧基苯基)一 2,3,4,5 —四氫嗒阱一3 —酮; 與環戊烷碳醯氯: 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ _ (請先閱讀背面之注意事項再填寫本頁) 475927 經濟部中央標準局員工消費合作社印製 A7 B7五、發明説明(7〇 ) 2 —(3 —環戊基氛基甲醯窄基)一 6 —(3,4 一 二甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; 與氯甲酸乙酯: 2 -(3 —乙氧裁基胺基爷基)一 6 —(3,4 一二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮; m . p . 1 7 9 ° ; 與甲草醯氯: 2— (3 —甲草酿胺基窄基)一 6 —(3 ,4 —二甲 氧基苯基)一2,3,4,5 —四氮卩荅哄一 3 —酬; 與氯甲醯氯: 2— (3 —脲基苄基)一 6— (3,4 —二甲氧基苯 基)一2,3,4 ,5 —四氮塔哄一3 —嗣; 與戊醯氯: 2— (3 —戊酿胺基爷基)一6 — (3 ’ 4 —二甲氧 基苯基)一2,3,4,5 —四氮塔哄一 3 —酮1; 與己醯氯: 2— (3 —己醯胺基苄基)一 6 — (3 ,4 —二甲氧 基苯基)一 2,3,4,5 —四氫嗒阱一 3 —酮; 與五氟丙醯氯: 2— (3 -五氟丙醯胺基爷基)一 6 -(3,4_二 甲氧基苯基)一2 ,3,4 ,5 —四氫嗒阱一 3 —酮。 以類似之方式,藉由令2 —( 3 —胺基爷基)—6 — (3 —環戊基氧一 4 —甲氧基苯基)一5 —乙基一2 ,3 本紙張尺度適用中國國家標準(CNS)A4規格( 210X297公釐)_ 73 _ (請先閱讀背面之注意事項再填寫本頁) 475927 A7 B7 五、發明説明(71 ) ,4,5 —四氫嗒阱一3 —酮與下述之反應物反應,以獲 致下述之產物(即,以~反應物':|產物#之方式表示 ); 與乙醯氯: 2 —(3 —乙醯胺基苄基)一6 —(3 —環戊基氧一 4 一甲氧基苯基)_5 —乙基一 2 ,3 ,4 ,5 —四氫嗒 阱—3 —酮; 與三氟乙醯氯: 2_ (3 —三氟乙醯胺基爷基)—6 —(3 —環戊基 氧一 4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四 氫嗒阱-3 - 酮,τώ.ρ·70° ; 與甲磺醯氯: 2 —(3_甲磺醯胺撑苄基)—6— (3 —環戊基氧 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5—四氯 嗒阱—3 -酮; 與丙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 -(3 -丙醯胺基苄基)一 6— (3 —環戊基氧一 4 一甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氫塔 阱一 3 —酮,m.p.113。; 與2 ,2 —二甲基丙醯氯: 2_(3—特丁基鑛基胺基爷基)一6_(3—環戊 基氧一 4 —甲氧基苯基)一 5_乙基一2 ,3 ,4 ,5 — 四氫塔哄一 3 —酮; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ ^ 475927 A7 B7 五、發明説明(72 ) 與丁醯氯: 2 —(3 —丁醯胺基窄基)一 6 —(3 —環戊基氧一 4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5_四氮塔 饼一 3 —酮; 與異丁醯氯: 2— (3 —異丁醯胺基书基)_6 —(3 —環戊基氧 —4 —甲氧基苯基)一5 —乙基一 2 ,3 ,4 ’ 5 —四氮 嗜阱一 3 _酮; 與氯甲酸甲酯: 2 —(3 —甲氧羰基胺基苄基)一6 —(3_環戊基 氧一 4 一甲氧基苯基)一5 —乙基一2 ,3 ’ 4 ’ 5—四 氫嗜阱_ 3 —酮; 與特戊醯氯: 2 -(3 -特戊醯胺基爷基)_6 -(3 —環戊基氧 一 4 —甲氧基苯基)一 5 —乙基一2 ,3 ,4 ,5 —四氮 塔阱一3 —酮; 與環戊烷碳醯氯: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2 —(3 —環戊基氨基甲醯笮基)一 6 —(3 —環戊 基氧_4 一甲氧基苯基)一5 —乙基一2 ,3 ’ 4 ’ 5 — 四氫塔哄一 3 —酮; 與氯甲酸乙酯: 2_ (3 —乙氧羰基胺基笮基)_6 —(3 —環戊基 氧一4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四 氫嗒阱—3—酮,m.p.153° ; 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 75 475927 A7 B7 五、發明説明(73 ) 與甲草醯氯: 2_ ( 3 —甲草醯胺基窄基)一6— ( 3 —環戊基氧 —4 —甲氧基苯基)一5 —乙基一2 ,3,4 ,5 —四氫 嗒阱—3 -酮; 與氯甲醯氯: 2_ (3_脲基笮基)-6 -(3 -環戊基氧—4 — 甲氧基苯基)一5 —乙基一 2 ,3 ,4 ,5 —四氮卩苔哄一 3 —酮; 與戊醯氯: 2— (3 -戊醯胺基爷基)_6 -(3 —環戊基氧一 4 —甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四氣口荅 哄—3 —酮; 與己醯氯: 2— (3 —己醯胺基窄基)一 (3 —環戊基氧— 4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5-四氫塔 阱—3 —酮; 與五氟丙醯氯: 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 2— (3 —五氟丙醯胺基窄基)—6— (3 —環戊基 氧一4 一甲氧基苯基)一5 —乙基一2 ,3 ,4 ,5 —四 氫11荅阱一 3 —酮。 實施例7 將溶於1 0 Om又冰醋酸之2 · 4g3— (3 ,4 — 二甲氧基苯甲酸基)丙酸溶液與1 . 7 g之對一硝基苄基 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 475927 A7 ____B7 五、發明説明(74 ) 肼反應,且於1 0 0 °C下攬拌達2小時。除去溶劑,以憤 用方式處理殘餘物,而獲致2 —(4 一硝基苄基)一6〜 (3 ’ 4 一二甲氧基苯基)一 2,3,4,5 —四氣π答哄 一 3— 酮,πι·ρ · 1260 〇 以類似之方法獲致下述之化合物,其係令3 —( 3 , 4〜二甲氧基甲酸基)丙酸與4 一硝基苯基肼反應: 2_ (4 —硝基苯基)_6 —(3,4 一二甲氧基苯 基)一 2 ,3,4,5—四氫嗒阱一 3 —酮。 下述實施例係關於藥學製劑: 實施例A :注射瓶 將1 0 0 g之式I活性化合物及5 g之磷酸氫二鈉所 形成之溶液,置於3 之二次蒸餾水中,利用2 N氫氯酸 將其pH値調整至6 . 5,進而經由無菌過濾,充塡至注 射瓶中,於無菌狀態下經冷凍乾燥後,加以無菌密封。每 一個注射瓶含有5 til g之活性化合物。 實施例B :栓劑 將2 0 g之式I活性化合物融合至1 〇 〇 g之大豆卵 磷脂及1 4 0 0 g之可可脂肪中,所形成之混合物係倒入 至模子中,且靜置加以冷卻。每一個栓劑係含有2 〇 m g 之活性化合物。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 77 / _ ----.------•裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 475927 經濟部中央標準局員工消費合作社印製 A7 B7_五、發明説明(75 ) 實施例C :溶液 將lg之式I活性化合物,9 · 38g之 N a Η 2 P 0 4 · 2Η2〇,2 8 . 4 8g 之 Na2HP〇4 • 1 2H2〇及Ο . 1 g之氯苄烷銨溶於9 4 Omj?之二 次蒸餾水中。調整所生成混合液之pH値至6 . 8,藉由 輻射線滅菌以製備1又之溶液。該溶液可作爲眼滴液。 實施例D :軟膏 於無菌狀態下,將5 0 Omg之式I活性化合物與 9 9 . 5 g之礦脂加以混合。 實施例E :藥片 將含有lkg之式I活性化合物,4kg之乳糖, 1 · 2kg之馬鈴薯澱粉,0 · 2kg之滑石及Ο · 1 k g之硬脂酸鎂的混合物,以慣用之方式加以壓縮處理, 以生成藥片,使得每一個藥片係含有1Omg之活性化合 物。 實施例F :塗覆藥片 以類似實施例E之方式,壓縮成藥片,以隨後以慣用 之方式塗覆一層蔗糖,馬鈴薯澱粉,滑石,黃蓍膠及著色 劑0 實施例G :膠囊 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ ^ _ (請先閱讀背面之注意事項再填寫本頁) 475927 A7 B7__ 五、發明説明(76 ) 將2 k g之式I活性化合物以慣用之方式’充塡至硬 明膠膠嚢中,使得每一個膠囊係含有2 〇mg之活性化合 物。 實施例Η :安瓿 將1 k g之式I活性化合物溶劑6 0又之二次蒸餾水 中,所生成之溶液係經無菌過減,充塡至安瓿中,於無菌 狀態下經冷凍乾燥後,加以無菌密封。每一個安瓿係含有 1 〇 m g之活性化合物。 -----------------裝------訂------ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)_ 79 -1T 475927 A7 B7 V. Description of the invention (54) 4 monofluoromethoxyphenyl) _5_ethyl-2,3,4,5-tetrahydro-trap well 3_one; and cyclopentanecarbamyl chloride : 2- (4-Cyclopentylaminomethylsulfanyl) -6- (3-methoxy-4 4-fluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro Datra-3 ketone; and ethyl chloroformate: 2_ (4-ethoxystidinylamino)-6- (3-methoxy-4 monofluoromethoxyphenyl) -5-ethyl -2, 3, 4, 5-tetrahydro tower trap-3-ketone; and formazan chloride: 2-(4-formazanylmethyl)-6-(3-methoxy-4-gas (Methoxyphenyl)-5-ethyl-2,3'4,5-tetraazapine_3-ketone; and methylformyl chloride: printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the back first) For the matters needing attention, please fill in this page again) 2 — (4 —ureidomethyl) — 6 — (3 —methoxy — 4 —fluoromethoxyphenyl) — 5 —ethyl — 2, 3, 4, 5 —Tetrazolium co-a 3-ketone; and pentamidine chloride: 2 — (4-pentamethylaminomethyl) — 6 — (3 Methoxy-4, 4-fluoromethoxyphenyl), 5-ethyl-2,3,4,5-tetrahydro tower trap, 3-ketone; and hexamethylene chloride: 2- (4-hexamidineamino) Yenyl) — 6 — (3 —methoxy — 4 _ I_ This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) _ 57-475927 A7 B7 5. Description of the invention (55) monofluoromethoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydroda- 3 -one; and pentafluoropropanyl chloride: 2-(4-pentapropoxyamidomethyl)-6 — (3-methoxy-4-fluoromethoxyphenyl) —5-ethyl-2,3,4,5-tetrahydro tower trap—3-ketone. In a similar manner ^ by making 2- (4-aminoamino) -6- (3-methoxy-4_difluoromethoxyphenyl) -5_ethyl-2, 3, 4, 5-tetrahydro trap-3-ketone reacts with the following reactants to obtain the following products (ie, expressed as% reactant ':% product'); and acetamidine: 2-(4 Monoethylaminomethyl) -6- (3-methoxy-4-difluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap- 3-ketone Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and trifluoroacetamido chloride: 2— (4-trifluoroacetamidofluorenyl) —6— (3 _Methoxy-4—dimethoxymethoxyphenyl) -5—ethyl-2,3,4,5—tetrahydro-trap-3-ketone; and methanesulfonyl chloride: 2— (4-methyl Sulfonamido) -6- (3-methoxy-4-difluoromethoxyphenyl) -5-ethyl-2,3,4,5—Four paper standards are applicable to Chinese national standards ( CNS) A4 specification (210X297mm) _ 58-475927 A7 B7 V. Invention theory (56) A gas tower coaxes a 3-ketone; and propanyl chloride: 2- (4-propanamidobenzyl) -6- (3-methoxy-4 difluoromethoxyphenyl) -5 —Ethyl-2,3,4,5—Four gas tower traps—3-Ketone; and Butanyl chloride: 2- (4-Butylaminomethyl) —6— (3-Methoxy—4— Difluoromethoxyphenyl)-5 -ethyl-2,3,4,5 -tetrahydrooranium trap-3 -ketone; and isobutylphosphonium chloride: 2-(4-isobutylamidoaminobenzyl ) A 6- (3-methoxy-4 difluoromethoxyphenyl) a 5-ethyl-2,3,4,5-tetrahydro-trap-a 3-ketone; and methyl chloroformate: 2- (4-methoxymethoxyaminomethyl) -6- (3-methoxy-4-difluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower Well one 3-ketone; printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) and Tetrazine Chloride: 2-(4-Tetrazolamine-based Book Base)-6 — (3-methoxy-4-difluoromethoxyphenyl)-5-ethyl-2,3,4,5 — Hydrogen trap—3-ketone; and cyclopentanecarbamyl chloride: 2— (4-cyclopentylcarbamidine 1-yl) —6 -— (3-methoxy—4—difluoromethoxyphenyl) — 5-Ethyl-2,3,4,5 This paper is again applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) _ 59-475927 A7 B7 V. Description of the invention (57) A tetrahydrotrap trap 3 —Ketone; and ethyl chloroformate: 2- (4-ethoxymineamino narrow group) —6- (3-methoxy-4—difluoromethoxyphenyl) and 5-ethyl-2, 3,4,5 — Tetrahydro trap_3_ ketone; and chlorfenone chloride: 2— (4- oxametaminobenzyl) —6— (3-methoxy-4—difluoromethoxy Phenyl) -Ethyl-5,2,3,4,5-Four gas tower traps 3-ketones; and chloroformyl chloride: 2- (4-adenosyl) -6- (3-methoxy 4- (4-difluoromethoxyphenyl)-(5-ethyl-2,3,4,5-tetrahydro-3) -ketone; and pentamidine chloride: 2- (4-pentamylamino) A) 6- (3-methoxy-4-dimethoxymethoxyphenyl) -5-ethyl-2,3,4,5-tetraaza Tower trap —3 — Ketone; Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and hexamethylene chloride: 2 — (4 —Hexamine amino group) — 6 — (3-methoxy-4, 2-dimethoxymethoxyphenyl) 5-ethyl-2,3,4,5-tetraaza- trap-3 -one; and pentafluoropropanyl chloride: 2- ( 4-Pentafluoropropanamidofluorenyl) -6- (3-methoxy-4 difluorofluorophenyl) 5-ethyl-2,3,4,5 — This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ go _475927 A7 B7 V. Description of the invention (58) Four gas towers coax a 3-ketone. In a similar manner, by making 2- (4-aminoamino) _6_ (3-methoxy-4_trifluoromethoxyphenyl)-5-ethyl_2, 3, 4, 5 —Tetrahydro-Trap — 3-ketone reacts with the following reactants to obtain the following products (ie, expressed as a reactant ':% product'); and acetamidine chloride: 2_ (4_ethyl Fluorenylbenzyl) -6- (3-methoxy-4-trifluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower trap-3 -one; and Trifluoroacetamyl chloride: 2- (4-trifluoroacetamidobenzyl) -6- (3-methoxy-4-4-trifluoromethoxyphenyl) -5_ethyl_2,3,4 , 5 — Tetrahydro tower coaxing a 3-ketone; and mesosulfuron chloride: printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) Narrow group) a 6- (3-methoxy_4-trifluoromethoxyphenyl) a 5-ethyl-2,3,4,5-tetrahydro trap-3 ketone; and propyl hydrazone Chlorine: 2- (4-propanamidobenzyl) -6- (3-methoxy-4, trifluoromethoxyphenyl) 5 —Ethyl-2,3,4,5 —Tetrahydrotraptra 3 —one; _ i__ This paper size applies to Chinese national standard (〇 奶) person 4 specifications (210 '乂 297 mm) _61_ 475927 A7 B7 V. Description of the invention (59) and Butanyl chloride: 2-(4-Butanylaminofluorenyl)-6-(3-methoxy-4-trifluoromethoxyphenyl)-5-ethyl- 2,3,4,5-tetrahydrothalada-3 ketone; and isobutylphosphonium chloride: 2- (4-isobutylamidobenzyl) -6- (3-methoxy-4 4-trifluoro Methoxyphenyl)-5 -ethyl-2,3,4,5-4-gas tower traps 3-ketones; and methyl chloroformate: 2-(4-methoxymethoxyaminomethyl)- 6_ (3-methoxy-4-4-dimethoxymethoxyphenyl)-5-ethyl-2,3,4,5_tetrahydro tower trap-3_one; and pivalamyl chloride: 2-(4 —Pentamidine group — 6 — (3-methoxy-4_trifluoromethoxyphenyl) — 5-ethyl-2, 3, 4, 5 — tetrahydrotrap — 3 — Ketones; and Cyclopentane Carbochloride: Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the note on the back first) Please fill in this page for the matters needing attention) 2— (4-Cyclopentylcarbamobenzyl) —6— (3-Methoxy-4—Trifluoromethoxyphenyl) —5—Ethyl-2,3, 4,5 -tetrakidone co-a 3-ketone; and ethyl chloroformate: 2-(4-ethoxyoxyamino narrow group)-6- (3-methoxy-4 -trifluoromethoxy Phenyl)-5 -ethyl-2,3,4,5-tetrahydro-trap trap 3 -one; This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _-475927 A7 B7 Description of the invention (60) and chlorantrol chloride: 2-(4-monomethoxamidinyl)-6-(3-methoxy-4-trifluoromethoxyphenyl)-5-ethyl-2 , 3,4,5-tetrahydrofluorene trap 3-ketone; and chloroformyl chloride: 2- (4-adenylyl) -6- (3-methoxy-4 difluoromethoxy Phenyl) -Ethyl-5,2-, 3,4,5-tetrahydrothalkan-3; one; and pentamidine chloride: 2- (4-pentamidoaminomethyl) -6- (3-methoxy-1 4-trifluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro tower co-a 3-ketone; and Ammonium chloride: 2- (4-hexamethyleneaminobenzyl) -6- (3-methoxy-4-4-trifluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro Tower coercion 3-keto; and pentafluoropropylchloride: Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 2 — (4 —pentafluoropropylamidobenzyl ) —6 -— (3-methoxy-4-trifluoromethoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap- 3-ketone. In a similar manner, by making 2- (4-aminoaminobenzyl) -6- (3-ethoxy-4-methoxyphenyl) -2,3,4,5-tetrahydro- 3 —Ketone, m · ρ · 12 0 ° reacts with the following reactants The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -63-475927 A7 B7 5. Description of the invention (61), In order to obtain the following product (that is, expressed as | Reactant #: 1 产品 #); and acetamidine chloride: 2-(4-ethylamidoamino narrow group)-6-(3-ethoxy_ 4-methoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone, m.p. 1 70 °; and trifluoroacetamidine: 2- (4-trifluoroethyl Fluorenylamino) -6- (3-ethoxy-4-methoxyphenyl) -2,3,4,5-tetraazaphosphonium co-a 3-ketone; and mesylsulfonyl chloride: 2 — (4-Methanesulfonamidobenzyl) —6— (3-Ethoxy-4—methoxyphenyl) —2,3,4,5—tetrazolium towers—3— 嗣 9 and propyl醯 Chlorine: Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back first) (Fill in this page again) 2 — (4-Propanamido) — 6 — (3-Ethoxy-4 —methoxyphenyl) — 2, 3, 4, 5 — Tetrahydrotrap — 3 —Ketone; and Butanyl chloride: 2- (4-Butanamidofluorenyl) —6- (3-ethoxy-4—methoxyphenyl) —2 ′ 3 ′ 4 ^ 5 —tetrazolium tower Co-a 3-keto 1; and isobutylphosphonium chloride: 2- (4-isobutylamidoaminofluorenyl) -6- (3-ethoxy-4-methoxyphenyl) -2,3,4 , 5 —Tetrahydro trap—3—Ketone The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) _ _ 475927 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (62 ), And methyl chloroformate: 2-(4-methoxymethoxyamino narrow group)-6-(3-ethoxy-4 -methoxyphenyl)-2, 3, 4, 5-tetra Hydrogen traps 3-ketones; and pentamidine chloride: 2- (4-pentamidine amino narrow group) -6- (3-ethoxy-4-methoxyphenyl) -2,3,4 , 5-tetrahydro-trap-a 3-ketone 9 and cyclopentanecarbamyl chloride: 2- (4-cyclopentylcarbamidine ) A 6- (3-ethoxy-4 4-methoxyphenyl) -2,3,4,5-tetrakidone-coated _3 monoketone; and ethyl chloroformate: 2-(4-ethyl Oxoylaminomethyl) -6- (3-ethoxy-4-methoxyphenyl) -2,3,4,5-tetragas towers co-a 3-ketone, m · ρ · 1 2 8 0; with chloroform: 2 -— (4-monomethoxenyl) —6- (3-ethoxy-4—methoxyphenyl) —2, 3, 4, 5—tetra Hydrogen trap 3-ketone 9 and chloroformyl chloride: 2-(4-ureidofluorenyl) 6-(3-ethoxy-4 -methoxyphenyl) _2,3,4,5- Tetrahydro trap-3_one; This paper size is applicable to China National Standard (CNS) A4 (210X297mm) _ 65 _ (Please read the precautions on the back before filling this page) 475927 A7 ^ __ E_ — V. Invention Explanation (63) and pentamidine chloride: 2- (4-pentamylaminofluorenyl) -6- (3-ethoxy-4 ~ methoxymethoxyphenyl) -2,3,4,5-tetrahydro Coaxing a 3-ketone; and hexamethylene chloride: 2- (4-hexamethyleneaminobenzyl) -6- (3-ethoxy -4-Methoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; and pentafluoropropanyl chloride: 2- (4-pentafluoropropylamidobenzyl) -6 — (3-Ethoxy-4—methoxymethoxyphenyl) —2,3,4,5—tetrahydro 11 hydrazone—3—one 0 In a similar manner, by making 2- (4-amino Fluorenyl)-6-(3-cyclopentyloxy-4-methoxyphenyl)-2 '3' 4, 5-tetrahydrodatrap-3-ketone reacted with the following reactants to obtain the following The product described above (ie, expressed as% reactant 〃: a 产品 #); and ethyl chloride: printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 2 — (4-Ethylaminomethyl) -6- (3-Cyclopentyloxy-4-methoxymethoxyphenyl) -2,3,4,5-tetrahydro-trapping well 3-ketone, and trifluoro Acetyl chloride: 2- (4-trifluoroacetamidobenzyl) -6- (3-cyclopentyloxy-4 monomethoxyphenyl) -2,3,4,5-tetrahydrodatra One 3-ketone; This paper size applies to China National Standard (CNS) A4 specification (210X2 97mm) _ _ Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 475927 A7 B7 V. Description of the invention (64) and methanesulfonyl chloride: 2 — (4 —methanesulfonyl benzyl) — 6 — (3 _Cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrahydrot trap-3-ketone; and propionyl chloride: 2- (4-propionylaminomethyl)- 6-(3-Cyclopentyloxy-4-methoxyphenyl)-2,3,4,5-tetrahydro-trap-a 3-ketone and 2,2-dimethylpropanyl chloride: 2-( 4-tert-butylcarbonylaminofluorenyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; and butyl Fluorine: 2- (4-butamidinomethyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone With isobutylphosphonium chloride: 2- (4-isobutylamidinylbenzyl) -6- (3-cyclopentyloxy-4 4-methoxyphenyl) -2,3,4,5-tetraaza tower Coax a 3-ketone; and methyl chloroformate: 2- (4-methoxymethoxyaminomethyl) -6- (3-cyclopentyloxy-4-methyl Phenyl) -2,3,4,5-tetrahydro-trap-3-ketone; This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ _. .......- i— 11-m. —1 111-I ——- ϋ (Please read the notes on the back before filling out this page) Order 475927 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (65) and Pentamidine Chloride: 2- (4-Pentamidine amino narrow group) -6- (3-Cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrazolium A 3-ketone; and cyclopentanecarbamyl chloride: 2- (4-cyclopentylaminomethylformyl)-6- (3-cyclopentyloxy-4 4-methoxyphenyl) -2,3 , 4, 5-tetrazolium tower coaxes a 3-ketone; with ethyl chloroformate: 2- (4-ethoxyminylamino)-6- (3-cyclopentyloxy-4-methoxybenzene A) 2, 3, 4, 5 —tetrazine coaxing a 3 -keto; and chloroform chloride: 2 — (4-amethoxamine benzyl) — 6 — (3-cyclopentyloxy — 4-monomethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone; and chlorine Formamidine chloride: 2-(4-ureidofluorenyl)-6-(3-cyclopentyloxy-4-methoxyphenyl)-2 ^ 3,4,5-tetrazolium tower coke 3-Li ; With pentamidine chloride: 2- (4-pentamylaminobenzyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrahydro-trap- 3 —Ketone and hexamethylene chloride: This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) _Ming-I. I —T · ―--* 1 -— -—-- (Please read first Note on the back, please fill in this page again), tr 475927 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (66) 2 — (4 —Hexamine base group) — 6 — (3 — Ring Amyloxy-4 -methoxyphenyl) -2,3,4,5-tetrahydrotrap -3-ketoline and pentafluoropropanyl chloride: 2-(4-pentafluoropropanamido narrow group ) -6- (3-Cyclopentyloxy-4-methoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone. In a similar manner, by letting 2_ (4-aminophenethyl) _6_ (3'4-dimethoxyphenyl)-2'3'4'5-tetra-portal trap trap 3-one with The following reactants are reacted to obtain the following products (ie, expressed as a reactant ':% product'); and acetamidine chloride: 2-(4-ethylaminoaminophenethyl)-6 — (3,4-dimethoxyphenyl) —2,3,4,5—tetrazolium coke—3—fluorene; and trifluoroacetamido chloride: 2— (4-trifluoroacetamidoaminobenzene) (Ethyl)-6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap- 3-ketone; and mesylsulfonium chloride: 2- (4-methaneamine Phenylethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro tower trap-3-one; and propionyl chloride: 2- (4-propanol Amine Phenethyl) _6_ (3 '4 — One paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) _ 69 _ (Please read the precautions on the back before filling out this page) • — ^ Binding and printing printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 475927 A7 B7 V. Inventions Ming (67) oxyphenyl) _2,3,4,5-tetrahydropyridine trap 3-ketone; and butanyl chloride: 2- (4-butyridinoaminophenethyl) -6- (3, 4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone; and isobutylphosphonium chloride: 2- (4-isobutylphosphoniumaminophenethyl)-6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone; and methyl chloroformate: 2- (4-methoxycarbonylaminophenethyl) A 6- (3 ^ 4-dimethoxyphenyl) _2,3,4,5-tetragas tower to coax a 3-ketone; and pivaloyl chloride: 2_ (4-pivaloaminophenylphenethyl) ) A 6- (3,4-dimethoxyphenyl) -2,3,4,5-tetraazapyrene 1-3-ketone; and cyclopentanecarbamyl chloride: 2- (4_cyclo Amylaminotolylethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone; and ethyl chloroformate: 2- (4 Monoethoxycarbonylaminophenethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; Chlorine: 2- (4-metapyridinophenethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; and Chloroform chloride: 2 — (4 —ureidophenethyl) — 6 — (3,4—dimethoxy —-— This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) _ — -· 1, !! --- ivtn ..... I--H (Please read the notes on the back before filling out this page) Order 475927 Printed by the Consumer Standards Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Explanation (68) Phenyl) -2,3,4,5-tetrahydrodatrapeptone 3-ketone; and pentamidine chloride: 2- (4-pentamidoaminophenethyl) -6- (3,4 _Dimethoxyphenyl)-2 ′ 3,4,5- four-gas tower coaxes a 3-ketone; and hexamethylene chloride: 2— (4-hexamethyleneaminophenethyl) -6— (3,4 A dimethoxyphenyl group) a 2,3,4,5-tetrazolium tower to cope with a 3-fluorene; and pentafluoropropanyl chloride: 2-(4 pentafluorobiamidoaminophenethyl) a 6 — (3,4-dimethoxyphenyl) _2,3,4,5-tetrahydrofluorene coaxes a 3-ketone. In a similar manner, by letting (3-aminomethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydrodatrapeptide-3 The reactants mentioned above are reacted to obtain the following products (ie, expressed as% reactants ::% products "); and acetamidine chloride: 2-(3-ammonylaminophenethyl)-6 — (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-trione, m.p. 1 0 5 °; and trifluoroacetamidine: 2— ( 3-difluoroacetamidomethyl) -6- (3'4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap well 3-ketone m.p. 13 6 ° ; This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ -I---I- · 1 -II ϋ (Please read the precautions on the back before filling this page) Order 475927 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards A7 B7 V. Description of the Invention (69) and Methanesulfonate Chlorine: 2-(3-Methanesulfonylpyridyl)-6-(3,4_dimethoxyphenyl) ) A 2,3,4,5-four air tower coaxes a 3-ketone, m.p. 1 7 7 °; With propionyl chloride: 2_ (3-Hamidinaminyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrazolium tower to cope with 3-3-fluorene; m p. 1520; with dimethylpropanyl chloride: 2- (3-tert-butylcarbonylaminobenzyl) -6- (3,4-dimethoxyphenyl) -2,3, 4,5-tetrahydro-trap- 3-ketone; with butyl chloride: 2- (3-butyridinoaminobenzyl)-6- (3,4-dimethoxyphenyl)-2, 3, 4, 5 —tetrahydro-trap — 3 — ketone; and isobutyryl chloride: 2 — (3-isobutyrylamino) — 6 — (3,4-dimethoxyphenyl) — 2, 3,4,5-tetrahydropyrene-3 ketone; and methyl chloroformate: 2- (3-methoxymethoxyaminomethyl) -6- (3,4-dimethoxyphenyl) A 2,3,4,5-tetrahydrothrapy-3 ketone; and pentamidine chloride: 2- (3-pentamidineaminofluorenyl) -6- (3,4-dimethoxybenzene Base) -2,3,4,5 -tetrahydro trap -3 -one; and cyclopentane carbochloride: This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ _ ( (Please read the notes on the back before filling this page) 475927 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Description (70) 2 — (3 —Cyclopentyl Aminomethyl Narrow Base) — 6 — (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro trap-one 3-ketone; and ethyl chloroformate: 2- (3-ethoxyamidoamino) A 6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trap-3-ketone; m.p. 1 7 9 °; and chloroform:- (3-Methosamine amino narrow group)-6- (3,4-dimethoxyphenyl) -2,3,4,5-tetraazepine to coax a 3-payer; and chloroformyl chloride : 2- (3-ureidobenzyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetraaza-tower to coke 3-3-fluorene; and pentamidine chloride: 2 — (3 —pentylaminomethyl) — 6 — (3 ′ 4-dimethoxyphenyl) — 2,3,4,5 —tetrazol tower coaxing a 3 —one 1; and hexamethylene chloride: 2- (3-Hexamidineaminobenzyl)-6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydroda-well 3-ketone; and pentafluoropropanyl chloride: 2- (3-pentafluoropropanylaminomethyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrakis Hydrogen trap-3-ketone. In a similar way, by making 2- (3-aminoamino) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3 this paper size applies China National Standard (CNS) A4 specification (210X297 mm) _ 73 _ (Please read the precautions on the back before filling this page) 475927 A7 B7 V. Description of the invention (71), 4, 5-Tetrahydrotrap trap 1-3 —The ketone reacts with the following reactants to obtain the following products (ie, expressed as ~ reactants': | product #); and acetamidine chloride: 2- (3-acetamidinebenzyl) A 6- (3-cyclopentyloxy-4 4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-trap —3-one; and trifluoroacetamyl chloride: 2_ ( 3-trifluoroacetamidomethyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydrotrap-3 -Ketone, τώ.ρ · 70 °; and mesylsulfonium chloride: 2- (3-methanesulfenylbenzyl) -6— (3-cyclopentyloxy-4—methoxyphenyl) -5 —Ethyl-2,3,4,5-tetrachlorodatra-3-one; and propanyl chloride: Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Education (please read the precautions on the back before filling out this page) 2-(3 -Propanylbenzyl)-6-(3-Cyclopentyloxy-4 -Methoxy Phenyl)-5-ethyl-2,3,4,5-tetrahydro tower trap 3-ketone, mp113. ; With 2,2-dimethylpropanyl chloride: 2- (3-tert-butylaminoamino)-6- (3-cyclopentyloxy-4-methoxyphenyl) -5_ethyl 1,2,3,4,5 — Tetrahydro tower coaxing a 3-ketone; This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ 475927 A7 B7 V. Description of the invention (72) and Ding Yi Chlorine: 2- (3-butanamido-narrow) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrazolium Cake-3 ketone; and isobutylphosphonium chloride: 2- (3-isobutylamidinosyl) -6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2 , 3,4 '5-tetraazawell-a 3-ketone; and methyl chloroformate: 2- (3-methoxycarbonylaminobenzyl) -6- (3-cyclopentyloxy-4 4-methoxy Phenyl)-5 -ethyl-2,3 '4' 5 -tetrahydrophilic _ 3-ketone; and pentamidine chloride: 2-(3-pentamidine aminomethyl)-6-(3 —Cyclopentyloxy—4-methoxyphenyl) —5—ethyl—2,3,4,5-tetraaza tower trap—3-ketone; With cyclopentane carbochloride: printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) 2 — (3 —cyclopentylcarbamoyl) — 6 — (3 —Cyclopentyloxy-4 monomethoxyphenyl) —5—ethyl—2,3 ′ 4 ′ 5—tetrahydro tower to cope with 3—one; and ethyl chloroformate: 2— (3-ethoxycarbonyl Aminofluorenyl) _6- (3-cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro trap-3, one ketone, mp153 °; This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 75 475927 A7 B7 V. Description of the invention (73) and formachlor chloride: 2_ (3-formazone amino narrow base)-6- (3-Cyclopentyloxy-4-methoxyphenyl) -5-ethyl-2,3,4,5-tetrahydro-3-well; and chloroformyl chloride: 2_ (3_urea Amidino) -6- (3-cyclopentyloxy-4-methoxymethoxy) -5-ethyl-2,3,4,5-tetraazapyridine, and 3-pentanone; and pentamidine Chlorine: 2- (3-pentamylaminomethyl) -6- (3-cyclopentyloxy-1 4 —Methoxyphenyl) —5—ethyl—2,3,4,5—tetrahydropyridine—3—one; and hexamethylene chloride: 2— (3-hexamidineamino narrow group) — (3 —Cyclopentyloxy—4-monomethoxyphenyl) —5-ethyl-2,3,4,5-tetrahydro tower trap—3-ketone; and pentafluoropropanyl chloride: Employees of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Consumer Cooperative (please read the precautions on the back before filling out this page) 2— (3-Pentafluoropropanamido narrow group) —6— (3-Cyclopentyloxy-4—methoxyphenyl) One 5-ethyl-2,3,4,5-tetrahydro 11 fluorene trap 3-ketone. Example 7 A solution of 2.4 g of 3- (3,4-dimethoxybenzoate) propionic acid dissolved in 10 Om of glacial acetic acid and 1.7 g of p-nitrobenzyl basic paper was used in China. Standard (CNS) A4 specification (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 475927 A7 ____B7 V. Description of the invention (74) Hydrazine reaction, and stirred at 100 ° C for 2 hours. The solvent was removed and the residue was treated in a manner that resulted in 2- (4-nitrobenzyl) -6 ~ (3'4-dimethoxyphenyl) -2,3,4,5-tetrakiπ Answering a 3-ketone, π · ρ · 1260 〇 In a similar way, the following compounds were obtained, which are 3- (3, 4 ~ dimethoxyformyl) propionic acid and 4-mononitrophenylhydrazine Reaction: 2- (4-nitrophenyl) -6- (3,4-dimethoxyphenyl) -2,3,4,5-tetrahydro-trapable 3-ketone. The following examples are related to pharmaceutical formulations: Example A: A solution of 100 g of the active compound of formula I and 5 g of disodium hydrogen phosphate in an injection bottle is placed in 3 times of distilled water, using 2 N Hydrochloric acid adjusted its pH to 6.5, and then filled it into an injection bottle through aseptic filtration, freeze-dried it under aseptic conditions, and sealed it aseptically. Each injection bottle contains 5 til g of active compound. Example B: A suppository is fused with 20 g of the active compound of formula I into 100 g of soybean lecithin and 1 400 g of cocoa fat. The resulting mixture is poured into a mold and left to stand. cool down. Each suppository contains 20 mg of active compound. This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) _ 77 / _ ----.------ • installed-(Please read the precautions on the back before filling this page) Order 475927 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7_V. Description of the Invention (75) Example C: The solution will be lg of the active compound of formula I, 9 · 38 g of N a Η 2 P 0 4 · 2 Η 2 0, 2 8.48 g of Na2HP04 • 12H20 and 0.1 g of ammonium chlorobenzyl ammonium were dissolved in 9 4 Omj? Of double distilled water. The pH of the resulting mixed solution was adjusted to 6.8 and sterilized by radiation to prepare a solution. This solution can be used as eye drops. Example D: Ointment In a sterile state, 500 mg of the active compound of formula I was mixed with 99.5 g of petrolatum. Example E: A tablet containing a mixture of 1 kg of the active compound of formula I, 4 kg of lactose, 1.2 kg of potato starch, 0.2 kg of talc and 0 1.1 kg of magnesium stearate is compressed in a conventional manner. In order to produce tablets, each tablet contains 10mg of active compound. Example F: Coated tablets In a manner similar to Example E, compressed into tablets, and then coated with a layer of sucrose, potato starch, talc, tragacanth and coloring agent in a conventional manner. 0 Example G: Capsule paper size Applicable to China National Standard (CNS) A4 specification (210X297 mm) _ ^ _ (Please read the precautions on the back before filling out this page) 475927 A7 B7__ V. Description of the invention (76) Use 2 kg of the active compound of formula I as usual The method is' filled in hard gelatin capsules so that each capsule contains 20 mg of active compound. Example IX: 1 kg of the active compound of formula I solvent 60 and secondary distilled water in an ampoule, the resulting solution was sterile diluted, filled into an ampoule, freeze-dried in a sterile state, and then sterile seal. Each ampoule contains 10 mg of active compound. ----------------- Equipment ------ Order ------ (Please read the notes on the back before filling this page) Employees of the Central Standards Bureau of the Ministry of Economic Affairs The paper size printed by the consumer cooperative is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) _ 79-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19514568A DE19514568A1 (en) | 1995-04-20 | 1995-04-20 | Arylalkyl pyridazinones |
Publications (1)
Publication Number | Publication Date |
---|---|
TW475927B true TW475927B (en) | 2002-02-11 |
Family
ID=7759974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW085102257A TW475927B (en) | 1995-04-20 | 1996-02-27 | Arylalkyl-pyridazinone |
Country Status (21)
Country | Link |
---|---|
US (2) | US6399611B1 (en) |
EP (1) | EP0738715B1 (en) |
JP (1) | JP4005157B2 (en) |
KR (1) | KR100428879B1 (en) |
CN (1) | CN1159299C (en) |
AT (1) | ATE231842T1 (en) |
AU (1) | AU705025B2 (en) |
CA (1) | CA2174472C (en) |
CZ (1) | CZ291868B6 (en) |
DE (2) | DE19514568A1 (en) |
DK (1) | DK0738715T3 (en) |
ES (1) | ES2191070T3 (en) |
HU (1) | HU226198B1 (en) |
NO (1) | NO307931B1 (en) |
PT (1) | PT738715E (en) |
RU (1) | RU2159236C2 (en) |
SI (1) | SI0738715T1 (en) |
SK (1) | SK284167B6 (en) |
TW (1) | TW475927B (en) |
UA (1) | UA43853C2 (en) |
ZA (1) | ZA963154B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19533975A1 (en) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Arylalkyl diazinones |
JP4017214B2 (en) * | 1996-06-11 | 2007-12-05 | 興和創薬株式会社 | 5-Phenyl-3-pyridazinone derivatives |
CA2264685C (en) * | 1996-08-27 | 2002-10-15 | Kyoji Noda | 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same |
DE19850701A1 (en) | 1998-11-04 | 2000-05-11 | Merck Patent Gmbh | Benzoyl pyridazines |
DE60043318D1 (en) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistic combination of pumafentrine and salmeterol |
DE10064997A1 (en) * | 2000-12-23 | 2002-06-27 | Merck Patent Gmbh | New 1-benzoyl-3-phenyl-tetrahydropyridazine derivatives, useful for treating e.g. allergy, are selective inhibitors of phosphodiesterase IV, and new intermediates |
KR20040012720A (en) * | 2001-02-12 | 2004-02-11 | 메르크 파텐트 게엠베하 | Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
US20040146561A1 (en) * | 2001-05-23 | 2004-07-29 | Naoki Sakurai | Compositions for promoting healing of bone fracture |
CN1537018A (en) * | 2001-05-23 | 2004-10-13 | 田边制药株式会社 | Therapeutic compositions for repairing chondropathy |
DE10150517A1 (en) * | 2001-10-12 | 2003-04-17 | Merck Patent Gmbh | Medicaments containing pyridazinone, thiadiazinone or oxadiazinone derivatives, used e.g. for treatment of osteoporosis, tumors, atherosclerosis, rheumatoid arthritis or multiple sclerosis |
SK1862004A3 (en) * | 2001-10-31 | 2004-08-03 | Type 4 phosphodiesterase inhibitors and uses thereof | |
US7074959B2 (en) * | 2002-08-01 | 2006-07-11 | New Mexico Highlands University | Methods and systems for remediating hydrazine-contaminated equipment and/or surfaces |
KR20050115331A (en) | 2003-04-01 | 2005-12-07 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | Inhibitors of phosphodiesterases in infertility |
EP1716123A1 (en) * | 2004-02-04 | 2006-11-02 | Altana Pharma AG | Pyridazinone derivatives and their use as pde4 inhibitors |
JP4778449B2 (en) * | 2004-02-04 | 2011-09-21 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 2- (Piperidin-4-yl) -4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors |
WO2008072784A1 (en) * | 2006-12-14 | 2008-06-19 | Astellas Pharma Inc. | Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
US8466198B2 (en) * | 2008-09-02 | 2013-06-18 | Bruce Kneller | Compositions comprising creatine salts and methods of use thereof |
ES2567779T3 (en) * | 2009-08-26 | 2016-04-26 | Jeffrey M. Golini | Pharmaceutical or nutraceutical composition |
MX2018011216A (en) | 2016-03-16 | 2019-08-29 | H Lee Moffitt Cancer Ct & Res | Small molecules against cereblon to enhance effector t cell function. |
KR20210032430A (en) | 2018-07-11 | 2021-03-24 | 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 | Dimeric immune-modulating compounds for cerebloon-based mechanisms |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1604863A (en) * | 1967-11-22 | 1972-04-17 | ||
US3975388A (en) * | 1971-02-22 | 1976-08-17 | Bdh Pharmaceuticals Limited | Pyridazinones |
DE2845456A1 (en) * | 1978-10-19 | 1980-08-14 | Merck Patent Gmbh | 6-ARYLPYRIDAZIN-3-ONE AND METHOD FOR THE PRODUCTION THEREOF |
US4397854A (en) * | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
US4734415A (en) * | 1982-08-13 | 1988-03-29 | Warner-Lambert Company | Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones |
PT78566B (en) * | 1983-05-11 | 1986-07-17 | Byk Gulden Lomberg Chem Fab | PYRIDAZINONE THEIR PREPARATION AND USE OF PYRIDAZINONE-CONTAINING MEDICINAL PRODUCTS |
US4666902A (en) | 1983-06-20 | 1987-05-19 | Cassella Aktiengesellschaft | Tetrahydropyridazinone derivatives, processes for their preparation and their use |
US4816454A (en) * | 1984-09-21 | 1989-03-28 | Cassella Aktiengesellschaft | 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use |
JPS61158969A (en) * | 1984-12-24 | 1986-07-18 | ワーナー‐ランバート・コンパニー | 4,5-dihydro-4,4-dialkyl-6-(substituted)phenyl-3(2h)- pyridadinones |
DE3704879A1 (en) * | 1987-02-17 | 1988-08-25 | Merck Patent Gmbh | PYRIDAZINE DERIVATIVES |
GB8903130D0 (en) | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
PT94954A (en) * | 1989-08-10 | 1991-04-18 | Glaxo Inc., | PROCESS FOR THE PREPARATION OF PYRIDAZINONE DERIVATIVES |
DE4237656A1 (en) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | benzimidazole derivatives |
JP2806192B2 (en) * | 1992-11-02 | 1998-09-30 | 日本曹達株式会社 | Platelet aggregation inhibitor |
DE19502699A1 (en) | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinones |
-
1995
- 1995-04-20 DE DE19514568A patent/DE19514568A1/en not_active Withdrawn
-
1996
- 1996-02-27 TW TW085102257A patent/TW475927B/en not_active IP Right Cessation
- 1996-04-11 AT AT96105702T patent/ATE231842T1/en active
- 1996-04-11 DK DK96105702T patent/DK0738715T3/en active
- 1996-04-11 DE DE59610081T patent/DE59610081D1/en not_active Expired - Lifetime
- 1996-04-11 PT PT96105702T patent/PT738715E/en unknown
- 1996-04-11 SI SI9630593T patent/SI0738715T1/en unknown
- 1996-04-11 EP EP96105702A patent/EP0738715B1/en not_active Expired - Lifetime
- 1996-04-11 ES ES96105702T patent/ES2191070T3/en not_active Expired - Lifetime
- 1996-04-16 AU AU50711/96A patent/AU705025B2/en not_active Ceased
- 1996-04-17 SK SK487-96A patent/SK284167B6/en unknown
- 1996-04-18 CN CNB961051086A patent/CN1159299C/en not_active Expired - Fee Related
- 1996-04-18 CA CA002174472A patent/CA2174472C/en not_active Expired - Fee Related
- 1996-04-19 HU HU9601034A patent/HU226198B1/en not_active IP Right Cessation
- 1996-04-19 JP JP12078096A patent/JP4005157B2/en not_active Expired - Fee Related
- 1996-04-19 RU RU96107677/04A patent/RU2159236C2/en not_active IP Right Cessation
- 1996-04-19 ZA ZA963154A patent/ZA963154B/en unknown
- 1996-04-19 CZ CZ19961132A patent/CZ291868B6/en not_active IP Right Cessation
- 1996-04-19 UA UA96041565A patent/UA43853C2/en unknown
- 1996-04-19 US US08/634,830 patent/US6399611B1/en not_active Expired - Fee Related
- 1996-04-19 KR KR1019960011859A patent/KR100428879B1/en not_active IP Right Cessation
- 1996-04-19 NO NO961578A patent/NO307931B1/en not_active IP Right Cessation
-
2002
- 2002-04-08 US US10/117,217 patent/US6531473B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW475927B (en) | Arylalkyl-pyridazinone | |
RU2695133C1 (en) | Oxadiazolamine derivatives as histone deacetylase 6 inhibitor and pharmaceutical composition containing them | |
TW411332B (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them | |
KR100747401B1 (en) | Phenyl or Pyridyl Amide Compounds as Prostaglandin E2 Antagonists | |
TWI344955B (en) | Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient | |
AU2010307006B2 (en) | Hematopoietic growth factor mimetic small molecule compounds and their uses | |
ES2712803T3 (en) | Histone deacetylase inhibitors | |
AU750019B2 (en) | Aryl alkanoylpyridazines | |
TW201125854A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
TW201043603A (en) | Substituted phenylureas and phenylamides as vanilloid receptor ligands | |
TW200403210A (en) | Benzamide derivatives | |
TW200307539A (en) | Cycloalkyl inhibitors of potassium channel function | |
WO2004020393A1 (en) | Dibenzylamine compound and medicinal use thereof | |
TW200824687A (en) | Compounds that inhibit TRPV1 and uses thereof | |
TW200815431A (en) | Azabenzimidazolyl compounds | |
HUT71593A (en) | Diketopiperazines, pharmaceutical compositions containing and process for producing the compounds | |
TW200536838A (en) | Oxazole derivatives, preparation thereof and use thereof in therapeutics | |
JP2008525419A (en) | Non-nucleoside inhibitors of HIV-1 reverse transcriptase | |
MXPA06014025A (en) | Substituted triazole derivatives as oxytocin antagonists. | |
CZ257892A3 (en) | Derivative of 1,4-benzodioxan, process of its preparation and a pharmaceutical preparation in which said derivative is comprised | |
TW200836739A (en) | Substituted 2, 5-dihydro-3H-pyrazolo[4, 3-c] pyridazin-3-one derivatives, preparation thereof and therapeutic use thereof | |
TW201006804A (en) | Triazole derivative or salt thereof | |
CA2194481A1 (en) | 2-ureido-benzamide derivatives | |
JP2007505888A (en) | Substituted triazole derivatives as oxytocin antagonists | |
KR20050119195A (en) | Pyrazole compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |